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HDR Prostate Brachytherapy
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University of Wollongong
ABSTRACT
High dose rate (HDR) brachytherapy is the preferred treatment option for clinically
localised prostate cancer. The underlying principle is simple: temporarily inserting a
highly radioactive source inside the target volume and moving it through a sequence of
predefined positions for pre-calculated dwell times. HDR brachytherapy is capable of
achieving a highly conformal dose distribution which cannot be matched by external
beam radiation therapy.
The success of HDR prostate brachytherapy treatment is highly dependent on the
accuracy of source placement within the prostate volume. In addition, ensuring min-
imum deviation from the planned source positions relative to the prostate minimises
the occurrence and severity of radiation toxicity in nearby organs such as the rectum,
urethra and bladder.
Several factors can result in an incorrect dose distribution, such as anatomical
changes between the time of planning and surgery, human error in measuring and
entering data to the afterloader system and changes in catheter location during the
treatment or between fractions. Therefore, a quality assurance method which can
perform accurate real-time source tracking will greatly assist in providing better target
coverage with reduced acute and secondary side effects.
In this Thesis, HDR BrachyView , a novel intra-fraction source position monitor-
ing system for quality assurance in HDR prostate brachytherapy, is presented. HDR
BrachyView is an in-body (trans-rectal) imaging system which is capable of inde-
pendently tracking the source position within the target volume in real time during
the source delivery operation. It consists of a multi-pinhole tungsten collimator which
projects images of the source onto an array of high resolution pixelated silicon detectors
(Timepix). The source position within the treatment volume is calculated by back-
projecting the centres of mass of the recorded projections through the corresponding
pinholes.
The design of HDR BrachyView is presented, followed by extensive validation
and characterisation via detailed Monte Carlo simulations. Preliminary experimen-
tal results from a prototype of HDR BrachyView confirm that the device is capable
of monitoring the source position with sub-millimetre accuracy within a sub-second
acquisition time.
KEYWORDS: Prostate Cancer, HDR brachytherapy, Quality Assurance
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Chapter 1
Introduction
The discovery of ionising radiation and its toxicity to cells has inspired the development
of radiation therapy as an alternative or complementary method to surgical interven-
tions in the treatment of cancer. It avoids incision or resection of the diseased organ,
and due to its penetrative nature provides a mechanism for reaching deep-seated tu-
mours. However, radiation deposits energy along its path which also damages healthy
tissue and may lead to serious complications, including the induction of secondary
cancers. Therefore, conformal delivery of the radiation to the target volume (i.e. the
cancerous region) is an important goal in radiotherapy.
Brachytherapy is a radiation delivery technique capable of providing excellent dose
conformity within the target volume. It involves the pre-implantation of a matrix
of catheters directly into the target volume. Depending on whether the form of
brachytherapy is low dose rate (LDR) or high dose rate (HDR), radioactive mate-
rial is either permanently implanted (LDR) or sequentially stepped through a series
of positions within each catheter. The desired dose distribution is achieved by the
permanent position of multiple radioactive seeds (in the case of LDR brachytherapy)
or by the positions occupied by the source and the dwell time in each position (in the
case of HDR brachytherapy). Ensuring that the planned dose distribution is correctly
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administered to the target organ is critically dependent on the accuracy of source
positioning with respect to the target organ. Improper radioactive source placement
( 192Ir in case of HDR, 125I or 103Pd in case of LDR brachytherapy) may result in
sub-optimal treatment of the cancer while potentially resulting in radiation toxicity
to nearby organs.
Brachytherapy treatment is particularly well-suited to the treatment of prostate
cancer. The anatomical location of the prostate facilitates the insertion of catheters,
and its proximity to critical organs (including the rectum, urethra and bladder) neces-
sitates excellent dose conformity. Errors in dose delivery may lead to post-treatment
complications such as incontinence and sexual dysfunction.
Although both forms of brachytherapy are widely used for treating prostate can-
cer, HDR brachtherapy has a number of advantages over LDR brachytherapy. In
particular, it results in much less exposure of clinicians to radiation, as the source is
sequentially moved through each of the catheters by an automated afterloader, and
is retracted within a shielded enclosure before and after treatment. Additionally,
there is some clinical evidence that prostate cancer is more effectively treated with a
small number of high-dose fractions rather than continuous low dose irradiation over
a longer time period. This Thesis exclusively deals with HDR prostate brachytherapy
(HDR-PBT).
During a typical HDR-PBT procedure, the patient is anaesthetised while 18 to
25 catheters are inserted into the prostate gland, guided by a transrectal ultrasound
(TRUS) image. A post-implant CT scan of the prostate is used to confirm the relative
positioning of the catheters with respect to the prostate; this is also used by the
treatment planning system (TPS) to calculate the specific duration and placement
of the radioactive source within each of the catheters. Typically, two to three dose
fractions are delivered within 24 hours, during which the catheters are connected to
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the afterloader system. Although the patient is kept immobile during the procedure
(on the hospital bed), catheter displacement still occurs during the interval between
the catheter implantation and the source delivery. Penetration of the bladder wall can
reduce the catheter movement and a repeat of the CT scans prior to the subsequent
dose fractions may be used to update the treatment plan. Anatomical changes and
movements may still result in a change in catheter position between treatment planning
and the source delivery. In addition, afterloader uncertainty (±1 mm), the possibility
of human error and afterloader malfunction all may result in significant differences
between the planned and delivered dose distributions, incidents of which have been
reported in previously published literature.
A reliable, accurate, real-time system for continuous independent monitoring of
the source position during the HDR-PBT procedure would be an important advance
in quality assurance (QA) and for prostate brachytherapy treatment. It would allow
the clinician to terminate or modify the treatment plan if anomalous source movement
is detected. To date, most current methods for providing real-time three dimensional
source position information are based on external imaging systems. The large distance
between the prostate and the detector in these systems leads to either a significant
uncertainty in the determination of source position or an acquisition time exceeding
that required for real-time source position monitoring.
An alternative approach is to insert the source imaging system into the patient’s
body. A concept of in-body imaging system for source tracking using highly spatial
resolution pixelated solid state detector was proposed at Centre for Medical Radiation
Physics (CMRP) by Prof. Anatoly Rosenfeld. The proximity of prostate to rectum
provides an ideal opportunity for the use of an in-body imaging system for HDR-PBT.
In-body imaging reduces the target-to-detector distance by a factor of four compared
to external imaging systems, and significantly reduces the acquisition time by reducing
1.1. Objectives, Overview of this Thesis 4
the signal attenuation. Additionally, by combining the source imaging system with a
colocated TRUS probe, it is straightforward to co-register the source position with the
prostate volume and minimise the impact of patient movement on the accuracy of the
tracked source position.
1.1 Objectives, Overview of this Thesis
The principal objective of this Thesis is to develop a robust, high-accuracy, real-
time in-body (trans-rectal) source imaging and position monitoring system for HDR
prostate brachytherapy intra-fraction QA. The main challenge in the design of such a
system is the limited space available inside the rectum, which places severe constraints
on the dimensions and composition of the components of the imaging system. The
image analysis and source tracking algorithms are also critical factors in the correct
performance of the system; each of these aspects is comprehensively investigated in
this Thesis. To ensure the safety of using the proposed system during the source
delivery, the additional dose delivered to the patient as a result of backscatter radiation
from the collimator was also thoroughly evaluated via simulation and experimental
studies. Based on these results, a prototype trans-rectal probe, HDR BrachyView ,
was designed and fabricated.
The device consists of an array of four Timepix detectors (with a total sensitive
area of 14 mm × 56 mm), placed within a 4 mm thick, multi-pinhole cylindrical tung-
sten collimator and encased within a thin rigid shell made of medical grade sterilisable
plastic. For every source position, multiple projection images are recorded by the de-
tector array. By backprojecting the centres of mass (CoMs) through the corresponding
pinholes, the 3-dimensional position of the source is determined. To accommodate the
poor signal to background ratio (SBR) obtained with a pinhole collimator yet still
provide accurate source monitoring within a sub-second acquisition time, a novel seg-
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mentation and thresholding method was developed to isolate all the projections from
background signal. The design of the HDR BrachyView probe, together with the
short prostate to detector distance results in a system capable of obtaining the source
position with sub-millimetre accuracy within a sub-second dwell time
The design of HDR BrachyView was evaluated by extensive validation and charac-
terisation through detailed Monte Carlo simulations. Preliminary experimental studies
were conducted with a prototype probe, which confirm the results of the simulation
studies. HDR BrachyView has been was recognised by the European Society for Ra-
diotherapy & Oncology (ESTRO) and American Brachytherapy Society (ABS) as one
of the most important recent advances in assisting with the provision of high quality
brachytherapy.
1.2 Structure and Summary of Contributions of
this Thesis
The thesis is divided into the following Chapters:
 Chapter 2 presents a comprehensive literature review.
 Chapters 3 and 4 present the details of HDR BrachyView design, and the meth-
ods for image analysis and 3-dimensional source tracking.
Z. Han, M. Safavi-Naeini, M. Petasecca, D. Cutajar, K. Loo, M. Lerch, J.A. Bucci,
A.B. Rosenfeld, “BrachyView for High Dose Rate (HDR) Brachytherapy,” in 21st
Annual Scientific Meeting of the Australasaian Brachytherapy Group, March,
2012
 Chapters 5 presents the evaluation of the effect of dose enhancement on rectum
wall due to the back-scatter radiation from HDR BrachyView probe. This work
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has resulted in the following publications:
Z. Han, M. Safavi-Naeini, S. Alnaghy, D. Cutajar, S. Guatelli, M. Petasecca,
D. Franklin, A. Malaroda, M. Carrara, J. Bucci, M. Zaider, M. Lerch, A. Rosen-
feld, “Radiation dose enhancement at tissue-tungsten interfaces in HDR brachyther-
apy,” Physics in Medicine and Biology, vol. 59, no. 21, pp. 6659, 2014.
Z. Han, M. Safavi-Naeini, S. Alnagy, D. Cutajar, S. Guatelli, M. Petasecca,
M. Lerch, D.R. Franklin, J.A. Bucci, M. Zaider, A.B. Rosenfeld, “Dose Enhance-
ment at tungsten-tissue interfaces with 192Ir source in HDR brachytherapy,” in
Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC), 2014
IEEE, 2014
 Chapters 6 and 7 present the validation of HDR BrachyView probe design
through simulation and experimental investigation, and have resulted in the
following publications:
Z. Han, M. Safavi-Naeini, M. Petasecca, M. Lerch, D. Cutajar, S. Guatelli,
J.A. Bucci, A.B. Rosenfeld, “BrachyView : Real-time Quality Assurance for
HDR Prostate Brachytherapy,” in Engineering & Physical Sciences in Medicine
Conference (EPSM), December, 2012
M. Safavi-Naeini, Z. Han, D. Cutajar, S. Guatelli, M. Petasecca, M. Lerch,
D. Franklin, J. Bucci, M. Zaider, A. Rosenfeld, “BrachyView, a novel inbody
imaging system for HDR prostate brachytherapy: design and Monte Carlo fea-
sibility study,” Medical Physics, vol. 40, pp. 071715, 2013
Z. Han, M. Safavi-Naeini, S. Alnaghy, D. Cutajar, S. Guatelli, M. Petasecca,
M. Lerch, D. Franklin, M. Carrara, J. Bucci, M. Zaider, A. Rosenfeld, “BrachyView,
A novel inbody imaging system for HDR prostate brachytherapy: Experimental
evaluation,” Physics in Medicine and Biology, 2015 (submitted)
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Z. Han, M. Safavi-Naeini, M. Petasecca, D. Cutajar, M. Lerch, D. Franklin,
J. Jakubek, J. Zemlicka, S. Pospisil, J. Bucci, M. Zaider, A. Rosenfeld, “Brachyview:
An in-body imaging system for real-time QA in HDR prostate brachyther-
apy,” in Nuclear Science Symposium and Medical Imaging Conference Record
(NSS/MIC), 2013 IEEE, 2013, pp. 1-4
 Chapter 8 presents a concluding summary of this thesis and offers suggestions
for potential future work.
Chapter 2
Literature review
This Chapter presents a comprehensive literature review. It starts with a brief discus-
sion of the prostate and prostate cancer (Section 2.1), followed by an introduction to
the main treatment options - namely, surgery, hormonal therapy and radiation ther-
apy, with a particular focus on high dose rate prostate brachytherapy (HDR-PBT)
(Section 2.2). Section 2.3 reviews a number of studies of the problem of source mis-
placement in HDR-PBT. Finally, quality assurance methods specifically designed for
HDR brachytherapy are reviewed in detail in Section 2.4.
2.1 Prostate and Prostate Cancer
2.1.1 The Anatomy and Function of the Prostate
The prostate is a walnut-shaped glandular organ found in males1 of most species,
with a maximum diameter in humans of around 40 mm. It is located anterior to the
rectum and immediately inferior to the bladder. The prostate encircles the urethra as
it exits the bladder and the ejaculatory duct as it exits the seminal vesicle [1, 2]. The
1A female homolog to the prostate gland, formerly known as Skeane’s gland, also exists, however
it is much less susceptible to cancer compared to the male organ.
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Figure 2.1: Sagittal cross-section showing prostate anatomy.
primary function of the prostate relates to the secretion of alkaline ejaculatory fluids;
it also includes smooth muscle which assists the expulsion of semen during ejaculation
Figure 2.1 and 2.2 illustrate the anatomy of the prostate in the sagittal and transverse
planes.
The peri-prostatic anatomy of the prostate is shown in Figure 2.2. The distance
between the posterior wall of the prostate and the anterior wall of the rectum in
healthy male adults is approximately 5.8 ± 0.7 mm. This space is primarily occupied
by fat tissue and venous plexus [4]. The median thickness of healthy rectal wall is
approximately 2.6 mm [5].
2.1.2 Incidence and Mortality of Prostate Cancer in Australia
The first mention of prostate cancer recorded in medical literature is from 1853, 315
years after the first description of the prostate gland itself [6]. Currently, prostate
cancer is one of the most common cancers diagnosed in Australia. Statistical data on
the incidence (to 2010) and mortality (to 2011) for all categories of cancer have been
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Figure 2.2: Transverse cross-section illustrating the peri-prostatic anatomy. The ab-
breviations are: Denonviller’s fascia (DF), levator ani (LA), lateral prostatic fascia
(LPF), pararectal fat (PF), prostate (P), rectum (Rec) [3].
collected by the Australian Institute of Health and Welfare (AIHW) and published
through the 2014 Australian Cancer Incidence and Mortality (ACIM) workbooks [7].
The incidence and mortality rate of prostate cancer from 1982 to 2011 are plotted in
Figure 2.3. In Australia, 19821 new cases of prostate cancer were diagnosed in 2010 and
3294 new deaths caused by prostate cancer in 2011, while the risk of diagnosis is 20.8%
and the risk of death is 4% for males below the age of 85. Prostate cancer is responsible
for 13.4% of all male deaths from cancer. According to AIHW’s statistics, prostate
cancer has the highest diagnosis rate of any cancers amongst the male population in
Australia, being detected at more than twice of the rate of bowel cancer, which is the
second-most frequently diagnosed cancer in men[7].
2.1.3 Factors Affecting the Risk of Prostate Cancer
Several well-known factors significantly increase the risk of developing prostate cancer,
of which age is the most pronounced. The diagnosis of prostate cancer is very rare for
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(a) Incidence rate of prostate cancer in Aus-
tralia
(b) Mortality rate of prostate cancer in Aus-
tralia
Figure 2.3: Incidence and mortality rate (per 100000 males) of prostate cancer in Aus-
tralia published in ACIM 2014, which is standardised to the Australian 2001 standard
population.[7]
men under the age of 40. However, diagnosis rates increase rapidly beyond 50 years
and reach a maximum at around the age of 70 [7, 8].
Another important factor related to the risk of developing prostate cancer is genet-
ics. A man has a higher incidence risk of prostate cancer if his genetic relatives have
been diagnosed with prostate cancer. Studies also indicate that this increased risk
depends on the how many family members have been diagnosed and the proximity of
their relationship [9, 10]. One possible effect of genetic factors on the development of
prostate cancer is through variations in sensitivity to androgens via androgen receptor
genes. The effect of androgens such as testosterone seems to be an essential condition
for the development of prostate cancer, since no case of prostate cancer is known in
animals or humans who have been spayed before sexual maturation [11].
The incidence of prostate cancer amongst different human populations is known
to vary significantly [12]. According to the global cancer statistics published in 2011,
Australia has the highest incidence of prostate cancer in the world. However, the in-
cidence rates in many Asian countries are less than one tenth of this value [13]. This
effect is likely be a combination of different factors, including the genetic predisposition
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of different ethnic groups, environment, lifestyle habits and diet. A higher incidence of
prostate cancer is observed amongst Asian emigrants living in Western countries com-
pared to their former compatriots, indicating that environmental, dietary or lifestyle
factors are significant contributory factors [14].
Besides age, genetics and location, other factors such as obesity and exposure to
sunlight appear to be involved in the development of prostate cancer. The relation
between obesity and the risk of prostate cancer is still obscure; although no significant
and constant association between obesity and the risk of low grade prostate cancer has
been found to date, a positive relation between obesity and high grade prostate cancer
has been observed in several studies [15, 16]. Although sunlight is usually associated
with an increased risk of skin cancer, studies indicate that exposure to sunlight leads
to a reduction of incidence of prostate cancer and certain other cancers [17, 18]. This
may be associated with exposure to the ultraviolet radiation [19, 20] or its influence
on the production of vitamin D [21, 22, 23].
2.1.4 Symptoms and Diagnosis of Prostate Cancer
Most prostate tumours are slow growing, often with no significant symptoms de-
tectable for less developed tumours. Due to the anatomical location and function
of the prostate, the symptoms of later stage prostate cancer are mostly related to
the urinary system symptoms, such as difficulty in starting or stopping the flow of
urine, high frequency of urination, weak or discontinuous flow of urine, or pain during
urination. Prostate cancer can also lead to erectile dysfunction, blood in the urine or
semen and frequent pain in the lower back hips, or upper thighs [24]
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Figure 2.4: Strategy for diagnosis of prostate cancer suggested by American Urological
Association guideline [25].
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2.1.5 Diagnosis of Prostate Cancer
The symptoms of early stage prostate cancer are not necessarily clear or specific, with
the result that many prostate cancers are not detected until the disease has significantly
progressed. Figure 2.4 illustrates the recommended procedure for definitive prostate
cancer diagnosis [25].
A number of biochemical markers associated with prostate cancer can be detected
in the blood. One of the earliest to be clinically applied was prostate acid phosphatase
(PAP), which was first isolated in men’s ejaculate in 1935 [26]. High levels of PAP
in serum indicate the probable presence of prostate cancer. However the application
of PAP is limited due to its fast deactivation at room temperature and the fact that
it can easily become contaminated by platelets and leukocytes [27]. In addition, PAP
level is unable to identify localised prostate cancer as less than 20% of patients with
localised prostate cancer exhibit abnormal PAP levels [28, 29].
The marker which is most commonly used to diagnose prostate cancer today is
the prostate specific antigen (PSA). PSA is a serine protease which is predominantly
secreted in the prostate. It was first identified in 1971 and detected in the serum of
patients with prostate cancer in 1980. Usually, the PSA level is determined through a
blood test; the level of PSA in serum for a normal man is generally less than 4 ng/ml
[30]. Presence of prostate cancer leads to the progressive destruction of the prostate.
which results in progressively higher levels of PSA released into circulation [31, 32].
Therefore, an abnormally high PSA level (in particular, where there is a sudden in-
crease in PSA level for a given patient) is a likely indicator of the presence of prostate
cancer. The association between PSA and the existence of prostate cancer is not ab-
solute, and there are many instances where the PSA tests of men without prostate
cancer gave positive results, and conversely, where patients with prostate cancer ex-
hibited a normal level of PSA [33, 34, 35]. This might due to that other factors besides
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Figure 2.5: Diagram illustrating ultrasound guided prostate biopsy [40]
the presence of prostate cancer can also affect the serum PSA level, such as benign
prostate enlargement, sexual activity and infection in the prostate [36]. Thus, instead
of being used as a monoindicator of prostate cancer, PSA is usually combined with a
digital rectal examination (DRE), and followed up by more invasive tests (including
biopsy) if there is a positive indication for cancer [37, 38].
DRE is a procedure performed to examine the physical status of prostate. During
DRE, a gloved finger is inserted into the rectum of the patient to check for any palpable
abnormality of the prostate by pressing and rubbing the prostate through the rectum
wall. Since DRE depends on the tactile impression of the prostate from within the
rectum, its efficacy in detecting tumours which are small or located to the posterior
of the prostate is poor [39]. Consequently, as with PSA, DRE alone cannot provide a
definitive diagnosis of prostate cancer.
The recommended course of action for patients with abnormal results for PSA
and/or DRE is to undergo a needle prostate biopsy. Prostate biopsy refers to a mi-
croscopical examination of small tissue samples taken from different parts of prostate
by ultra-fine biopsy needles. The needles can be inserted through rectum, urethra
or perineum, of which transrectal method is the most common. Transrectal needle
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insertion is usually guided by real-time transrectal ultrasound (TRUS) imaging [41].
A biopsy needle is mounted on the TRUS probe and guided to the desired insertion
position (Figure2.5). Typically, 12 cylindrical tissue samples, the majority from the
base and the apex of the peripheral prostate, are sampled for the further microscopical
examination [42, 41]. Provided that at least one needle intersects a cancerous region
of the prostate, a biopsy provides both a definitive diagnosis of prostate cancer and
an evaluation of its aggressiveness.
2.1.6 Prostate Cancer Classification
Like all cancers, prostate cancer can be categorised based its severity (grading) and
level of spreading (staging). Grading measures the degree of cell abnormality, which
is correlated with the aggressiveness of the cancer, while staging measures the degree
of disease progression.
To grade the severity of prostate cancer, Donald Gleason and his colleagues devel-
oped a histological grading system, based on clinical trials from 1960 to 1975. In the
early version of Gleason grading system, it defined nine histological patterns based on
the unique appearance of prostate cancer. These patterns are then integrated into five
grades according to the associations between the pattens and their biologic phenotypes
[43, 44]. The five Gleason patterns are shown in Figure 2.6.
By comparing the appearance of prostate biopsy samples under a microscope with
the Gleason pattens, the samples are given a Gleason score, indicating the grade of the
cancer. As mentioned in Section 2.1.5, usually, 12 samples are removed from prostate
for biopsy. However, the Gleason scores of these samples may not necessarily be the
same; the mortality rate for patients with prostate cancer exhibiting a range of Gleason
scores - for example, in the range a to b - is higher than for patients whose prostate
cancer has a uniform Gleason score of a and lower than for patients with prostate
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Figure 2.6: Gleason pattens of prostate cancer cells and a brief description for each
grade.
cancers exhibiting uniform Gleason scores of b. To provide an overall indicator of the
severity of a particular prostate cancer, Gleason and his colleagues suggested to use the
sum of the Gleason scores of the two most dominant patterns among all the samples
from a prostate biopsy as the total Gleason score of a cancer Gleason1992. This
calculation of the total Gleason score was changed following the 2005 International
Society of Urological Pathology (ISUP) consensus conference on Gleason grading of
prostatic carcinoma. The new calculation uses the sum of the Gleason score of the
most dominant pattern and the highest Gleason score as the total Gleason score of
prostate cancer whose biopsy samples have three or more Gleason scores [45]. Since
the total Gleason score is always the sum of two Gleason scores, it is in a range from
2 to 10. A prognosis can be vaguely made according to total Gleason score. Patients
with prostate cancer of total Gleason score higher than 7 may die in a short period of
time while patients with prostate cancer with a total Gleason score less than 7 may
not exhibit any symptoms at all [46].
The most popular method for staging prostate cancer is TNM system, introduced
by the International Union Against Cancer in 1974 [48]. This systems classifies the
2.1. Prostate and Prostate Cancer 18
Table 2.1: Stages of prostate cancer defined in the TNM system [47]
T TX Primary tumour cannot be assessed
T0 No evidence of primary tumour
T1
Clinically inapparent tumour not palpable or visible by
imaging
T1a
Tumour incidental histological finding in ≤ 5% of
tissue resected
T1b
Tumour incidental histological finding in > 5% of
tissue resected
T1c
Tumour identified by needle biopsy (because of el-
evated prostate specific antigen [PSA] level)
T2
Tumour confined within prostate; tumours found in 1 or
both lobes by needle biopsy but not palpable or reliably
visible by imaging
T2a Tumour involves one-half of 1 lobe or less
T2b
Tumour involves more than one-half of 1 lobe but
not both lobes
T2c Tumour involves both lobes
T3
Tumour extends through the prostatic capsule; invasion
into the prostatic apex, or the prostatic capsule is clas-
sified not as T3 but as T2
T3a Extracapsular extension (unilateral or bilateral)
T3b Tumour invading seminal vesicle(s)
T4
Tumour fixed or invades adjacent structures other than
seminal vesicles (eg, bladder, levator muscles, and/or
pelvic wall)
N NX Regional lymph nodes were not assessed
N0 No regional lymph node metastasis
N1 Metastasis in regional lymph node(s)
M0 No distant metastasis
M1 Distant metastasis
M1a Nonregional lymph nodes(s)
M1b Bone(s)
M1c Other site(s) with or without bone disease
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stage of tumour progression using three measurable disease parameters: the status of
primary tumour (T), the involvement of regional lymph nodes (N) and the situation of
distant metastasis (M). The most important aspect is T, which is divided into 4 stages
for the presenting tumour (T1-T4) and two additional stages - TX (which refers to
the situation where the primary tumour is not accessible and therefore not assessable)
and T0 (which refers to the case where there is no evidence of a primary tumour). The
stages T1-T4 are further divided into different subcategories. Table 2.1.6 shows each
of the stages defined by the TNM system [47, 48]. By combining the result of TNM
staging with patient’s Gleason score, the prostate cancer can be grouped into one of
four overall stages, as showin in Table 2.2, where G refers to the total Gleason score
[49]:
 GX: Gleason score is not accessible
 G1: Gleason score 2-4, Trifling anaplasia
 G2: Gleason score 5-6, Medium anaplasia
 G3-4: Gleason score 7-10, Conspicuous anaplasia
These four stage groups give an indication of the likely progression of the dis-
ease. Patients with Stage I cancers have the lowest 5, 10 and 15 year mortality rate,
while patients with Stage IV cancers have the highest mortality rate. This has been
quantitatively demonstrated via randomised trials of 1500 patients investigated by the
Radiation Therapy Oncology Group [50].
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Table 2.2: American Joint Committee on Cancer (AJCC) Stage grouping [49]
Stage T N M G
Stage I T1a N0 M0 G1
Stage II T1a N0 M0 G2-4
T1b-c N0 M0 Any G
T2 N0 M0 Any G
Stage III T3 N0 M0 Any G
Stage IV T4 N0 M0 Any G
Any T N1 M0 Any G
Any T Any N M1 Any G
2.2 Prostate Cancer Treatment
2.2.1 Surgical Treatment
Currently, the most common treatment option for localised prostate cancer is radical
prostatectomy, which refers to the surgical resection of the entire prostate [51]. During
the operation, one or more incisions will be made in order to visualise and access the
prostate and its surrounding tissues, such as the pelvic lymph nodes, seminal vesicles
and bladder. After the excision of the prostate and any other tissues adjacent to
the prostate into which the cancer may have diffused, the urethra and bladder are
reattached. Urination is usually performed using a catheter for about one week. In
addition to the removal of the prostate, the access to the pelvic lymph nodes also
provides important information for prostate cancer staging.
Depending on the size and nature of the incision(s) during the operation, radical
prostatectomy can be classified either as open radical prostatectomy (ORP) or laparo-
scopic radical prostatectomy (LRP). In ORP, an incision from 8 to 10 cm is usually
opened in the lower abdomen (radical retropubic prostatectomy) or in the perineum
(radical perineal prostatectomy) for both removal of the prostate and direct visual in-
spection of the surrounding area [52]. LRP is a less invasive treatment, which is often
performed with the assistance of a surgical robot [53]. In LRP, multiple trocars of
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5 mm and 10 mm are inserted in the patient to provide visualisation using the laparo-
scope and to provide physical access to the prostate. The cumulative size of all of
these incisions is approximately 5 cm [54, 55]. As the procedure is less invasive, LRP
generally results in less blood loss compared to ORP, which reduces the need for blood
transfusions and the potential complications that result [56]. Although other benefits
might be expected, such as reduced hospitalisation time and reduced post-operative
pain, these is currently little evidence showing significant improvement in either these
aspects or overall efficacy of the procedure compared to ORP [57, 55].
2.2.2 Hormonal Therapy
Hormonal therapy for prostate cancer focuses on the influence of androgen on prostate
cell growth and survival. One condition of the growth and survival of prostate cancer
cells is the binding of dihydrotestosterone (DHT) and androgen receptors. In the
prostate, DHT is converted from androgen under the presence of 5α-reductase. Thus,
the key to eliminating prostate cancer cells is to reduce the level of androgen. The
majority of male androgen production occurs in the testes, with smaller amounts
produced in the adrenal glands. The process of androgen production starts at the
hypothalamus, where the luteinising hormone-releasing hormone (LHRH) is produced.
LHRH moves from the hypothalamus into the pituitary gland, where it binds with
LHRH receptors to stimulate the release of luteinising hormone (LH). LH then travels
to the testis and binds to the LH receptor, which finally causes the synthesisation of
androgen (testosterone) from cholesterol in testis. In a negative feedback loop, the
level of androgen limits the production of LHRH and hence LH, such that the level
of testosterone in the blood remains stable. Therefore, the use of hormonal therapy
to treat prostate cancer primarily aims to either reduce the androgen level (androgen
ablation), inhibit the binding of the androgen receptor with its ligands in the prostate,
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or to combine these approaches [6]. Although studies indicate that hormonal therapy
is able to reduce the androgen-responsive growth of prostate cancer cells, it leads to
a number of significant side effects depending on the specific hormone used; more
importantly, it is not curative due to its inability to prevent the growth of androgen-
independent prostate cancer cells, which exist not only in advanced prostate cancer
but also in early stage prostate cancer [58, 59, 60, 6].
2.2.3 Radiation Therapy
2.2.3.1 Radiation Induced Cell Death
Radiotherapy aims to control cancer by using ionising radiation to induce cancer cell
death through damage to cell DNA. The damage to the DNA molecule caused by
ionising radiation results in the destruction of the double helix structure of DNA,
either through direct action of the radiation on the DNA molecule itself, or indirect
action on the surrounding medium (mostly water) which results in free radicals that
cause chemical damage to the DNA. For particle radiation, the destruction of DNA
occurs mainly as a result of direct action, while indirect action dominates in the case
of electromagnetic radiation [61, 62].
It is obvious that the higher the energy deposited per unit mass by the applied ra-
diation field (i.e., the higher the absorbed dose), the higher the rate of cancer cell mor-
tality. However, although cancer cells are more susceptible to radiation damage than
healthy cells (due to their rapid growth cycle and impaired self-repair mechanisms),
healthy tissues are also damaged by exposure to radiation. Therefore, increasing the
amount of radiation given to patients will also increase the rate of side effects and
complications. These risks are more serious when the cancer occurs deep inside the
body or in tissues adjacent to critical or highly radiation-sensitive organs. Therefore,
the objective of radiotherapy is to deliver sufficient radiation to kill cancer cells while
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limiting the dose received by healthy tissues as much as possible.
The effect of radiation on human tissues is also determined by the mode of de-
livery - that is, both the dose rate and the distribution of dose over time (temporal
fractionation). One reason for this is the ability of cells to repair damage to their own
DNA. DNA is composed of two strands of nucleotide molecules twisted together in the
well-known double helix structure, and encodes an organism’s genetic instructions.
The nucleotides are of one of four types - adenine (A), thymine (T), guanine (G), or
cytosine (C) - and are bonded across the helix in pairs (A/T or G/C). Damage to one
strand of the helix can be repaired (e.g. if the thymine base is damaged, it can be
replaced as only thymine can pair with the adenine base opposite). However, the DNA
molecule will be completely disrupted and destroyed if both strands are broken, since
that base pair is completely lost. Double-strand breaks become increasingly likely for
a given radiation type as the dose rate increases.
Based on the origin of the radiation relative to the patient, radiotherapy can be
classified into one of two types: external beam radiotherapy (EBRT) or brachytherapy.
These will be discussed in detail in the following section.
2.2.3.2 External Beam Radiotherapy
EBRT is the most common and mature radiotherapy technique for cancer treatment.
It achieves the desired dose distribution in the target volume by directing an external
radiation source to the target. Depending on the type and location of the cancer,
the most appropriate radiation source is applied. Electrons and keV photons (under
500 keV) are usually preferred for treatment of skin or superficial cancer [63], while
hadron therapy and megavoltage treatment systems have better performance in treat-
ing cancer which is relatively deep inside the patients. Although hadron therapy has
developed rapidly in the past few years due to its ability to easily select the depth
of maximum energy deposition Bragg peak, it is still far less common than photon
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therapy due to the very high costs of establishing hadron beam facilities.
Several types of EBRT are suitable for the treatment of prostate cancer, which
are distinguished by their approaches to achieve the desired dose distribution. Two-
dimensional conformal radiation therapy (2D-CRT) is the most established form of
EBRT. It shapes the 2D dose distribution in the prostate by spatially modulating
the beam geometry using a set of movable collimating plates (multi-leaf collimator).
This results in a beam which conforms to the geometry of the target volume in two
dimensions. Although 2D-CRT is a simple technique to plan an implement, it cannot
achieve a large contrast between the dose delivered to the target volume and sur-
rounding healthy tissue, since the only control over dose distribution in the depth
dimension is the energy, intensity and radiation type of the beam (electrons or X-rays
for a normal linear accelerator). This problem is more serious when critical and/or
radiation-sensitive organs are adjacent to the target volume, which is the case for
prostate cancer.
A more sophisticated approach is three-dimensional conformal radiation therapy
(3D-CRT). With the use of modern imaging technology, it is possible to obtain detailed
3-D anatomical information for the target volume and its surroundings. As in 2D-CRT,
a dose distribution is constructed which is accurately conformal to the 2-D outline of
the target volume from one particular perspective. However, the multi-leaf collimator
reshapes the beam as the beam applicator moves around the patient in order to apply
radiation from a number of different directions. In this way, the incidental dose to
healthy tissues is distributed over a larger volume, reducing the dose received by any
one region of non-cancerous tissue, while the tumour volume receives are more uniform
dose compared to 2D-CRT.
If the intensity and/or energy of the beam are also computed for each angle of
application in 3D-CRT, the peak dose can be made to conform even more precisely
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to the shape of the tumour. This is known as intensity modulated radiation therapy
(IMRT). The desired dose distribution in the tumour is defined in a treatment planning
system, which then optimises beam delivery to achieve this distribution while minimis-
ing exposure to sensitive organs and healthy tissues in general. The treatment plan
created using this computer-assisted inverse method conforms more precisely to the
target geometry compared to traditional 3D-CRT. However, IMRT assumes that the
target geometry is time-invariant, while in practice organs are continuously in motion
due to respiration and other involuntary movements; the patient may also not be pre-
cisely physically registered to exactly the same position as during the pre-irradiation
imaging procedure. To reduce the impact of geometry changes between treatment plan
and beam delivery, imaging can be performed concurrently with treatment, allowing
the treatment plan to be adjusted in real time. This technique is known as image
guided radiation therapy (IGRT). A further refinement is to use continuous rather
than discrete adjustment of beam orientation, shape and intensity - this is known as
volumetric modulated arc therapy (VMAT). IGRT and VMAT are the state of the art
in external beam radiation therapy.
At least 70 Gy is required for the treatment of prostate cancer and higher doses at
the target area will increase the rate of cancer control [64, 65, 66, 67, 68, 69]. Although
the development of modern imaging technology, computer power and treatment plan-
ning algorithm significantly has improved the conformity of EBRT, the maximum dose
at target region is still limited by the damage in the surrounding healthy tissue caused
by the externally applied radiation. This is an intrinsic property of EBRT, since radi-
ation has to pass through and will hence deposit energy in the healthy tissues between
between the source of radiation and the target. Thus, the maximum dose that can be
delivered to a tumour can be increased by directly placing the radiation source inside
the tumour, This is the approach used in brachytherapy.
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2.2.3.3 Brachytherapy
Since brachy has a meaning of ’short’ in Greek language, brachytherapy treats cancer
by either temporarily or permanently placing a radiative source in very close proximity
to the tumour. The source may be placed either immediately adjacent to the tumour,
as in ocular plaque brachytherapy, or directly inside the tumour volume itself, as in
the case of prostate brachytherapy (PBT). The dose received by tissue drops rapidly
with increasing distance from the source, such that the dose distribution can be made
to closely conform to the tumour geometry. For localised cancer, brachytherapy is able
to deliver a higher dose to the tumour with a lower risk of complications compared to
EBRT [70, 71, 72, 73, 74, 75]. In addition, brachytherapy can be more cost effective
than EBRT for the treatment of prostate cancer [76].
Two brachytherapy modalities, distinguished by the dose rate and duration of
implantation, are commonly used for the treatment of prostate cancer: low dose rate
(LDR) brachytherapy, in which the initial dose rate is less than 2 Gy/hr, and high
dose rate (HDR) brachytherapy, where the dose rate exceeds 12 Gy/hr. In LDR
brachytherapy, a short-lived radioisotope such as 125I, 103Pd or 131Cs is encapsulated
in a small inert cylinder (typically LDR PBT uses around 100 individual seeds, each
about 4-5 mm long) and permanently implanted into the target. The desired dose
distribution is programmed into the treatment planning system, and the arrangement
of seeds is calculated. Stranded seeds spaced along a dissolvable polymer filament are
loaded into in a thin needle, which is then withdrawn leaving the seeds permanently
implanted.
More recently, the advantages of HDR PBT have led it to becoming a popular op-
tion for the treatment of prostate cancer. In HDR PBT, a single cylindrical radiation
source, most commonly 192Ir embedded in a palladium or gold capsule, is attached to
the end of a flexible steel cable which is driven by a remote controlled source delivery
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system known as an afterloader. A series of catheters are inserted into the prostate
and attached to the afterloader, which sequentially inserts the HDR source into each
catheter in turn and translates it through a series of pre-planned positions, with a
dwell time of a few seconds in each position. The desired dose distribution is achieved
via the choice of source positions and the dwell times in each position. At the end
of the treatment, the HDR source is retracted into the shielded chamber of the after-
loader. Efficacy of treatment of prostate cancer with HDR PBT has been compared
to IMRT by Fatyga et al. in 2009; HDR PBT was shown to be offer significantly bet-
ter outcomes in terms of minimising dose in the bladder and rectum, and its ability
to control the tumour [72]. Hermesse et al. conducted a similar study, also in 2009,
comparing the dose specificity which is achievable with HDR PBT with IMRT and
helical tomotherapy for the treatment of prostate cancer [73]. Again, the conformity
of the high dose region to the geometry of the prostate was shown to be the best for
HDR PBT, which also offered the lowest incidental dose to other tissues.
In this Thesis, the focus is on instrumentation for HDR PBT quality assurance.
An equivalent design optimised for LDR-PBT has also been developed as the subject
of a separate project; therefore, LDR-PBT will not be discussed further in this Thesis.
The next section discusses the problem of the errors which may exist between
the desired and actual position of the HDR brachytherapy source during HDR PBT
treatment.
2.3 Errors in Source Placement in HDR Prostate
Brachytherapy
Maximising the efficacy of cancer treatment and minimising the damage to healthy
tissues both require that the actual positioning of the radioactive source relative to
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the prostate conforms as closely as possible to the position specified by the treatment
plan during the treatment process. Positioning uncertainty in HDR PBT has been
investigated extensively in the literature. In 2014, Kirisits et al. performed a compre-
hensive review of the causes of positioning errors based on the HDR-PBT guidelines
published by the American Association of Physicists in Medicine (AAPM) and GEC-
ESTRO [77]. The sources of positioning uncertainty in HDR PBT were found to
include uncertainty in source strength, intrinsic limitations of (and human error in)
operating treatment planning systems, difficult-to-model heterogeneity effects, imag-
ing limitations (signal-to-noise, contrast and resolution), source delivery uncertainty
and patient-related uncertainties such as physiological changes which occur during
the procedure or between pre-treatment imaging and the start of the procedure itself.
The objective of the HDR BrachyView system presented in this Thesis is to moni-
tor source misplacement resulting from either the error in source delivery within the
catheter (due to the limits of mechanical precision of the afterloader) or the displace-
ment of the catheter relative to the prostate and surrounding critical organs between
planning and treatment.
According to published manufacturer specifications, commercially available after-
loaders can achieve source positioning to within ±1 mm of the desired position (with
a confidence interval of 95%) [78, 79]. This positioning uncertainty has also been
confirmed independently in measurements of source placement in straight catheters,
performed at different institutions [80, 81]. In the case of curved applicators, the pre-
cision of source positioning is significantly worse - with an error as large as -5 mm
depending on the curvature of the catheter [82, 83, 84, 85, 86, 87]. The negative-
depth positioning error in source placement in a bending catheter occurs because the
diameter of the catheter is usually larger than that of the source and its driving wire.
When the source is driven into a curved catheter, the source is pushed toward the
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Figure 2.7: Causes of catheter position shift relative to the prostate.
catheter wall, which is away from the central axis of the catheter. In this case, the
real source path is longer than the nominal path along the axis of the catheter, leads
to an inadequate source depth inside the catheter compared to the depth required by
the treatment planning system [88].
While the precision of the afterloader mainly depends on its mechanical design (gear
backlash, stepper motor resolution and reduction ratios etc.), changes in the geometry
of the catheter and prostate can be classified into three types: deformation of the
prostate, the shift in catheter position external to the patient’s body, and prostate
migration relative to the body outline (Figure 2.7) in [89, 90].
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Prostate deformation due to the oedema of the prostate and its surrounding tissue
after a HDR brachytherapy fraction was studied in a number of publications [91, 92,
93, 94, 95, 96]. Maritinez et al. reported that significant prostate volume change
(with mean volume increasing from 30.0 cc to 37.0 cc) only occurred between the
first two fractions out of a total of four treatment fractions based on a study of 41
patients [91]. Kim et al. compared the prostate volume between two fractions in
treatment delivered to 13 patients, which were separated by approximately 20 hours.
In their study, prostate enlargements were observed with a range from 2% to 17% in 5
patients, while volume reductions were observed in 8 patients with a range from 2%-
13% [93]. The prostate volume change was also evaluated by Cury et al. CT scans were
performed for 31 patients 7 days after a single-fraction HDR brachytherapy, which were
used to compare with the planning CT for these patients. 32% of the measurements
shows a decrease of prostate volume up to 14.2%, while 68% demonstrated an increase
in prostate volume of up to 23.8% [94]. Dinkla et al. investigated prostate volume
changes during pulsed-dose rate brachytherapy by analysing catheter configurations in
two CT scans conducted 24 and 48 hours after the planning CT scan. Prostate volume
variations from -9.3% to +15.6% were observed after 24 hours, and a similar range
(-7.5% to 16.3%) was observed at 48 hours [96]. As demonstrated above, significant
variation, both positive and negative, in the prostate volume was observed following
a HDR BT fraction. The observed patient-to-patient variations are likely due to a
combination of the diversity of both patients and their cancers, although there is also
some uncertainty in image-based volume estimates themselves. Despite these observed
variations in prostate volume, it generally appears to be assumed in the literature that
for most patients, the overall impact of the prostate deformation on dose distribution
within the prostate volume is insignificant. However, the large variation in prostate
volumes observed in some patients indicates that, at least in some cases, better dose
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conformity to the desired treatment volume will be achieved if real-time feedback for
source position and/or spatial dosimetry can be combined with real-time imaging of
the prostate during treatment. This is an important requirement for quality assurance
(QA) in HDR prostate brachytherapy.
Correct positioning of the external applicator with respect to the prostate is also
a potential source of errors in source placement. Currently, the most common ap-
plicator fixation technology is based on an out-of-body template which is sutured
to the skin of the perineum prior to implantation. During the implantation, the
catheters are affixed to the template in order to prevent catheter displacement exter-
nal to the body. Numerous studies on catheter movement occurring in the interval
between catheter implantation and the administration of treatment fractions has been
performed. Significant catheter displacement resulting from improper placement of
the catheters relative to applicator template external to the body are quite rare due
to the high reliability of fixation methods currently used [90]. However, significant
catheter displacements relative to the interior of the body - measured as displacement
either from bony markers or implanted gold markers have been reported. Inter-fraction
catheter displacement of up to several centimetres have been reported by many authors
[97, 91, 89, 98, 99, 90, 100, 95]. Mullokandov and Gejerman studied the shift between
the catheter, the template and anatomical bony markers by analysing CT scans of 50
patients. No measurable displacement of the catheter relative to the template is ob-
served; however, a shift between the catheter and ischial tuberosity (a bony marker on
the lower pelvis) was observed in the range of 2 mm to 10 mm, depends on the interval
between measurements [98]. A CT scan study on applicator displacement between two
fractions of HDR BT performed by Hoskin et al. in 2003 reported a mean inter-fraction
catheter shift of 11.5 mm in the direction away from the bladder [89]. The same group
published a more comprehensive investigation on inter-fraction catheter shift through
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a series of treatments comprising three fractions. A mean catheter displacement of
7.9 mm (with the full range from 0 mm to 21 mm) was observed between the first
and second fraction, while a mean shift of 3.9 mm (with the full range from 0 mm to
25.5 mm) was observed between the first and third fraction. Among all the catheter
displacements observed in this study, 70% of displacements were found to exceed 5 mm
for the second fraction and 35% exceeded 5 mm for the third fraction [90]. Similarly, a
median catheter shift of 7.5 mm between the planneding CT scan and treatment was
observed by Whitaker et al. from study of 48 implants in 25 patients. 67% of such
measured implants had offsets exceeding 5 mm [100]. In addition, the relationship be-
tween the applicator displacement and the interval after implantation was investigated
in most of these studies. Although the time for the catheter displacement to reach its
maximum varies from 10 hours to 20 hours, catheter displacement consistently ceased
to increase beyond approximately 20 hours in all of these studies [90].
A possible reason for the catheter displacements observed in the previously-discussed
studies is prostate migration, which could be caused either by the oedema of tissue
between the prostate and the point of catheter insertion (peri-prostatic oedema), or
sudden increases in intra-abdominal pressure caused by patient coughing and/or vomit-
ing [89, 90]. In addition, the oedema of prostate itself can push the catheter away from
the prostate base [90]. The easiest approach to correct the applicator displacement is
replanning the source positions in each catheter with a shift corresponding to the dis-
placement of such catheter. However, this correction is only feasible when the catheter
still penetrates the whole prostate at the time of correction. If the catheter has shifted
away from the base of the prostate, physical re-advancement of the catheter must be
performed [89, 90]. Thus, Hoskin et al. recommended to implant the catheter further
than necessary and perform a CT scan before each fraction to correct the catheter
shift by simply redefining source to catheter tip distance [89]. This recommendation
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assumes that the catheter has only been linearly displaced and is not deflected into a
curved shape.
Even when inter-fraction catheter motion is compensated for by adjusting the
catheter with imaging guidance prior to each fraction, the displacement of the catheter
after adjustment remains significant. A mean catheter displacement of 3.5 mm (with
a maximum of 13 mm) following adjustment was observed by Kovalchuk et al. through
multi-fraction HDR PBT for 26 patients. The impact of such displacement on dosime-
try is then investigated by comparing the results from applying the original treatment
plan to the adjusted catheter positions. A prostate V100% < 95% was obtained in 46%
of the cases, which represents a significant under-dosing of the target volume for many
patients [95].
In addition to the factors of afterloader positioning uncertainty and applicator
displacement, equipment malfunctions (e.g. undetected afterloader failure) and the
inevitable human errors which occasionally occur during the treatment planning, pa-
tient transfer and the treatment could also lead to significant source movement errors,
both in terms of positioning and dwell time. A series of accidents in HDR PBT were
reported by the International Atomic Energy Agency (IAEA) in 2000. The factors
contributing to these accidents were also analysed [101]; although the incidence of
equipment failure was significantly reduced by the progressive improvements in after-
loader systems and their associated QA, it remains non-zero with the possibility of
equipment failures unlikely to ever be completely eliminated. In addition, current QA
methods are insufficient to detect all errors in real time in source placement during the
source delivery, especially those resulting from human error. Thus, real-time source
tracking during each fraction is crucial to improve the quality of HDR PBT treatment.
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2.4 Quality Assurance Methods in HDR Prostate
Brachytherapy
As discussed in Section 2.2.3.3, the principal advantage of brachytherapy is the highly
conformal dose distribution which it provides within the target volume. This is due
to the steep dose gradients provided by the source (or sources, for LDR brachyther-
apy) inside the target. However, the steep gradients of the brachytherapy source is
a double-edged sword, since if it is incorrectly positioned, the high activity can re-
sult in significant overdoses being delivered to surrounding critical organs; equally, it
will reduce the effectiveness of treatment since cancerous regions may be underdosed.
Therefore, reliable and accurate source monitoring is an essential aspect of HDR PBT
quality assurance (QA), and can be performed either by measuring the 3D radiation
field or by monitoring the source position in three dimensions. This potentially allows
real-time adjustments to be made to the treatment plan during treatment.
In the following parts of this section, after a general introduction to existing meth-
ods used for QA in HDR PBT, the methods applied in for general quality assurance
of the equipment (e.g. calibration procedures) are discussed, followed by various ap-
proaches which have been proposed for QA during a specific HDR PBT procedure.
This section particularly examines methods used for intra-operation real-time source
tracking due to the correlation with the objectives of the HDR BrachyView system
presented in this Thesis.
A considerable body of work exists on the subject of QA methods for HDR PBT.
These methods either provide dosimetric information or track the source in terms of
its position and dwell time. Clinically, information regarding dose distribution can
be obtained using dosimeters such as ionisation chambers, gel dosimeters, thermolu-
minescent detectors (TLDs), radiochromic films, semiconductor detectors/dosimeters
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such as metal oxide semiconductor field effect transistor (MOSFET) based detectors,
scintillation detectors and so on [102].
A number of methods can be applied to obtain an independent estimate of the
source position in HDR BT. If the source tracking system is dosimetry-based, the 3D
source position is usually estimated using trilateration. After careful calibrations, the
radial source-to-detector distance (SDD) can be estimated based on its correspondence
with dose measurements normalised to the strength of source. Each dosimeter provides
an estimated distance from the source, inscribing a spherical shell of potential source
positions around the dosimeter. With two dosimeters, the source can be localised to the
circle of intersection between the two spheres, and with three or more dosimeters, the
source position can be unambiguously resolved to a single point. Thus, 3D dimensional
source position can be uniquely determined using dose measurements from at least
three calibrated dosimeters [103, 104]. No collimator is required for this method,
however the relationship between distance and dose rate depend on the attenuating
medium between source and detector, limiting the achievable accuracy. External-
beam computed tomography (CT) imaging could be used to image the source in three
dimensions, but would result in a substantial additional radiation dose to the patient,
with the resolution limited to a few millimetres. More problematically, imaging would
need to be repeated at each source position, which is not feasible due to the short
source dwell times used in HDR PBT.
Alternatively, by using a collimator, it is possible to limit the acceptance angle
of the detector/dosimeter, and thereby obtain direction source information from the
shape of the projections through the collimator. This could be performed tomograph-
ically - essentially a form of single photon emission computed tomography (SPECT).
However, the exposure time required to obtain a high quality image outside of the
body would exceed the source dwell time at any particular point. Reducing the dis-
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tance between the source and imaging system by locating it in the patient’s body will
reduce this problem by several orders of magnitude; therefore, this is the approach
which is adopted in this Thesis.
2.4.1 General QA Methods for HDR Prostate Brachytherapy
General QA processes required for HDR PBT aim to ensure that all elements of the
system are operating within tolerance limits. The QA process follows a well-defined
program, which detailed the commissioning measurements and the frequency with
which they need to be repeated. Practical guidelines and recommendations for HDR
PBT systems have been published by a number of different institutes [105, 106, 107,
108, 109]. According to these recommendations, besides the regular testing of basic
functionality, the main tasks of routine QA procedures include source calibration and
source delivery accuracy tests. The methods either proposed or applied to accomplish
such tasks are reviewed in this section.
Although the source strength is calibrated by the vendor prior to delivery, the un-
certainties corresponding to the source strength calibration values from vendors are
significant. Therefore, methods of independent source strength measurement are re-
quired [110, 111]. The ionisation chamber is one of the most common dosimeters used
for source calibration. It detects radiation by collecting charges created by the in-
teraction of radiation with the gas contained in the chamber. Because of its stable
response to a wide range of energies and excellent reproducibility, the ionisation cham-
ber is considered the gold standard for accurate clinical dose measurement. Ionisation
chambers have been used to calibrate 192Ir HDR sources since 1980 [112]. Well-type
ionisation chambers were further studied for source calibration by Goetsch et al. in
the early 1990s [113, 114]. Reynaert et al. directly calibrate an 192Ir source in water
with an ionisation chamber. Their measurements demonstrate an uncertainty within
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1% of the result from the reference air-kerma rate calibration method [115]. DeWerd
et al. designed an insert based on the calibration well chamber introduced by Goetsch
et al. to achieve QA for the afterloader in terms of source position and dwell time
[114, 116]. In their system, the positional and temporal information for the source was
obtained using a lead collimator insert with an acrylic spacer. The whole measurement
takes approximately 5 minutes. Source position error of less than 0.4 mm within the
catheter and timing uncertainty of less than 1.5% was reported by the authors [116].
The accuracy of source position determination was further improved to 0.2 mm by Li
et al. who developed a technique for tracking the source using a trilateration method
with a rotating double disk phantom, which is able to accurately control the position
of catheter and ionisation chambers [103]. Although precise measurement of source
position is achievable by some of above methods, the information observable is limited
to a single dimension (depth, i.e. parallel to the axis of the catheter). In addition,
the dependence of these methods on predefined catheter and detector positions makes
these methods only feasible for the routine testing of afterloader delivery precision.
While source strength is usually calibrated using an ionisation chamber, another
important task of QA for HDR PBT is evaluating the dose distribution of the source,
which is usually described by the radial dose functions, dose rate constant and anisotropy
functions. Although this task is also theoretically achievable using an ionisation cham-
ber array or accurately shifting the chambers for scanning measurement, this approach
would be prohibitively expensive, time consuming and will result in measurements with
very poor spatial resolution. In addition, the large sensitive volume and physical size
of ionisation chamber limit its application in dosimetry when the dose distribution has
a steep gradient, especially for in-vivo measurements.
TLDs are physically smaller than ionisation chambers, and have no need for either
a wire connection or high voltage power supply. These advantages make TLDs a
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popular choice for in-vivo dosimetry for the QA of many forms of radiation therapy.
However the requirement of the time-consuming post-irradiation annealing process
means that TLDs cannot be used for real-time dosimetry; therefore, they are not a
realistic choice of dosimeters for use during HDR PBT treatment to validate agreement
between the actual and planned dose delivery during treatment. However, TLDs are
still useful tools to measure the dose distribution surrounding the HDR source (that is,
the anisotropy of the source). Kirov et al. measured the dose rate distribution in two
dimensions (transverse-axis and polar) of a current generation 192Ir source using TLDs,
and the result of the measurement was used to validate calculations from a Monte-
Carlo simulation [117]. An average deviation of 5% was observed between the readout
from the TLD and the predictions of the simulation when the sampling position is
more than 3 cm from the source. However, larger uncertainties of up to 10% were
found in the measurement with distance less than 2 cm from the source, where smaller
(and hence higher spatial resolution) TLD chips were used. Similarly, Karaiskos et
al. used Monte Carlo simulations compared with experimental TLD measurements
to investigate the radial dose function, dose rate constant and anisotropy function
of an 192Ir source [118]. Compared to previously published simulation results for an
HDR brachytherapy source in an infinitely large water phantom [119], deviations of
up to 25% were observed in their investigation of the radial dose function of an HDR
brachytherapy source in finite-dimension phantoms (with phantom diameters from 10
to 50 cm). Meigooni et al. evaluated the sensitivity of TLDs at different distances from
the source by comparing TLD measurements with an ionisation chamber located at
the same distance [120]. The difference between the doses measured by the TLD and
ionisation chamber was approximately 8.5%, measured at distances of 1 cm and 10 cm
from the source. It is hypothesised that this was caused by the energy-dependence
of TLDs, since the spectrum of photons was observed to shift toward lower energies
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when the sampling position moved further away from the source.
An alternative method which can be used to obtain a two-dimensional dose distri-
bution measurement at a certain distance from the source is radiochromic film. Ra-
diochromic film is used to measure dose information by measuring changes in optical
density before and after irradiation. By calibrating the film in a highly uniform radia-
tion field, absolute dose information can be retrieved from the ratio of the film optical
density before and after the irradiation [121, 122]. Duggan et al. used radiochromic
films to measure dose distribution in planes parallel to the axis of the HDR source at
radial distances from 2 to 6 mm [123]. A line profile of the dose rate was generated
from each film exposure by averaging the dose rate measured across a 24.5 mm wide
strip centred on the source axis. The results demonstrated a mean deviation of 7.5%
from ionisation chamber measurements.
The accuracy of a radiochromic film dosimetry system with a He-Ne laser film
scanner in HDR brachytherapy radiation fields was evaluated by Dempsey et al. in
2000 [124]. The uniformity of the optical density of radiochromic film irradiated under
a uniform radiation field, as measured by calculating pixel-to-pixel standard devia-
tion, was found to vary from 1% to 5% depending on the total dose. This variation
could be further reduced by sampling a cluster of pixels (i.e. averaging out noise re-
sulting from film granularity). Agreement of 1.5%-4% in absolute dose measurements
compared to both Monte Carlo simulation predictions and ionisation chamber mea-
surements were demonstrated in this study. Similarly, an uncertainty of 4.12% was
observed in measurements of dose above 1 Gy performed using a radiochromic film
dosimetry systems designed by Aldelaijan et al. in both a water phantom and the Solid
Waterpolymer [125]. To evaluate the anisotropy of a HDR PBT source caused by the
self-absorption of the source core and asymmetric attenuation of the source capsule,
Sharma et al. measured its anisotropy function using radiochromic films in a water
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phantom [126]. Dosimetry results agree with previous measurements performed using
an ionisation chamber to within 3%, with Monte Carlo simulation results to within 3%
and within 5% of measurements performed using TLDs; however, radiochromic film
offers superior spatial resolution compared to all of these methods. Beside dosime-
try, radiochromic film can also be used as a QA tool to track the source position due
to its high spatial resolution imaging capability. In a 1993 study, Evans et al. used
radiochromic film to track the source position when it is driven to the most distal
distance (the catheter end as determined by the afterloader) [127]. Positioning errors
of up to several millimetres from the intended position at the end of the catheter were
demonstrated, which is likely to be a combination of catheter flex and the afterloader’s
intrinsic linear positioning uncertainty. Rickey et al. proposed a rapid QA system to
verify afterloader source delivery accuracy using a combination of radiochromic film
with co-registered with photodiode detectors. The authors claimed this system is able
to accomplish commissioning of an HDR PBT afterloader in about six minutes with
a spatial uncertainty of 0.5 mm and a time resolution of 1 ms [128].
Several other dosimetery systems for source calibration or routine testing of after-
loader source delivery accuracy have also been described in the literature. Kirov et
al. used silicon diode radiation sensors to measure the dose rate along the transverse
axis of both an 192Ir and pulsed dose-rate source at distances between 2 and 40 mm
from the source [117]. The results agree with the predictions of Monte Carlo simu-
lation to within 0.5% with an uncertainty much smaller than the TLD measurement
performed in a similar scenario. Jursinic used diodes to measure the source position in
catheters fixed in a designed template to evaluate the source delivery accuracy of the
afterloader [129]. Uncertainty of up to 0.3 mm (depending on the type of applicator)
in determining source dwell position and 0.3% in determining source dwell time over
a 20 s period was described by the author. Austerlitz et al. measured the strength
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of an 192Ir source by inserting the source at the end of a sleeve which is located at
the centre of a balloon filled with Fricke solution [130]. Therefore, the dose can be
estimated by measuring the change in the Fricke solution’s optical density before and
after irradiation. According to their study, 11.3 ml of Fricke solution is sufficient for
the measurement of the radiation from a HDR source at a radial distance of 2.5 cm. It
was noted that dose estimates were inaccurate when the thickness of the sleeve is too
small; this is because of the very high dose rate immediately adjacent to the source
exceeding the linear range of Fricke solution. Finally, a MOSFET detector was used
by Zilio et al. to measure the depth dose of 192Ir source [131]. The result show good
agreement with Monte Carlo simulations, with a discrepancy less than 5% for most
sample points .
2.4.2 Methods for QA during HDR Prostate Brachytherapy
Treatment
QA procedures periodically conducted on HDR PBT equipment are not sufficient to
guarantee dose distribution conformity with a treatment plan during treatment of a
specific patient. The aim of intra-fraction QA for HDR prostate brachytherapy treat-
ment is to address this requirement. The primary cause of discrepancies between
planned and delivered dose distributions is the source misplacement, which is caused
either by the displacement of the catheter relative to the prostate and its surrounding
critical organs, or by malfunction of the afterloader. Since the risk of catheter dis-
placement increases as the time between treatment planning and the delivery of the
fraction increases, it is essential that intra-fraction QA methods can provide a result as
quickly as possible - ideally, in real time. Therefore, the trend in QA methods has been
toward systems which can provide real-time information regarding either dose distri-
bution or source position. Clearly, passive dosimetry methods such as radiochromic
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film and TLDs are not capable of provide such information. The obvious candidate
technologies are solid-state semiconductor radiation detector systems.
Several alternatives methods for practical real-time QA in HDR PBT have been
proposed, mostly based on comparing real time in-vivo dosimetry around critical or-
gans such as the urethra and rectum with the planned dose. Comprehensive review of
real time in-vivo dosimetry in HDR brachytherapy with latest development in a field
was presented by Kertzscher [132]. However, it is also recognized that widespread im-
plementations are hampered by the lack of available high-accuracy in-vivo dosimetry
systems that are straightforward for the clinical staff to use. Metal oxide semicon-
ductor field effect transistor (MOSFET) detectors have been investigated as a tool
for real-time in vivo absolute dose measurements in HDR brachytherapy [133, 134].
The angular dependence an dosimetric response of an implantable MOSFET dosime-
ter to radiation from 192Ir and 60Co sources at a variety of dose rates was studied by
Fagerstrom et al. with a Virtual Water phantom [133]. The study shows that their
MOSFET dosimeter was more sensitive to the lower-energy radiation from 192Ir com-
pared to 60Co, and angular dependence of the MOSFET was insignificant. Qi et al.
reported on the key characteristics of a novel MOSFET dosimetry system developed
by the Centre for Medical Radiation Physics at the University of Wollongong (MOSkin
[135]), including energy dependence and angular dependence, when used to measure
the radiation field produced by a HDR brachytherapy source [134]. The deviation
between the planned dose and the dose values estimated using the MOSkin detector
were found to be consistently less than 5%. It was recently demonstrated that the
combination of MOSkin detectors placed on a surface of the rectal TRUS probe used
for planing in HDR is reliable real time in-vivo dosimetry system. It allows accurate
localization of the MOSkin on a rectal wall relative to prostate anatomy, which main-
tain a reliable comparison of measured dose with planned in real-time, avoiding error
2.4. Quality Assurance Methods in HDR Prostate Brachytherapy 43
with uncertainty in MOSkin position on a rectum wall [136].
Scintillation-based dosimetry/detector systems are an alternative to direct detec-
tion of γ-rays in silicon. There are a number of examples of scintillation-based dosime-
try systems in the literature, typically consisting of a plastic scintillator coupled to
an optical fibre placed in the urethra and rectal wall. A survey of several such de-
vices shows that they can provide an accurate dose measurement, with an angular
dependence of less than 2% and a variation in depth dose readings of less than 3%
[137, 138, 139, 140]. Archambault et al. have presented and validated a readout system
for in-vivo dosimetry based on a charge-coupled device (CCD) with multiple plastic
scintillation detector (PSD) arrays that is compatible with clinical rectal balloons
[141]. While these methods perform direct dose measurements, they only record the
dose received at single or limited number of sample points, and are unable to track
the source position in real time.
Cartwright et al. have proposed a dosimetry system in which an array of Brachy-
FOD detectors are placed within a rectal probe to measure the dose delivered during
treatment [139]. The device is capable of measuring dose delivered to different parts of
the rectal wall and can track the progression of the source in one dimension (parallel
to the needles) with an accuracy of 2 mm; this provides limited information about
the absolute position of the source within the prostate. In addition, the assump-
tion of perfect pre-treatment knowledge of catheter position make it unsuitable for
intra-operation source tracking, since the catheter position may shift between catheter
insertion and the delivery of the fraction [139]. A more complicated QA system which
can track source position without requiring explicit knowledge of catheter location has
been investigated by Espinoza et al. in 2013 [104]. A phantom combined with a silicon
diode array, the Magic Plate, was used to determine source position in three dimen-
sions based on the correlation between the measured dose and the distance between
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the source and the corresponding diode elements. This method is capable of providing
real time pre-treatment QA information, and can calculate the source position in 3D
with sub-millimetre accuracy using the radial dose function for a source-to-detector
distance (SDD) between 5 mm and 30 mm. It can also accurately provide independent
measurements of source dwell and transit time. While this QA method was demon-
strated in a phantom currently, its in-vivo application is possible by placing the Magic
Plate on a patient couch and registering in TRUS data set used for HDR planning .
A small number of methods for intra-fraction tracking of the source position in real
time have been proposed in the literature. Systems based on external imaging devices
using pinhole or similar collimators have been proposed in these methods; as they
take the most directly comparable approach to the methods proposed in this Thesis,
they are specifically discussed in the remainder of this Section. It is noted that while
several in-body dosimetric positioning methods have previously been proposed, none
of the existing imaging-based source positioning systems are designed for internal use.
Duan et al. have proposed a monitoring system composed of a dual-pinhole collima-
tor (with the pinholes being 0.5 and 1 mm in diameter, respectively) combined with
a standard radiographic screen film and an X-ray fluoroscope [142]. During source
delivery, real-time source images projected through the pinholes are captured by the
fluoroscope to verify the source movement. The source projections at all dwell posi-
tions are recorded permanently by the film, which can be used for a post-treatment
QA. The source position can be calculated using the two source projections obtained
by pinholes separated by 3 cm. The method was validated in an experiment performed
using a cubic polystyrene phantom. The source was placed at a depth of 10 cm in-
side the phantom and the pinhole collimator was located 15 cm away from the source
while the distance between the film and the pinhole was fixed at 20 mm. The source
was moved through a series of positions separated by 5 mm. An acquisition time of
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at least two seconds is required by the system in order to acquire source projections
with sufficient contrast for reliable position determination; however, optimal results
were obtained for an acquisition time of 8 seconds. The authors claimed the source
projections are distinguishable if separated by 1 mm laterally and 5 mm along the axis
of the source. However, the peaks in these acquisitions were largely merged since their
separation was smaller than the full width at half maximum (FWHM) of each peak,
which leads to a shift of the position of the centre of mass of the projection, introducing
a source of error to the calculated source position. In their experiment, the accuracy
of 3D source tracking is only investigated in case of the film measurement. For the
extended acquisition time of 8 seconds, an overall accuracy of better than one millime-
tre was observed in the reconstructed source position in three dimensions. However,
this accuracy is only relevant to the post-treatment source position reconstruction. In
addition, the spatial resolution of the pinhole/film system is insufficient to be able to
unambiguously and accurately resolve an arbitrary source position. This is because
the film is not replaced during a given HDR fraction, with the result that it is possible
that projections of the source become merged with previous projections obtained at
different depths but within the same pinhole field of view. In this case, as the images
are overlaid, the source positions cannot be resolved. Replacing the film periodically
during the treatment would be inconvenient and likely to result in additional position-
ing errors due to the need to move and disconnect/reconnect equipment. Beside the
defect of pinhole/film system discussed above, there are several shortcomings which
limit its usefulness as an intra-fraction real-time source tracking tool. The minimum
acquisition time of this system is 8 s which is too long to accomplish real-time source
tracking during the source delivery. The minimum resolvable spacing between source
positions of 5 mm is also too large for effective quality assurance, since a minimum po-
sitioning step size of 2 mm is achievable by modern HDR brachytherapy afterloaders.
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Finally, the proposed method has no intrinsic mechanism to register the calculated
source position with internal anatomical markers or the prostate itself; therefore, the
accuracy of the position measurements could be significantly affected by patient move-
ment.
Batic et al. proposed a similar real-time source tracking method using source pro-
jections collimated by a two-pinhole collimator [143]. Pixelated silicon detectors were
used as the image acquisition system in this design, which eliminates the projection
overlapping problem observed in Duan’s design. A field of view (FoV) of 20 cm diam-
eter is achieved at 40 cm away from the collimator plane, while the silicon detectors
were placed 4 cm below the pinholes. Because of the large object-to-pinhole distance, a
large pinhole aperture (4 mm in diameter) was chose to improve the detector efficiency.
The detector used in this system contains 256 pixels with a size of 1.4 mm×1.4 mm.
Experimental results are presented in which a source is moved through the FOV driven
by the afterloader. Although the acquisition time is as low as one second, the discrep-
ancy between true and reconstructed source position was an average of 4.9 mm with
a maximum error of 12 mm. This could be caused by the oversized pinhole aperture,
large source-to-pinhole distance and poor intrinsic spatial resolution of the detector.
A variation of pinhole method for source tracking was proposed by Song et al.
[144]. Instead of using source projections through pinholes, they tracked the source
position using shadows on a flat panel detector generated by spherical attenuators
(4 mm in diameter) placed between the source and the detector. In their study,
frame acquisition time of five seconds was used to obtain the shadow images from a
150 kVp Orthovoltage X-ray source. During the experiment, acquisition and storage of
images was triggered manually. However, the authors suggested that a real-time source
tracking system based on their design is feasible with an improved readout system for
the flat panel detector. While there is no information describing the measured absolute
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source position presented in the paper, a mean error of -0.7 mm was found in their
measurement of relative distance between the two nearby source positions. However,
this figure is an average of negative and positive difference. Although the sign of these
error may depend on the position of source relative to the spherical attenuators, these
informations are not discussed in the article. The mean of the absolute difference
between the real source positions and measurements is actually 1.43 mm. Although
this method may be feasible in HDR brachytherapy, no experimental results have
yet been presented showing the performance of the proposed system with an HDR
brachytherapy source, and no further development of the idea appears to have been
undertaken since 2009.
2.5 Conclusion
This Chapter summarised the current status of treatment options for prostate cancer,
with a particular focus on HDR brachytherapy, which is the subject of the quality
assurance system (HDR BrachyView ) developed in this Thesis. Studies of source
misplacement in HDR prostate brachytherapy were discussed, demonstrating the need
for a real-time position monitoring system for HDR prostate brachytherapy quality as-
surance (QA). Existing QA methods which either been applied clinically or proposed
in the literature were comprehensively reviewed. Several QA methods comparable
to HDR BrachyView were discussed in detail. The trade-off between source tracking
accuracy and detection efficiency was discussed, demonstrating the difficulty in using
external imaging systems for real-time source tracking. The need for an in-body imag-
ing system is clearly identified; the design of such a system, HDR BrachyView , is
presented in Chapter 3.
Chapter 3
Design of HDR BrachyView
system
This Chapter describes the design of the HDR BrachyView imaging system. The
proposed method of source monitoring and the global coordinate system used for co-
registration of the calculated source position within the prostate volume is introduced.
The overall arrangement of the components in HDR BrachyView probe is presented
in Section 3.1, followed by a brief introduction of TimePix detector and its associated
readout system (Section 3.2). The collimator design is presented in two sections: the
choice of collimator material and thickness (Section 3.3), and the pinhole geometry
(Section 3.4).
The HDR BrachyView system is a transrectal imaging system for intra-fraction
real-time source monitoring in the prostate volume during HDR prostate brachyther-
apy. The probe consists of a multi-pinhole semi-cylindrical tungsten collimator mounted
above an array of pixelated silicon detectors. The assembled probe is housed within a
disposable, sterile, rigid, medical grade plastic shell.
Once the source enters the field of view (FoV), the radiation emitted from source
is collimated via a double-conical pinhole and projected onto the detector array. For
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Figure 3.1: Schematic diagram showing the HDR BrachyView probe relative to
prostate phantom; seven equidistant pinholes are utilised to extend the field of view
to cover the whole treatment volume.
every source position, multiple source projections are obtained. The source position in
the treatment volume relative to the probe is then calculated by a simple backprojec-
tion method that using the centres of mass (CoMs) of the source projections and the
centres of their corresponding pinholes (Figure 3.1). Since these back-projected lines
do not always perfectly intersect, the best estimate of the source position is defined
as the point with the minimum mean squared distance to the set of all back-projected
lines.
Since the BrachyView probe provides an estimated source position relative to its
predefined coordinate system, a common or global coordinate system is needed to
establish its relative location within the prostate gland. Therefore, fiducial markers
are placed on the surface of the rigid plastic shell, which is inserted in the patient’s
rectum prior to acquiring the planning CT scan. Once the shell has been inserted,
insertion or removal of the probe results in no further tissue displacement.
The acquired CT image is used to determine the relative positioning of the shell
to the prostate and the catheters (In case of transrectal ultrasound based treatment
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planning, the registration of prostate and the global coordinate system can also be
achieved by transrectal ultrasound imaging performed in the rigid plastic shell of
HDR BrachyView probe). Transrectal ultrasound (TRUS) imaging may be performed
through the rigid plastic shell to monitor any anatomical change in the prostate or
needle positions that may require intraoperative repositioning immediately prior to
treatment and between each fraction. Finally, the TRUS probe is withdrawn and the
BrachyView probe inserted into its shell to the correct depth by an electromechanical
stepper unit prior to the commencement of treatment. TRUS imaging may be repeated
between fractions to account for any further anatomical changes in the prostate which
may occur during treatment. The ultrasound functionality will be added to the final
design of the BrachyView probe.
3.1 Arrangement of Collimator and Detector
The schematic of the proposed probe and the coordinate system used throughout this
Thesis are shown in Figure 3.1. A transrectal probe with an outer diameter in excess
of 25 mm may lead to patient discomfort during and post treatment; therefore, this
is set as the absolute maximum diameter of the rigid plastic shell surrounding HDR
BrachyView , which serves as the ultimate constraint on the dimensions of the colli-
mator and other components of the probe. In particular, the maximum outer diameter
of the probe assembly limits the thickness of the collimator, the detector width (along
the x axis) and its placement relative to the pinhole centre. The magnification factor
of a pinhole camera is defined as the ratio of the object (source) to pinhole distance
(hsp) to the distance between the pinhole and the imaging plane (detector) (hpd):
MF =
hsp
hpd
(3.1)
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Figure 3.2: Illustration of the collimator
During the HDR treatment, the prostate is enlarged and the source may be placed
between 5 mm to 45 mm away from the top surface of the collimator (5 mm ≤
hsp ≤ 45 mm). The ability to image the source within the entire potential treat-
ment volume is crucial to the success of the proposed QA system; therefore, while the
detector array should be positioned as far below the collimator as possible in order to
maximise the size of the projections, it must not be placed so far below the pinholes
as to artificially limit the field of view to less than the full potential treatment volume.
A three-dimensional drawing of the semi-cylindrical tungsten collimator is shown
in Figure 3.2. In order to ensure that at least two projections of the source are visible
from all positions within the prostate volume, seven pinholes are uniformly spaced
at intervals of 6.5 mm along a straight line parallel to the y axis of the probe. The
detector plane is positioned close to the central axis of the probe’s outer cylindrical
shell, with the sensitive volume of the detector located 8.5 mm below the pinhole
centre (i.e. hpd = 8.5 mm)). The cross-section of the probe and the collimator are
shown in Figure 3.3.
An imaging area of 14 mm×56 mm (256 × 1024 pixels) is made by seamlessly
tiling four Timepix detectors. When combined with the multi-pinhole collimator, the
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Figure 3.3: Cross section of the probe (top half)
FoV is extended to the full prostate volume in the yz plane. Furthermore, the probe
can be rotated around its axis to track the source in the xz plane and ensure that
the catheter remains within the FoV. The lower half of the probe houses a passive
cooling system. The surrounding rigid shell ensures the probe is capable of rotating
smoothly during the treatment and acts as a barrier between the tungsten shell and
the rectal wall. The dose enhancement in the vicinity of tissue-tungsten interfaces in
HDR brachytherapy will be discussed in detail in the Chapter 5.
3.2 Detector and Data Acquisition System
Two main requirements govern the choice of pixelated solid-state imaging device for
HDR BrachyView . Firstly, the short source dwell time in HDR prostate brachytherapy
requires a photon detection system with a sufficiently fast readout time. Secondly, high
detector image resolution is essential, since as the source-to-probe distance (hsp) is
increased in the z direction, its projection is minified such that the physical movement
of the source is scaled to a smaller change in the position of the projection. Therefore,
a high-resolution device is needed in order to achieve sufficient accuracy when the
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source is located near the extremities of the treatment volume.
The pixelated silicon ASIC Timepix is a derivative of the well-known Medipix2
device. Timepix is a radiation-hardened 256×256 array of single-pixel analog/digital
pulse processing cells with a common CMOS digital readout system. The chip is de-
signed to be bump-bonded to a flip-chip pixelated array of 256×256 55 µm×55 µm
semiconductor radiation sensors, each of which produces a charge pulse whose ampli-
tude is proportional to the energy of the incident particle or photon. The Timepix chip
satisfies both the high resolution and fast readout requirements, and its dimensions
are compatible with the constraints of HDR BrachyView [145, 146].
The material and thickness of the sensor array is selected based on the application,
with silicon wafer thickness of 300 µm available as the standard option. Since the
majority of photons emitted from 192Ir are above 100 keV, the signals generated by
the detector with silicon sensor are mainly contributed by the incoherent scattering
interactions of photons and silicon. Considering that HDR BrachyView tracks source
positions only using the centre of the source image, its accuracy mainly depends on
the symmetry of counts distribution to the projection centre rather than a well de-
fined projection shape. In this case, the requirement of quantum efficiency is low. The
standard 300 µm thick silicon sensor is sufficiently sensitive to the energy of photons
emitted from HDR PBT sources such as 192Ir (validated by both simulation and ex-
periment results presented in Chapter 6 and 7). Thicker silicon substrates (500 µm
or 1 mm) or higher Z semiconductors such as GaAs and CZT are also available to
improve the sensitivity and detection efficiency of the device in future design[147, 148].
A schematic of the assembled detector is shown in Figure 3.4
Each analog signal processing cell within Timepix is radiation-hardened and in-
cludes a preamplifier, discriminator and counter [149]. Discriminators are used to sup-
press noise and select the energy range of interest; the discriminators can be adjusted
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Figure 3.4: Schematic of the Timepix detector coupled electrically to a pixelated
radiation sensor array[146].
globally and with a per-pixel fine adjustment to compensate for the non-uniformity of
detector response. Each pixel of Timepix can be independently configured to operate
in one of the following four modes [149, 146]:
 Masked mode, in which no counts are collected for that pixel (for example, if the
pixel is permanently damaged);
 Medipix mode, which counts the number of detected particles but does not pro-
vide temporal information
 Time over Threshold (ToT) mode, which permits the measurement of particle
energy; and
 Time of Arrival (ToA) mode, which permits the measurement of the time of
interaction of each particle.
For this application, Timepix is used in count mode. The schematic of an individual
Timepix pixel is shown in Figure 3.5. The block diagram is divided into the following
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Figure 3.5: Schematic of a Timepix pixel [149]
two main functional blocks [145, 149]:
 The analog block, composed of a preamplifier which is DC coupled to a polarity-
controlled discriminator with 4 bit threshold adjustment; and
 The digital block, which includes the Timepix Synchronisation Logic (TSL) and
a Pixel Configuration Register (PCR).
An external reference clock signal is buffered and used to synchronise the internal
counters. Each pixel is configured using its own 8 bit PCR. Four bits contain control
the equaliser threashold, one bit is used as a pixel mask, and two bits are select the
mode of operation (counting, ToT or ToA) [149].
The electron-hole pairs resulting from interactions between ionising radiation and
the sensitive detector volume are collected by the detector anode (and common cath-
ode) and integrated. The output is compared to a global threshold (fine-tuned by
the 4 bit pixel specific threshold adjustment). When the pre-amplifier output exceeds
the threshold, a pulse is generated with a duration proportional to the input pulse
height (i.e. time spent above the threshold). The readout process for the entire chip
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Figure 3.6: Schematic of the Fitpix interface [151]
is triggered when the shutter signal goes high; when the shutter is low, the counter
for each pixel is incremented after each detected photon when the chip is operating in
Medipix (counting) mode, while in ToT mode it increments with each clock pulse (at
a rate of 10 MHz) while the pulse exceeds the threshold and in ToA mode the counter
counts from the moment of detection until the moment of readout, giving a timestamp
for the first event detected prior to readout [149].
An associated Field Programmable Gate Array (FPGA) controlled USB readout
system (Fitpix) is used to communicate with the detector; its block diagram is shown
in Figure 3.6. The Fitpix data acquisition system consists of a FPGA, and analog
and digital interfaces to the chip. It also provides a bias voltage to the detector
(powered from the USB interface) and supports all of the Timepix modes of operation.
Through its associated user interface Pixelman, the mode of operation (counting, ToT
or ToA), clock frequency and source (internal/external) and trigger mode (internal,
external) are chosen [150]. A single Fitpix module can manage an array of up to
sixteen Timpix chips, making it a suitable interface to the quad-Timepix array used
in HDR BrachyView .
Therefore, the complete imaging system consists of a 4 × 1 array of Timepix de-
tectors and their associated FPGA-controlled USB readout system (Fitpix). The total
sensitive detector area is 15 × 60 mm2 (with a thickness of 300 µm). The Timepix/-
Fitpix system allows a frame rate of about 20 frames per second to be obtained with
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very low electronic noise [152, 149].
3.3 Collimator Material and Thickness
The material and thickness of the semi-cylindrical shell collimator is selected to block as
many of the photons which do not intersect with the apex of the pinholes as practically
possible. The previously-discussed spatial constraints limit the outer diameter of the
cylindrical shell to a maximum of 25 mm. Since the width of the Timepix detector
(along the x-axis) is 14 mm, after allowing for the thickness of the outer rigid plastic
shell, the maximum possible thickness of the collimator is 4 mm.
The remainder of this Section provides a brief introduction to the physics of photon
interactions with matter and the mass attenuation coefficient, followed by discussion
on the choice of the HDR BrachyView collimator material and its performance along
with the impact of penetrated photons on the signal to noise ratio.
3.3.1 Photon Interaction with Matter and Photon Attenua-
tion
When traversing a region containing matter, photons may interact with the medium
through absorption or scattering, or penetrate the medium without interaction. Which
of these outcomes applies to a given photon is random, however the probabilities of
each case are well-defined and depend on the properties and thickness of the material.
Assuming the probability a photon’s absorption along its path through some material is
µ per unit thickness, then the fraction of photons which penetrate through a thickness
L of this material is expressed by the following equation [153, 154]:
NL
N0
= e−µL (3.2)
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where N0 is the number of incident photons and NL is the number of penetrat-
ing photons. This equation does not account for secondary photons (e.g. resulting
from fluorescence). µ is a linear attenuation coefficient and determined by weighted
composition of material, atomic number of ingredients and photon energy. It is of-
ten normalised by the density of the attenuating material as the ratio µ/ρ; in this
form it is referred to as the “mass linear attenuation coefficient”. Equation 3.2 can
be rearranged to express the number of photons which penetrate a slab of material of
thickness L:
NL = N0 × e−µL (3.3)
This model applies to the situation where a collimated radiation beam is attenuated
by an obstruction and detected by a small detector - that is, a photon can only reach
the detector if it did not interact with material comprising the obstruction. A table of
mass linear attenuation coefficient for elements (from Z = 1 to 92) and some common
compounds (for energies between 1 keV and 20 MeV) can be found on the National
Institute of Standards and Technology (NIST) website [155]. Generally, the mass
linear attenuation coefficient is higher when the atomic number is higher.
In the case where multiple kinds of interactions must be considered during the
attenuation, µ can be expressed as:
µ =
n∑
i=1
µi (3.4)
where µi, the partial linear attenuation coefficient, refers to the probability of the
ith process occurring when a photon travels through a unit depth of material.
Photons and matter can interact in five different ways, the three most important
of which are the photoelectric effect, Compton scattering and pair production; the
other two interactions, Rayleigh scattering and photonuclear interaction, would occur
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extremely rarely in this application and are not discussed here. The probability with
which an interaction occurs when a photon travels through some material is mainly
determined by the energy of the photon and the atomic number of the material. For a
given material, the dominant interaction at low photon energies (above the minimum
ionisation energy for the element or compound) is the photoelectric effect; as energy
increases, Compton scattering increasingly dominates (although photoelectric interac-
tions are still possible); and for energies exceeding the rest mass of an electron-positron
pair, pair production (particle-antiparticle pair generation) begins to become more
probable, dominating at high energies. For example, for photons travelling through
lead (Z = 82), the photoelectric effect dominates at photon energy above 7.41666 eV
and below approximately 500 keV, pair production dominates at photon energy higher
than approximately 4.5 MeV and Compton scattering dominates for the photon energy
range in between. Let τ , σ and κ be the partial linear attenuation coefficients for the
photoelectric effect, Compton scattering and pair production respectively. (3.4) can
be written as:
µ = τ + σ + κ (3.5)
By substituting (3.5) into (3.2), the fraction of photons which do not interact after
passing through a depth of L of matter can be written as:
NL
N0
= e−(τ+σ+κ)L (3.6)
In HDR brachytherapy, the radiation from the source usually contains photons
with a range of different energies. In this case, The total population of the photons
after attenuation by matter can be calculated as the sum of the remaining photons
calculated for each energy separately. Assuming that the radiation beam contains
photons with n different energies, the total number of photons (N0) before attenuation
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can be expressed as:
N0 =
n∑
i=1
N0 × pi (3.7)
where pi is the emission probability of photons with energy in the ith energy bin.
Let µi be the linear attenuation coefficient for the ith energy. Applying (3.3) to (3.7),
the population of photons remaining in the beam after attenuation by a material of
thickness of L for photons beam with multiple energies can be obtained as:
NL =
n∑
i=1
N0 × pi × e−µiL (3.8)
or in the form of fraction:
NL
N0
=
n∑
i=1
pi × e−µiL (3.9)
3.3.2 Comparison of the Attenuation of Photons from HDR
Source for Different Collimator Materials
192Ir is most commonly used radioactive source in HDR brachytherapy, and is a source
of both β and γ radiation. The therapeutic action is primarily due to the γ-rays
emitted from 192Ir →192Os electron-capture decay, which results in a range of γ photon
energies. The spectrum of photons emitted by 192Ir is complicated, covering energies
ranging from 10 keV to nearly 900 keV with an average energy of 380 keV. Although
a rough calculation of photon attenuation can be performed using the mean energy,
ignoring the true energy spectrum will result in an overestimate of the value of NL
N0
when the absorbing material is thin, and an underestimate when the material is thick.
When a multi-energy photon beam enters an attenuating medium, photons with lower
energy are more likely to be attenuated (i.e. µ is larger); conversely, higher-energy
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Figure 3.7: NL
N0
calculated with the linear attenuation coefficients of all energies in-
cluded in 192Ir emitting photon spectrum for different attenuating material.
photons are more likely to pass through (µ is lower). Thus as L increases, the lower-
energy photons are more severely attenuated than the high energy photons leading to
a shift in the average energy towards the high-energy end of the spectrum.
Table 3.1 listed the mass lineear attenuation coefficients and linear attenuation coef-
ficients for tungsten, lead and gold at all the energies included in 192Ir ’s spectrum[156,
155]. These materials are potential candidates for HDR BrachyView ’s collimator due
to their high attenuation coefficients. Since most of the specific energies of interest
are not specifically listed in NIST’s data, the actual value of mass lineear attenuation
coefficient for each energy listed in Table 3.1 is a linearly interpolation between the
two closest energies listed in NIST’s published. The linear attenuation coefficients are
calculated by multiplying the mass lineear attenuation coefficients with the density of
each material.
The ratio NL
N0
for each of the three proposed materials is calculated using the full
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Tungsten Lead Gold
Primary
Energy
Emission
Prob-
ability
(%)
µ/ρ
(cm2/g)
µ
(cm−1)
µ/ρ
(cm2/g)
µ
(cm−1)
µ/ρ
(cm2/g)
µ
(cm−1)
10.5 keV 2.46 217.518 4187.228 120.125 1362.213 107.082 2066.685
64 keV 4.54 3.225 62.090 4.501 51.037 4.059 78.346
75 keV 1.22 9.442 181.767 3.070 34.808 2.771 53.475
136.5 keV 0.08 2.365 45.522 2.968 33.662 2.750 53.084
201.5 keV 0.20 0.777 14.967 0.990 11.222 0.913 17.625
205.5 keV 1.41 0.759 14.612 0.966 10.952 0.891 17.202
283.5 keV 0.11 0.400 7.696 0.501 5.685 0.465 8.968
295.5 keV 12.21 0.345 6.632 0.430 4.875 0.399 7.701
308.5 keV 12.7 0.313 6.018 0.389 4.407 0.361 6.969
316.5 keV 35.04 0.302 5.816 0.375 4.252 0.349 6.728
374.5 keV 0.30 0.226 4.350 0.276 3.128 0.258 4.977
416.5 keV 0.28 0.183 3.532 0.221 2.502 0.207 4.000
468.5 keV 20.23 0.155 2.984 0.184 2.084 0.173 3.348
484.5 keV 1.34 0.146 2.816 0.172 1.955 0.163 3.147
489.5 keV 0.18 0.144 2.763 0.169 1.915 0.160 3.085
588.5 keV 1.90 0.113 2.167 0.129 1.463 0.123 2.379
604.5 keV 3.45 0.109 2.092 0.124 1.406 0.119 2.290
612.5 keV 2.23 0.108 2.070 0.123 1.390 0.117 2.264
884.5 keV 0.12 0.075 1.435 0.081 0.921 0.079 1.526
Table 3.1: Primary 192Ir photon energies with their respective emission probabilities,
mass lineear attenuation coefficients and linear attenuation coefficients.
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spectrum of 192Ir and plotted in Figure 3.7. Among the three materials, gold offers the
greatest photon attenuation, followed by tungsten and lead. Although lead has the
highest atomic number and mass lineear attenuation coefficients among these three
materials for photons with energy above 100 keV, its linear attenuation coefficient is
the smallest because of its relatively low density compared to gold and tungsten. As
shown in Figure 3.7, the curves level off (i.e. NL
N0
does not significantly change with
respect to the thickness of material) beyond approximately 8 mm for tungsten and
gold and 10 mm for lead. Furthermore, to attenuate 90% of the photons emitted
by 192Ir , requires a thickness of 4.7 mm for gold, 5.3 mm for tungsten and 7.4 mm
for lead (calculated with the full spectrum of 192Ir ). Although gold would be the
best choice of material for its ability to attenuate photons emitted by 192Ir , tungsten
is almost as effective while being a fraction of the cost and with greatly superior
mechanical properties (hardness and strength). Therefore, tungsten is chosen as the
optimal material for the HDR BrachyView probe.
As previously mentioned, it is impractical to make the wall of HDR BrachyView
thicker than 4 mm. Thus, with a 4 mm thick tungsten collimator, a non-trivial fraction
of the photons emitted by the 192Ir source will still able to penetrate the collimator.
The effect of these penetrated photons will be investigated in the following section
(Section. 3.3.3).
3.3.3 Impact of Penetrated Photons on Source Imaging
In pinhole-collimated imaging system, the photons arriving at the detector can be clas-
sified into three categories: direct photons, penetrated photons and scattered photons
(Figure 3.8). Direct photons are defined as photons reached the detector by travelling
through pinhole aperture. Both penetrated and scattered photons are photons which
have travelled through the collimator body before they reach the detector. The dif-
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Figure 3.8: This figure shows three classes of photons detected by detector - direct,
penetrated and scattered (+ secondary). An intensity profile of an acquired image is
also plotted to illustrate the different components of the image.
ference is that penetrated photons have no interaction with the collimator material,
while scattered photons have interacted with the collimator material, resulting in a
change in momentum [157]. In these Thesis, secondary photons (those resulting from
X-ray fluorescence in the collimator) are also included in the scattered photons.
For a pinhole gamma camera, these three classes of photons contribute to different
components of a image. All of the direct photons, which contain most of the useful
information of source position, contribute to the projection of an image of the source
onto the detector plane. The scattered (and secondary) photons no longer provide
much useful information regarding source position because their momentum is changed
during the interaction with the collimator. Thus, the scattered photons manifest as
two-dimensional random noise, with a maxiumum directly under the source and a
very wide spread; this contributes to a continuum of background noise in the image.
Penetrated photons retain some information regarding source position, although they
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have passed through the body of the collimator. However, it is difficult to make use
of the source position information carried by the penetrated photons during the back
projection since they are not collimated by pinhole. The penetrated photons have two
significant impacts on imaging in HDR BrachyView . The first is due to penetration
through the edge of the pinhole, where the thickness of the collimator is less than in
the main body of the collimator. This has the effect of enlarging the source projection.
The second effect is a region of pixels in the area of the detector immediately under the
source with excess counts compared to the background. This effect is more significant
when the source is closer to the collimator, since as the source moves farther away,
the radiation field resulting from penetrated photons becomes both less intense and
more uniform across the detector. Importantly, for 4 mm thick tungsten, the photon
counts seen in the penetrated component of the image are much lower than those in
the direct projection component, while the scattered / secondary photon component
is even less significant. Although HDR BrachyView uses the CoMs of the observed
projections to track the position of source centre independently of the size of the
source projections, the effect of photon penetration through the edge of the pinholes
may still contribute a small error in determining the CoMs. This is because other
than the case where the source is immediately above the pinhole, the attenuation of
photons passing through different regions of pinhole edge will be different, which will
result in a small asymmetric perturbation of the source projections. In addition, if the
source projections are too large, the projections of the source from two neighbouring
pinholes may overlap. This problem can be avoided by ensuring sufficient separation of
pinholes and limiting the collimator-detector distance; the ability of HDR BrachyView
to distinguish the projections from two adjacent pinholes is validated in Chapter. 6.
The second effect of penetrated photons - the increased photon counts immediately
under the source - will be treated specifically later in this subsection.
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As illustrated in Figure 3.8, the high count region immediately under the source is
denoted the penetration source shadow (PSS). The Direct source projection (DSP) is
defined as the area of pixels with counts corresponding to the detection of direct pho-
tons. The extended region surrounding the DSP region caused by photons penetrating
through the edge of pinhole is defined as penetration penumbra (PP). The combination
of DSP and PP is denoted the extended source projection (ESP). However the exact
region of ESP is difficult to define due the highly specific dependence on the geome-
try of the source position, pinhole geometry and pinhole location. For simplicity, any
region of source projection including the DSP and all or part of the PP is referred to
as ESP.
As previously discussed, the thickness of the HDR BrachyView collimator is 4 mm.
From the calculation of NL
N0
(plotted in Figure 3.7), more than 16% of photons from
an 192Ir source are able to pass through a 4 mm thick tungsten collimator. These
penetrated photons boost the level of background counts, resulting in the need to use
a higher threshold to properly isolate the ESP or DSP. Thus, a critical capability for the
HDR BrachyView probe is whether the source projections can be distinguished from
the PSS. To validate the capability of source projection isolation in HDR BrachyView
, the signal to background ratio (SBR), which is represented by the ratio of the counts
in each pixel in region of PSS (CPSS) and DSP (CDSP ) will be considered.
Considering a photon beam with a fixed spectrum. The photon count observed
in each pixel (C) in a photon detector is proportional to the number of photons that
impinge on the detector (N , which can be expressed as:
C = A×N (3.10)
where A is a coefficient determined by the spectrum of photon and the properties
of the detector. Assuming the response of all pixels in the detector is uniform, and
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Figure 3.9: Figure demonstrating the calculation of NPSS
NDSP
. h is the height between the
source and the top surface of detector; t is the thickness of the collimator; θ is the
incidence angle from the source to pinhole centre; β is the incidence angle from the
source to an arbitrary pixel of the detector; W is the width of pixel.
neglecting the effect on A of changes in the spectrum resulting from attenuation due
to the passing through the patient’s body and the collimator, for a photon counting
detector, CPSS and CDSP can be expressed as:
CPSS = A×NPSS (3.11)
CDSP = A×NDSP (3.12)
where NPSS and NDSP are the number of photons which arrive at each pixel in the
PSS and DSP regions, respectively. Thus,
CPSS
CDSP
=
NPSS
NDSP
(3.13)
Let Ntotal be the total number of photons emitted from the
192Ir source per unit
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time, β be the angle of photon incidence to an arbitrary pixel, h be the height of source
above the detector plane and Spixel be the area of each pixel (Figure 3.9). The number
of photons which can reach an arbitrary pixel per unit time can be expressed as:
N =
Spixelsinβ
4π( h
sinβ
)2
×Ntotal ×
n∑
i=1
pi × e−µiL (3.14)
Assuming the source is placed above the full thickness of the collimator (i.e., outside
of the acceptance cone of the pinhole), the maximum value of NPSS is obtained when
β = 90◦. This is denoted as MPSS. Then, NPSS and NDSP can be derived from (3.14)
as:
MPSS =
Spixel
4πh2
×Ntotal ×
n∑
i=1
pi × e−µit (3.15)
NDSP =
Spixelsinθ
4π( h
sinθ
)2
×Ntotal =
Spixelsin
3θ
4πh2
×Ntotal (3.16)
Here, θ is the incidence angle of direct photon (Figure 3.9). The term
∑n
i=1 pi×e−µit
in (3.15) is the fraction of photons that can pass through the body of the collimator,
which has been derived previously in (3.9) and shown to equal approximately 16% for
the case of the HDR BrachyView collimator. By dividing (3.15) with (3.16), the ratio
of MPSS and NDSP is:
MPSS
NDSP
=
∑n
i=1 pi × e−µit
sin3θ
(3.17)
Then, substituting the value of 16% into
∑n
i=1 pi × e−µit into (3.17), a formula
yielding MPSS
NDSP
for the HDR BrachyView design can be obtained as:
MPSS
NDSP
=
0.16
sin3θ
(3.18)
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Figure 3.10: Ratio of MPSS and NDSP against θ
Figure 3.10 shows a plot of MPSS
NDSP
calculated using (3.18) with θ from 90◦ to 30◦.
Since MPSS
NDSP
is proportional to sin−3θ, it increases slowly with the decreasing of θ at
the beginning, then rapidly increasing with decreased θ. MPSS becomes larger than
NDSP when θ is smaller than 32
◦. In this case, the projection of the source cannot be
distinguished from the background by simply applying a threshold. Although an edge
detection method may be able to detect the edge of the projection, it is difficult to
apply in reality, since unexpected structures or patterns may also be detected by the
edge detection algorithm when the background is not successfully filtered out.
The algorithm for the segmentation of source projections will be discussed in Sec-
tion 4.2.1.
3.4 Pinhole Geometry
Two different pinhole geometries were considered for the HDR BrachyView collimator:
a single-cone and double-cone structure. The two alternative designs were evaluated
via Monte Carlo simulations with a simulated 192Ir point source. The results from
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these simulations were compared in terms of sensitivity, signal to background ratio
and resolution in order to choose the optimal pinhole geometry for this application.
This section begins with the designs of both single-cone and double-cone pinholes,
followed by an introduction to the Geant4 Monte Carlo simulation platform. The
results from a set of Monte-Carlo simulations is presented to compare the performance
of the two alternative pinhole designs, resulting in the adoption of the double-pinhole
geometry. The optimal position of the pinholes along the central axis of the probe
is then calculated such that the probe can unambiguously resolve the source position
anywhere within the entire prostate volume.
The concept of ideal centre of mass (CoMi) for a projection is defined here for
convenience. The CoMi of a projection of an active source through a pinhole is defined
as the projection of the centre of the source’s active volume onto the detector plane
through the centre of such pinhole. It is distinct from the CoM of the projection image,
which is affected by many geometric and physical artefacts, including the penetrated
and scattered photons and the path length differences travelled by photons emitted
from different points along the axis of a cylindrical point source. The actual CoM
obtained from these images is only an approximation of CoMi.
3.4.1 Design of pinholes
The detector is placed 1.5 mm above the central axis of the probe (Figure 3.3). To
maximum the FOV, the optimal acceptance angle of the pinholes, denoted α, is de-
termined as:
α = 2× tan−1( Wd
2×Hpd
) (3.19)
where Wd is the width of the detector (14 mm) and Hpd is the height of pinhole
centre above the detector plane. For the double-cone pinhole (Figure 3.11(a)), the
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Figure 3.11: Cross section of the probe showing different potential pinhole geometries.
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centre of pinhole’s aperture is located half-way through the thickness of the collimator
body. In this case, Hpd = 8.5 mm, resulting in α = 82
◦. For the single-cone pinhole,
the centre of the pinhole’s aperture is located on the inner surface of the collimator.
This results in a Hpd being 2 mm less than for the double-cone geometry. Therefore,
the opening angle α = 98◦, which is slightly larger than for the double-cone design
(Figure 3.11(b)). Instead of using a knife-edge pinhole, a 0.5 mm diameter cylindrical
channel is added at the aperture of pinhole to increase the fraction of direct photons
and to simplify the alignment of the drilling of the two cones in the double-cone design
(by the use of a pilot hole).
3.4.2 Monte Carlo Simulations with Geant4
Geant4 is a C++-based Monte Carlo simulation platform which is capable of accurately
modelling the interactions of radiation and matter [158, 159]. Geant4 was originally
developed for use in high energy physics, but is increasingly being used for other
applications including space science and medical physics. A Geant4 simulation requires
the following to be defined:
 The geometry of the simulation;
 The physics interactions;
 The generation of primary particles; and
 The acquisition of data through the simulation.
Accurate models of complex structures can be built with the help of the abstrac-
tions provided by Geant4. Geometries in Geant4 are defined through three layers: the
solid volume, logical volume and physical volume. The geometry of the each component
is defined in the solid volume. Geant4 provides functions to create a group of elemen-
tary shapes and a set of operations which may be performed between these shapes.
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Irregular shapes can be achieved by the intersection or union of the basic geometries.
The logical volume defines the physical properties of the component, such as the ma-
terial properties and whether it is a sensitive volume (i.e. part of a detector). The
material may defined in different ways, depending on whether it is a single element
or a compound; a single element can be directly defined in terms of its atomic num-
ber, mass number and density, while compounds are defined by their density and the
proportions of individual elements in the compound (which must already be defined).
After the shape and physical properties of the geometry are determined, its spatial
position and orientation in relation to the other defined components in the system
is defined by the physical volume. In Geant4, all the components except the world
volume have to be enclosed within another component, with which it has a ‘mother-
daughter’ relation. The world volume is the whole volume of the simulation, which
containing all other volumes. Each component may have multiple daughter volumes,
but only one mother volume.
The physics interactions of interest in the simulation are defined in libraries asso-
ciated with each respective particle, and in some cases a number of alternative models
can be used for the same particle. The Geant4 Low Energy package, using the Liver-
more Evaluated Data Library, was employed to model the physics interactions in the
simulations involved in this Thesis. The Livermore Library is able to accurately track
and simulate the interaction of electrons and photons in the range from 250 eV to 1
GeV, including the thresholds below which secondary particles cease to be tracked.
After a secondary particle is generated through an interaction, the energy and range
of the particle is compared to these thresholds, and will only be stored for further
analysis when its energy or range is larger than the threshold, otherwise all the energy
of the secondary particle will be considered to be absorbed in the position where it
was generated.
3.4. Pinhole Geometry 74
The primary particle is the initial particle that the simulation starts to track, and
is defined in terms of the particle type, energy, position and momentum. After the
simulation starts, the status of the tracked particles can be retrieved at different points
in the tracking process. Geant4 provides functions to access the information of the
tracked particle and its interaction with the geometric objects through which it is
travelling either before or after each calculation (either interaction or transportation
of the particles).
A comparison of different pinhole shapes using a point source is presented in the
following part of this section, since it was conducted prior to the finalisation of the
design of HDR BrachyView . The Monte Carlo evaluation of source tracking capa-
bilities of the final pinhole design is presented in Chapter 6, while the Monte Carlo
evaluation of dose enhancement in rectum due to the backscatter dose from the HDR
BrachyView probe is presented in Chapter 5.
3.4.3 Monte Carlo Evaluation of Alternative Pinhole Geome-
tries
To investigate the response of two alternative pinhole designs for HDR BrachyView
to radiation from a point 192Ir source, Monte Carlo simulations were performed using
Geant4.9.4. In this subsection, the geometric models for a double-cone and single-
cone pinhole design are described, and the results of the Monte Carlo simulations of
each design will be evaluated in term of sensitivity, signal to background ratio and
resolution.
3.4.3.1 Simulating Single-Cone vs. Double-Cone Pinhole Geometries
The models of single-cone and double-cone shape pinhole described in Section 3.4.1
were developed in Geant4. The point source images obtained with these models were
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(a) Transversal cross-section of double-cone
pinhole geometryl
(b) Transversal cross-section of single-cone pin-
hole geometry
(c) Longitudinal cross-section of double-cone
pinhole geometry
(d) Longitudinal cross-section of single-cone
pinhole geometry
Figure 3.12: Visualization of Geant4 models with different pinhole design.
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analysed to select the best pinhole geometry for HDR BrachyView . Figure 3.12
illustrates the simulations for evaluating the two proposed pinhole geometries. The
collimator was modelled as a cylindrical tungsten tube with a wall thickness of 4 mm
and is shown in Figure 3.12(a) and 3.12(b). The pinholes (shown in blue in Figure 3.12)
with double-cone and single-cone pinhole geometries (as discussed in the previous
description) were modelled in corresponding simulations. In this group of simulations,
only one pinhole is simulated at a time, as this is sufficient to compare the sensitivity,
signal-to-background ratio and spatial resolution achievable with each design. The
pixelated silicon detector (shown in green in Figure 3.12) is placed 1.5 mm above the
central axis of the tungsten collimator. To simplify the geometric description of the
pinhole in Geant4, the area immediately surrounding the pinhole was approximated as
a trapezoidal prism (shown as the red trapezoid in Figure 3.12). A 0.6 mm diameter
sphere of 192Ir, encapsulated in a 0.15 mm thick steel shell, was used as the model for
the point source (shown as the red dot in Figure 3.12). The geometry of the steel shell
is identical to the thickness of the model of the microSelection HDR source (192Ir)
used to simulate the attenuation of the source shell [156]. For both models, the centre
of the point source was placed 5 mm above the collimator and 2.34 mm away from
the centres of the of pinholes, which are spread parallel to of the axis of probe. The
materials and their compositions are shown in Table 3.2.
Limited to the computing time, it is not feasible to generate the total number of
photons emitted in 1 s by a HDR source. 20 billion photon events were generated
in each simulation, which are sufficient to generate a solvable image. The photon
energy distribution was generated according to the spectrum of 192Ir (see Table 3.3)
[156]. It is assumed that all beta radiation is absorbed by the steel shell and the
surrounding phantom. To improve the simulation speed, different thresholds for the of
production of secondary particles were applied by creating a virtual volume of interest.
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Table 3.2: Table shows the materials used in the GEANT4 simulations
Compound Element
Weight
(%)
Atomic Number
Mass Number
(g/mole)
Density
(g/cm3)
Water
H 66.67 1 1.01
1
O 33.33 8 16
Steel
Si 1 14 28
8.02
Cr 19 24 52
Mn 2 25 54.9
Fe 68 26 55.8
Ni 10 28 58.7
Air
N 75 7 14
1.2 × 10−3
O 25 8 16
Ir 77 192 22.39
W 74 183.84 19.25
This virtual volume is a cylinder with a diameter slightly larger than the probe and
concentric to the probe (shown as the yellow circle in Figure 3.12(a) and 3.12(b)).
The cut-off range of secondary particles was set as 4 mm outside the virtual volume
and 1 µm inside the virtual volume (secondary particles with range smaller than the
threshold will release all their energy at the place it generated and will not be tracked).
In each pixel, the energy deposited was recorded for each event and a count will be
generated when the energy deposited by an event was exceeding a threshold (16 keV).
The simulated projection maps obtained from the simulations are then used to
evaluate the SBR, FWHM and the efficiency of the two different pinhole geometries.
The SBRs of the images were calculated as the ratio of the mean counts in two regions
selected in the projection and on the image background. A one-dimensional profile in
the direction along the axis of the probe was produced for each image by averaging
10 columns which intersect with the centre of the projection. The profile was fitted
using a Gaussian function, and the FWHMs of the projections in each image was then
calculated from the profile.
Usually, the efficiency of a photon counting detector can be evaluated using its
sensitivity. The sensitivity can be defined as the percentage of photons emitted from
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Table 3.3: Primary 192Ir photon energies and their respective emission probabilities
per decay used in GEANT4 simulations.
Primary Energy Emission Probability(%)
10.5 keV 2.46
64 keV 4.54
75 keV 1.22
136.5 keV 0.08
201.5 keV 0.20
205.5 keV 1.41
283.5 keV 0.11
295.5 keV 12.21
308.5 keV 12.7
316.5 keV 35.04
374.5 keV 0.30
416.5 keV 0.28
468.5 keV 20.23
484.5 keV 1.34
489.5 keV 0.18
588.5 keV 1.90
604.5 keV 3.45
612.5 keV 2.23
884.5 keV 0.12
3.4. Pinhole Geometry 79
the source which are detected by the detector. Since the counts generated by the
detector is proportional to the number of photon detected, the sensitivity of each
design was calculated as the ratio of the total counts of the corresponding image to the
number of photons generated in each simulation. However, since the approach of HDR
BrachyView is to track the source centre using the CoMs of the source projections, the
evaluation of detector efficiency should relate to the statistics of correctly locating the
CoM. In addition to the sensitivity of the detector (represented by the total counts of
the image), the uncertainty in calculating the CoM also depends on the dispersion of
the projection from its CoM. The CoM is the sample mean of the coordinates of all the
photons detected by the detector (all counts in all the pixels) within the projection of
source. Thus, the uncertainty of using the calculated CoM to estimate CoMi can be
evaluated using the standard error of the sample mean (SEM). Statistically, the SEM
represents the range of the interval within which a given sample mean (i.e. the mean
of a sampled subset of the entire population) is expected to fall. A small SEM means
that sufficient samples have been taken to give a good estimate of the true mean value
of the population. For example, for a normally-distributed random variable, there is
a 95% probability that the for a given sample size, the sample mean will fall within
±1.96× SEM.
After the source projection was selected by applying a threshold of a certain per-
centage of the maximum count observed in the image, the SEM can be calculated
as:
SEM =
σ√
n
(3.20)
where σ is the standard deviation of the distribution and n is the sample size.
While the true value of σ is unknown, it can be estimated by the standard deviation
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of the set of samples. Then (3.20) could be rewritten as:
SEM =
S√
n
(3.21)
where S is the standard deviation of the sample set. It can be obtained by applying
a 2D Gaussian fit to the projection region or directly calculated as,
Si =
√√√√√√
∑
Proj
C(i, j) · (i− iCoM)2∑
Proj
C(i, j)
(3.22)
Sj =
√√√√√√
∑
Proj
C(i, j) · (j − jCoM)2∑
Proj
C(i, j)
(3.23)
where (iCoM , jCoM) are the coordinates of the CoM, (i, j) are the coordinate
indices of each pixel within the projection and C(i, j) is the photon count in pixel
(i, j).
3.4.3.2 Results
Figure 3.13 shows the projected images of the point source placed in the positions
described in Section 3.4.3.1 through the double-cone and single-cone pinhole designs.
From these images, it is clear that the boundary of the projection obtained from
the double-cone pinhole model is better defined compared to that obtained from the
single-cone pinhole, in which the projection is spread across the whole detector area.
The regions selected to calculate the signal to background ratio are shown as the red
squares in Figure 3.13. These two background sample regions are visually determined,
which are uniform and outside the projection region. The position right under the
source (2.34 mm from the pinhole centre) was not selected because such position
is still covered by the opening of the pinhole, which results to much higher counts
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Figure 3.13: Projection images of a point source obtained from both proposed pinhole
geometries.
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(a) Double-cone pinhole geometry
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(b) Single-cone pinhole geometry
Figure 3.14: Profiles through the centre of the source projection in images obtained
from each pinhole design. The curves fitted using Gaussian functions with a varying
number of terms are also plotted in each profile.
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Table 3.4: Characteristics of the single-cone and double-cone pinhole designs
Double Cone Single Cone
Mean Counts in Projection 256.14 269.23
Mean Counts in Backgroud 71.96 88.58
SBR 3.56 3.04
FWHM 30.00 71.00
Sensitivity 0.21% 0.33%
SEM (x direction, th=50%) 0.0214 0.0206
SEM (y direction, th=50%) 0.0212 0.0211
compared to region shielded by full thickness of tungsten. The line profile through
the centre of the projection in the image from each design is plotted in Figure 3.14.
At least 3 terms are required in a Gaussian function to accurately fit the curve to the
profile.
The SBR, FWHM, sensitivity and SEM of both pinhole designs are listed in Ta-
ble 3.4. The SBR of the image from the double-cone pinhole is 3.56, which is approx-
imately 20% higher than the SBR of the image from the single-cone design (3.04).
The FWHM of the profile for the double-cone pinhole is less than half of the FWHM
for the single-cone pinhole, which are 30 pixels and 71 pixels correspondingly. The
sensitivity of the double-cone design is lower, at approximately 63% of the single-cone
design. Considering the sensitivity calculated includes significant amount of photons
refer to the leakage of the tungsten shielding, the efficiency of the detector can not be
evaluated only by the sensitivity. Furthermore, the high sensitivity observed for single
cone shape design also indicates its lower capability of background radiation shield-
ing. In this case, the SEM is more relevant for the evaluation of detector efficiency.
The SEM in the two designs are similar in both x and y directions when the source
projections were isolated using a threshold set at 50% of the maximum.
The SEM of projections selected by different thresholds are shown in Figure 3.15.
A smaller SEM in both x and y directions was observed from the projection obtained
from the double-cone design. In particular, the SEM for the double-cone design is
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significantly smaller than the SEM for the single-cone design when the threshold is
high (approximately half for thresholds greater than 75% of the maximum). The SEMs
for both designs decrease rapidly with the reduction of threshold until it reaches 75%
of the maximum, after which the SEM of the double-cone shape design starts to
rise slowly while the SEM of the single cone design continues to gradually decrease.
The SEM of both designs converges to a similar level (approximately 0.02) when the
threshold is less than 55% of the maximum.
3.4.4 Discussion
The results demonstrate the capability of HDR BrachyView to distinguish between the
projection of a point source and the background due to the penetrated and scattered
/ secondary photons, while the boundary of the source projection is more clearly
defined in the case of the double-cone designed compared to the single-cone geometry.
Although the mean counts in the projection region of the image from the single-cone
pinhole design are slightly higher, its SBR is lower than the double-cone design because
of the high background level in the image from the single-cone design. Gaussian
functions with at least 3 terms are needed to provide a good fit to the line profile.
This is due to the complex relationship between the photon path length and the
position of detector pixels along the profile. The count distributions corresponding
to the photons travelled though the aperture of pinhole, cone shape opening and the
full thickness of tungsten could be represented by the different terms of the Gaussian
fit. The smaller FWHM observed in the image of the double-cone design is expected
since its full opening angle (the sum of the opening angle at the top and bottom of
the pinhole; the opening angle for the bottom of the single-cone design is considered
to be 180◦) is much smaller than for the single-cone design. Although the sensitivity
of the double-cone pinhole is significantly lower, the resulting from using its source
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Figure 3.15: SEM of source projection in x and y directions with varying thresholds
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Figure 3.16: Projection subsets selected by applying different thresholds (as a per-
centage of the maximum count value observed). The thresholds are from 90% to 40%
of the maximum with a step of 5%, corresponding to the projection from the top-left
corner to the bottom-right corner.
projection to estimate the CoM is superior (i.e. it exhibits a lower SEM) compared
to the single-cone design. The difference in SEM is significant when the threshold
was higher than 75% of the maximum. In practice, thresholds higher than 65% were
applied to the data from the simulations and experiments due to the high penetration
of photons, which will be discussed in detail in subsequent chapters. For a threshold
of 65%, the SEM of double-cone pinhole is still slightly lower than for the single-cone
design.
The increase observed in the SEM when the threshold is below 75% of the maximum
results from the pixels in the penetration penumbra region (defined in Section 3.3.3)
starting to distort the shape of projection, by adding more additional brightness to
one side of the projection than the other. This can be seen in Figure 3.16; after the
threshold is reduced below 75%, more scattered outliers start to appear in the area sur-
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Figure 3.17: Pinhole array capable of covering the entire potential treatment volume
prostate with at least two projections.
rounding the concentrated bright central region in the projection. The distinct regions
of direct source projection and penetration penumbra can be clearly distinguished in
the last projection in the set (with the lowest threshold of 40%).
Although the single-cone pinhole is able to provide a slightly wider FoV, it also leads
to a larger ratio of hsp to hpd, which magnifies the systemic errors in source tracking
with the pinhole imaging system. In addition, the disadvantage of a smaller FoV for
the double-cone pinhole could be overcome by increasing the number of pinholes along
the probe (to extend the FoV in the yz plane) and rotating the probe before the source
delivery in each catheter (to extend the FoV in the xz plane). Thus, the double-cone
pinhole is the best choice for the HDR BrachyView probe because of the superior
resolution, SBR and efficiency that it offers.
Following the selection of the double-cone pinhole geometry, the number and spac-
ing of pinholes can be determined in order to ensure that at least two projections of
the source are visible from all positions within the prostate volume (the source can
be tracked when two or more projections are visible on the detector). Seven pinholes,
uniformly spaced at intervals of 6.5 mm along a straight line parallel to the y axis
of the probe, will be sufficient to accomplish this. The resulting design is shown in
Figure 3.17.
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3.5 Conclusion
This Chapter presents the design of the HDR BrachyView probe in detail. Monte
Carlo simulations were performed to compare the performance of two alternative pin-
hole designs, based on double-cone and single-cone geometries. The double-cone pin-
hole geometry was chosen for HDR BrachyView over the single-cone design due to
the superior spatial resolution that it can achieve, and its ability to obtain lower un-
certainty for determining the CoM of the source projection within a given acquisition
time. However, the acceptance angle of one double-cone pinhole located within the
rectum is insufficient to cover the entire prostate. Therefore, to achieve a field of view
(FoV) which is sufficient to cover the entire target volume, a total of seven uniformly
spaced collinear pinholes were required.
In the following Chapter, the process of source tracking in three dimensions will
be discussed in detail.
Chapter 4
Image Processing and Source
Tracking
This Chapter describes the source tracking techniques used in HDR BrachyView .
Each step in the sequence is described, from image acquisition to 3D position esti-
mation. The calculation of the source position within the treatment volume is based
on an analysis of the projections of the source through the pinholes. Since the source
projections on the imaging plane are obtained by detecting the photons emitted from
each point of the source, the geometric centre of mass (CoM) of each projection repre-
sents the projection of the source centre through the corresponding pinhole (however,
as discussed in the previous chapter, a number of additional factors bias the estimated
position of the CoM). Therefore, the centre of mass of the source can be estimated
by computing the intersection of the lines projected from the CoMs of each projection
through the centres of their corresponding pinholes. In practice, due to the intrinsic
noise in the projections, the projected lines are unlikely to ever intersect at a single
mathematical point; therefore, the best solution is the point with the minimum total
perpendicular distance to the set of projection lines (i.e. the least-squares solution).
The software which implements the source position tracking algorithm is writ-
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ten in Matlab. It is highly modular, with the full three dimensional source position
calculation calculation process split into a series of independent functions, for conve-
nient debugging and future modification. Since a dedicated user interface for HDR
BrachyView will eventually be developed using C++, some of Matlab’s native func-
tions are replaced with low-level implementations to simplify porting to C++ or other
high-level languages in the future.
A general flowchart illustrating the process by which the source location is calcu-
lated is shown in Figure 4.1.
The process of image acquisition is briefly described in Section 4.1. The localisation
of the CoMs is discussed in Section 4.2 and the calculation of source position within
the treatment volume is discussed in Section 4.3. The Matlab software developed
to implement each part are also introduced, the source code of which is included in
Appendix A.
4.1 Image Acquisition
Images acquired by the detector array are recorded on a host PC, which interfaces with
Timepix through a FPGA-controlled USB readout system (Fitpix) [151]. The process
of configuring and equalising the detector and acquiring image frames is controlled by
a user interface, Pixelman, which was developed by the Medipix collaboration for use
with the Medipix2/Timepix ASICs [150]. In the final design of HDR BrachyView , a
plug-in for Pixelman will be designed for the image processing and three dimensional
source position calculation. However, at this stage, the source projection images ob-
tained from simulations or experiments were analysed by proof-of-concept software
developed in Matlab. Therefore, frames downloaded from the Timepix array via Fit-
pix and Pixelman are recorded to ASCII output files for convenient importation into
Matlab.
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Figure 4.1: Flow chart showing the process of the calculation of the source position
within the treatment volume
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4.2 Locating the CoM
The process of locating CoMs can be generalised as isolating the source projections and
averaging the coordinates of pixels in each projection weighted by the pixels’ counts.
Prior to source projection isolation, the image from HDR BrachyView probe is prepro-
cessed for the noise reduction. Threshold equalisation and gap correction/interpolation
may also be performed in this stage if required, depending on the condition of detec-
tors array (for example, if there are any regions of dead or noisy pixels). Threshold
equalisation requires calibration of the Timepix detector array in a dark environment
and in a flat radiation field; calibration coefficients are then saved by Pixelman and
can be used during subsequent acquisitions. If regions of the detectors are defective,
they can also be masked out and the missing pixel values estimated through bilinear
interpolation from either side of the damaged region. This will be discussed in greater
depth in Chapter 7, where it needs to be applied to deal with a gap caused by defective
pixels at the border of two chips in the array.
Noise reduction is performed using a 2D median filter, implemented with the Mat-
lab function medfilt2(). Since accurate localisation of the CoM is highly dependent
on the symmetry of the projection, median filtering has only a minor impact on the
accuracy of finding the CoM.
4.2.1 Projection Isolation
As discussed previously, due to significant penetration of the high energy components
in the spectrum of 192Ir through the 4 mm tungsten collimator, the background counts
are high and there is no sharply-defined boundary for the projections obtained by HDR
BrachyView system. In this case, gradient based image segmentation methods such
as the well-known Canny edge detection algorithm are not effective at isolating the
projections (Figure 4.2(b)) [160]. Instead, in HDR BrachyView , source projections are
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(a) Sample image showing a single projection
(b) Canny edge detection algorithm applied to the
sample image
Figure 4.2: Canny’s edge detection algorithm applied to a simulated source projection.
Edge detection is performed with a threshold of 0.6, which is the lowest threshold that
can remove all the background. Due to the high level of speckle in the image, the
Canny algorithm is unable to identify the boundary of the projection.
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isolated by simple thresholding. Unlike traditional thresholding which returns a binary
image, the pixel values above the threshold are retained, while pixels with counts below
the threshold are considered as background and are eliminated by setting their value
to 0. Thus, if matrix Im(i, j) represents the original image, the thresholded image
can be expressed mathematically as:
Imth(i, j) =

Im(i, j), Im(i, j) ≥ T
0, Im(i, j) < T
(4.1)
where T is the threshold. The pixels value in the region of the projection are
preserved as the weight when averaging the coordinates in each projection for the
calculation of CoM.
The optimal choice of threshold can be defined as that which results in the best
possible estimate of the CoM location. Because of the high background count from the
penetrated photons, the threshold value usually needs to be at least 65% of the max-
imum, based on observations of both simulations and experiments. In addition, the
locally optimal threshold value may change according to the source position. There-
fore, a dynamically-adjusted threshold method is necessary. Gonzalez and Woods
introduced an iterative method to automatically determine a suitable image segmen-
tation threshold, which is widely used in digital image processing [161]. It starts with
an initial estimation of the threshold T0, which is used to segment the image into two
subsets Gh and Gl:
Gh = { Im(i, j) | Im(i, j) ≥ Ti }
Gl = { Im(i, j) | Im(i, j) < Ti }
(4.2)
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Then a new threshold value can be calculated:
Ti+1 =
1
2
× (Gh +Gl) (4.3)
If the difference between Ti+1 and Ti is smaller than a predefined limit, the algo-
rithm is terminated; otherwise, it repeats until T converges. (4.3) implies that the
result of the iterative algorithm is the median value of the average of the pixel values
in the two groups delineated by the threshold. However, as previously mentioned, the
optimal threshold for CoM determination is usually larger, especially when the source
is close to the edge. Figure 4.3(b) shows the result of thresholding with the above
iterative method. Considerable background counts remain in the thresholded image.
Although this problem could be improved by weighting more to the average of Gh in
(4.3), the outcome is ambiguous and hard to precisely control. Matlab also provides an
inbuilt function (graythresh.m) which can automatically determine a threshold using
Otsu’s method, but the projections are still unable to be isolated in the threshold
image (Figure 4.3(a)) [162].
Since the statistical information in each projection depends on the its size, an
optimal method to automatically determine the optimal threshold is to use the number
of remaining pixel clusters (source projections) as the threshold condition. Assuming
only one projection is contained in the image, the size of the isolated source projection
is determine by the number total number of the pixels remaining after thresholding,
which can be assessed from the histogram of the image. Thus, a threshold method
based on the image histogram can be used to achieve a successful dynamic threshold.
In this method, the whole range of pixel counts is equally divided into Bcounts bins. A
histogram of these bins is generated as H(i) = Ni, where Ni is the number of pixels
with a count within the range of the ith bin, i = 1.2, . . . Bcounts. Then the cumulative
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(a) Otsu’s method
(b) Iterative method (Gonzales and Woods, 2004)
Figure 4.3: Images segmented by different automatic thresholding algorithms
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sum of the histogram is calculated:
CH(i) =
i∑
j=0
H(j) (4.4)
Subsequently, the threshold (T ) can be determined by comparing the cumulative
sum to the expected value of the total number of remaining pixels, which is denoted
the pixel number threshold (TPN).
T =
Mcounts
Bcounts
×max{ i | CHi ≤ CHBcounts − TPN } (4.5)
where Mcounts is the maximum pixel count value in the image. Pixels with values
less than T are considered as background and are eliminated by setting their value to
zero.
Thus, if only one source projection is obtained, this threshold method, based on
image histogram, can solve the projection segmentation problem caused by the vari-
ance of source position. However, the image obtained by HDR BrachyView usually
contains multiple source projections, with the number of projections depending on the
source position relative to the pinhole array. In this case, TPN has to be the total
number of the pixels in all of the extracted projections. In addition, due to the differ-
ence of the distances between the source and each pinhole, the overall counts seen in
source projections corresponding to different pinholes are each unique to that projec-
tion, which further leads to the disparity of the sizes of isolated projections. Problems
occur when the difference in projection sizes is too large, in which case the smallest
projection may not contained sufficient statistics to accurately calculate its CoM while
the largest projection contained too many penetrated or scattered photons. Therefore,
blindly applying this algorithm to a multi-projection image will result in unacceptably
high uncertainty in CoM determination and cause a significant systematic shift from
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the ideal centre of mass when attempting to locate the CoM (Figure 4.4(b)). This
problem can be addressed by segmenting the image into regions, each of which only
contains a single projection, and performing pixel number thresholding independently
within each region.
During the regional thresholding process, the image is coarsely segmented into re-
gions, each containing a single source projection, and different thresholds are applied
on each of these regions (the threshold could be same if the threshold method is based
on the sub-region histogram). This is achieved by using a simple weak global thresh-
old to isolate the approximate position of the projection CoMs, and then performing
image segmentation centred on these approximate locations to separate these projec-
tions from each other. The global threshold can be based on either a percentage of the
maximum count or the histogram of the image. The width of the coarsely segmented
regions is selected so that the largest expected projection size can be fully captured
in a single region. Generally, applying a single global threshold is sufficient to seg-
ment all the source projections. However, thresholding and segmentation may need
to be repeated multiple times on some sub-regions when more than 4 projections are
detected, which may occur when the source is located far away from the collimator.
In this case, after the application of the global threshold and the CoMs of recognised
projections are calculated, the size of the detector area in which no source projection
was detected (the idle region), normally located at one side of all detected projections,
is compared with the average distance between each pair of detected projections. If
the width of the idle region is larger than twice the average distance, the idle region
will be thresholded again to obtain more potential projections. If the global threshold
is based on a histogram, the TPN used on the idle area (TPNidle) is calculated according
to its ratio to the whole-detector threshold and the number of recognized projections
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(a) Before thresholding
(b) After global thresholding
(c) After regional thresholding
Figure 4.4: Source projections isolated both by global and regional thresholds. The
high count region (two vertical white strips) in the centre of Figure 4.4(a) was masked
and interpolated, and will be explicitly discussed in Section 7.3.1
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(Nproj0), which is:
TPNidle =
TPN0
Nproj0
× ⌊Nproj0 ×
Aidle
Awhole − Aidle
⌋ (4.6)
where TPN0 is the TPN just applied, Aidle is the area of the idle region and Awhole
is the area of the whole detector.
After the coarse segmentation isolates the approximate regions containing the pro-
jections, all pixels which are not included in any regions are eliminated while the
pixels within each region are left untouched. Then a TPN corresponding to the ex-
pected size of single source projection is applied to each selected region. Figure 4.4(c)
demonstrated the source projections isolated using a regional threshold method.
In addition to the pixels belong to the source projections, some individual pixels
with high counts, which are caused by noise or detector artefacts, may also remain in
the image after thresholding. These pixels are denoted ‘poison pixels’ here, as if they
are not removed, they can have a significant detrimental effect on the accuracy of the
CoM calculation. Such poison pixels can either be scattered throughout the image, or
occur in one particular row or column of the detector (typically at the edge, due to
stresses induced by physically cutting the detectors from the wafer) (Figure 4.5(a)).
Although some of the poison pixels may be gathered together as a cluster, the size
of such clusters are usually much smaller than the size of the clusters representing
the source projections. Thus, it is feasible to remove these poison pixels or clusters
by using the mathematical morphology opening operator. The opening operator is
a combination of erosion and dilation. During the opening operation, a image is
firstly eroded by a predefined pattern matrix (the structuring element), then dilated
by the same pattern. Since the erosion operation will eliminate any shape in the
target image which is too small to contain the whole structuring element, the poison
pixels can be eliminated while the cluster corresponding to the projections remain
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(a) Before applying the opening operator
(b) After the opening operator
Figure 4.5: Images demonstrating the removing of ‘poison pixels’ using the mathe-
matical morphology opening operator
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Figure 4.6: Illustration of a pixel and its 4-connected and 8-connected neighbours. The
coloured pixels are the 8-neighbours of P1, the blue pixels indicate the 4-connected
neighbours of P1, and the green pixels indicate the pixels which are 8-connected but
not 4-connected neighbours of P1
undamaged, by using a carefully-designed structure element with the proper size and
shape. Subsequently, the dilation operation is applied to restore the shape of the
source projections. Figure 4.5 shows the source projections before and after applying
the opening operator.
4.2.2 Projection Grouping
After the image is coarsely segmented, the remaining pixels (hereafter simply referred
to as ‘pixels’) are grouped into different clusters, which represent the source projec-
tions. Two kinds of grouping methods are employed in HDR BrachyView , each of
which has its own advantages and disadvantages.
The first method groups pixels on the basis of the type of spatial relationship
between neighbouring pixels. The definition of the relationship types starts from a
simple classification of the pixels in the immediate neighbourhood of a particular pixel.
The types of adjacency between two pixels (P1, P2) include 4-connected, 8-connected
and not-connected [161]. As shown in Figure 4.6, P2 is 4-connected to P1 only if it
shares a common edge with P1. The connection of pixels is transmissible, which means
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two pixels are also 4-connected, if they are both 4-connected to the same pixel, thus
building up large contiguous areas of pixel connectivity. Thus, a 4-connected pixel
cluster is defined as a cluster where all pixels contained are 4-connected. 8-connected
pixel clusters is similarly defined as having at least one common vertex or common
edge (i.e. all 4-connected pixels are also 8-connected) [161]. In HDR BrachyView ,
contiguous 8-connected pixels clusters in the thresholded image are selected as the
source projections. The selection of 8-connected pixels clusters can be accomplished
using the inbuilt Matlab function bwlabel(). An completely independent Matlab
function for image segmentation for HDR BrachyView has also been built in Matlab
for the convenience to more easily allow the code to be ported later to C++. This
code scans all the pixels in the image and examines their 8-connected pixels. One of
three operations will be performed on each image pixel, based on the relationships
with its 8-neighbours:
 A pixel will be subsumed into a cluster, if all its 8-neighbours belong to only one
existing cluster;
 If the 8-neighbours belong to multiple existing clusters, these clusters are merged
and the scanned pixel is included in the merged cluster; and
 If the 8-neighbours of this pixel don’t belong to any existing cluster, a new cluster
will be created which contains the scanned pixel as an element, .
After all pixels have been processed, the index of grouped clusters and the sets of
coordinates of all the clusters are outputted. The process of grouping pixels based on
their neighbours is illustrated in Figure 4.7
The grouping method described above relies on an assumption that the pixels in
the cluster corresponding to each projection are continually connected (8-connected).
This assumption is valid in practice because of the high activity of the HDR source,
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Locate the 8-neighbors
of scanned pixel
Include the pixel to 
the existing cluster
Merge the clusters and 
include the pixel
Create a new cluster 
with the pixel
Figure 4.7: Flow chart showing the process of grouping thresholded pixels based on
the connections of each pixel to its neighbours
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and has been validated experimentally in Section 7.3.3. However, as will be discussed
in Section 6.3, island-clusters corresponding to a single source projection might be
obtained in the threshold image, if the total number of photons counted in the image
is too low. Although this situation has only been observed in simulations, a grouping
method independent of the continuity of the cluster representing source projections is
desirable so that this case can be safely handled.
A method for grouping pixels by comparing the distance between the pixel and
the CoM of the existing cluster was developed in Matlab, which is especially well-
suited to images with insufficiently high photon count to achieve a contiguous cluster
corresponding to a single source projection. The proposed method is described in
Figure 4.8. Pixels are grouped in a cluster if the distance from a pixel to the CoM
of existing clusters is smaller than a predefined length (lD), which corresponds to
the maximum possible radius of the projection. The number and size of the clusters
increasing as each pixel in the image is scanned. The CoMs are recalculated after every
new pixel is evaluated, and the next evaluated pixel will be compared to the renewed
CoMs. Although this pixels grouping method based on their distance to the existing
CoMs can successfully select source projections even when the projection is discrete,
its application is limited by the size of the projection and the spacing between the
projections; specificlly:
 lD must to be greater than the maximum possible radius of the largest possible
projection. Failure to maintain this limitation will lead to multiple clusters
grouped in the region of a single source projection; and
 The minimum distance between the pixels in different clusters must be larger
than lD. Failure to maintain this limitation will lead to overlapping clusters
containing pixels from different source projections.
It is obvious from above limitations that this method is only effective when ∀dCoMs >
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Calculate the distances
between the pixel and 
the CoMs of exsiting clusters
Figure 4.8: Flow chart showing the process by which thresholded pixels are grouped
based on the their distance to the CoM of an existing cluster
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3 × rmax, where dCoMs is the distance between the CoMs and rmax is the maximum
radius of the projections. As discussed in Section 4.2.1, the size of each cluster can be
controlled by adjusting the threshold. The distance between the CoMs depends on the
distance between pinhole centres (dpinh), the height of source from the pinhole centres
(hsp) and the distance between the pinhole centres and the detector (hpd), which can
be expressed as:
dCoMs = dpinh × (
hpd + hsp
hsp
) (4.7)
dCoMs reduces with the increasing source height and approaches dpinh when dsp is
much bigger than dpd. Since the distance between two nearby pinholes is 6.5 mm, a
source projection radius smaller than 2.17 mm (corresponding to approximately 40
pixels) is appropriate for the application of above grouping method.
4.2.3 Calculating the Centre of the Projection
After constructing the clusters of the pixels corresponding to each projection, the po-
sition of the CoM of each projection (PCoM) is calculated by averaging the coordinates
of the pixels in each projection weighted by their pixel value (C(i,j)):
PCoM =
∑
Proj
(i, j) · C(i,j) (4.8)
By removing the weighting term C(i,j), the position of the geometric centre of
the projection (PCoG) can also be calculated. PCoG can predict the centre of the
projection more accurately (compared to PCoM with CoM i as a reference) in some
case, e.g. when pixels or regions within the selected projection were masked and
interpolated. However, using PCoG will discard a great deal of useful information,
since the actual counts in the pixels are ignored. The full process, including grouping
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and the calculation of CoM, is accomplished by a function (BV MultiCentroid())
developed in Matlab, which also outputs PCoG, dCoMs and an estimate of the number
of projections.
4.3 Localisation of the Source Position in the Treat-
ment Volume
Having determined the CoMs of the projections, each CoM is associated with a pinhole
to determine the LCPs. Without pre-knowledge of source position, the combination
of CoMs and pinholes could be ambiguous, since for many source positions there
will be less than seven visible projections. Thus, a method to choose the correct
assignment of projections to pinholes is required in order to determine the real source
position. In this section, the mapping of projection CoMs to pinholes is introduced in
subsection 4.3.1 and the final calculation of the source position within the treatment
volume is described in subsection 4.3.2.
4.3.1 Selection of Projection Pinhole Combination
The CoMs of the projections will be approximately collinear and lie on a line on
the detector plane which is parallel to the row of pinholes. Since the lines drawn
from the CoMs to their (true) corresponding pinholes should never intersect between
the collimator and the detector, the order of projection CoMs in y will be the same
as the order of the pinholes through which the lines to the source must be projected.
Therefore, for the case where the number of identified projections (Nproj) is identical to
the number of pinholes (Npinh) (i.e., seven, for the current design of HDR BrachyView
), then there is only one possible combination of CoMs and pinholes. This is normally
the case when the source is far away from the collimator and located in the FoV of all
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Figure 4.9: Example source location with four projections visible, illustrating the
ambiguity of the estimated source location; the ambiguity is resolved by considering
the relative intensity of the projections.
the pinholes. However, when the catheter is placed close to the collimator, the target
area is not covered by the FOV of all the pinholes. In this case, Nproj is likely to be
less than Npinh. The collimator placement has been deliberately chosen such that all
potential source locations within the treatment volume are covered by the FoVs of at
least two pinholes, and will therefore result in at least two projections of the source
on the detector (i.e. 2 ≤ Nproj ≤ Npinh). Thus, there will be Npinh−Nproj +1 possible
sets of consecutive pinholes through which the source may have been projected onto
the detector. Each of these sets results in a different potential source position. An
example where Nproj = 4 is illustrated in Figure 4.9.
This ambiguity can be resolved by considering the relative intensity of each source
projections. The intensity of the source projections will not be the same, due to the
inverse square law; the brightest projections will be those at the minimum distance
from the source. Therefore, either the brightest projection may be associated with
its nearest pinhole, or the centre of mass of the overall image field can be used to
determine which of the Npinh − Nproj + 1 possible sets of consecutive pinholes the
projections have actually passed through. This will uniquely identify the location of
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the source. Therefore, for the case where Nproj < Npinh, potential source positions are
calculated with all the possible combination of CoMs and pinholes. Then, the real
source position is selected by comparing the potential positions to the CoM of the
whole image.
4.3.2 Final Calculation of the Source Position Within the
Treatment Volume
As discussed in the beginning of this chapter, the source centre is defined as the point
of intersection (or the best least-squares fit if the lines do not precisely intersect) of
all the 3D lines joining visible projections to pinholes. Let the simultaneous equations
of the ith line be:

Ai1 · P +Bi1 = 0
Ai2 · P +Bi2 = 0
(4.9)
where Ai1 and Ai2 are the normal vectors of the two planes defined by the i1th and
i2th line, and P represents any point on the line. Thus, for a set ofNproj projected lines,
the coordinates of the source centre Ps are the solution of the following simultaneous
equations:

A11 · Ps +B11 = 0
A12 · Ps +B12 = 0
. . . . . .
ANproj1 · Ps +BNproj1 = 0
ANproj2 · Ps +BNproj2 = 0
(4.10)
Usually, the number of equations in this system is larger than the dimensions of
Ps (i.e. Nproj2 ≥ 2). In this case, Ps can be calculated as the least-squares solution
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of the simultaneous equations, either using a Penrose-Moore pseudoinverse matrix or
via an iterative gradient-descent method such as the Nelder-Mead simplex algorithm
implemented via the Matlab function fminsearch() [163, 164]. In either case, the
result is the point Ps which is the minimum total distance to all of the projected lines;
the gradient-descent method is currently used in the Matlab software developed for
HDR BrachyView , but the pseudoinverse method can easily be substituted.
4.4 Conclusion
In this Chapter, the source tracking process used by HDR BrachyView was discussed.
The source position is determined by finding the centres of mass (CoMs) of source
projections on an imaging plane and then back-projecting these points through the
corresponding pinholes to obtain an estimate of the three dimensional source position.
Several alternative methods for image segmentation for automatic CoM identification
were discussed, and a simple adaptive two-step thresholding method adopted. A novel
post-reconstruction projection selection method was developed to solve the problem
of multiple projection-pinhole combinations to obtain a unique solution for the source
position.
Chapter 5
Effect of Dose Backscatter from
HDR BrachyView Probe on
Rectum Dose Distribution
5.1 Introduction
In the previous chapters, the design of HDR BrachyView probe and the principle of
source tracking were explained in detail. In summary the HDR BrachyView probe
consists of an imaging plane (a 14 mm × 60 mm pixelated silicon detector) encased
within a half-cylindrical multi-pinhole tungsten collimator. Tungsten was selected as
the collimator material due to its high density and high atomic mass, which result
in good collimation despite the volumetric constraints of the probe. However, pho-
tons emitted by the source incident on the collimator surface generate backscattered
secondary electrons, resulting in an enhancement in the dose delivered immediately
adjacent to the collimator surface [165, 166, 167]. Thus, a potental concern with the
HDR BrachyView project is that increased tissue damage to the anterior wall of the
rectum may result due to its proximity to the collimator, depending on the range of
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these secondary electrons. To date, little work has been done to evaluate the dose
enhancement due to backscatter specifically from tungsten inserts, particularly for the
range of photon energies used in HDR PBT, as tungsten and tungsten alloys are rarely
used for permanent medical implants.
Substantial work exists on backscatter radiation in specific medical applications,
primarily related to the consequences of the irradiation of permanent metallic implants
used in dental prostheses and bone repairs. Radiation mucositis has been observed
in tissue immediately adjacent to regions with high electron density (such as gold
crowns, amalgam fillings and mandibular reconstructions) in patients treated with
therapeutic radiation in the head and neck region [165, 168]. Regulla et al. have
exposed single layers of mouse embryonic fibroblasts in contact with a thin metallic
gold foil and enclosed within a tissue equivalent polymethylmethacrylate (PMMA)
phantom to heavily filtered X-ray beams with mean effective energies of 40 to 100 keV
[165]. Radiation dose and cell survival curves were compared to those obtained from
irradiation of cells held between two PMMA control plates. An increase of 55% to
114% in dose was measured within the ≈100 µm airgap formed between the gold
surface and the detector (a 0.1 µm thick Beryllium oxide (BeO) layer deposited on a
thermally stimulated exoelectron emission (TSSE) substrate). The biological effect of
this dose increase was different due to the higher LET of the backscattered low energy
electrons; survival curves of the irradiated cells which were in contact with gold lack
the pronounced shoulder observed at lower doses and resemble those of cells irradiated
with high LET radiation.
Castillo et al. have reported a 17% increase in dose on the entrance side of a
stainless steel mandibular implant for a 6 MeV photon beam [168]. Farahani et al.
have measured the absorbed dose in a tissue equivalent polymer phantom adjacent
to various dental restoration materials including 18 carat gold alloy, a silver-mercury
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dental amalgam, nickel-chromium dental casting alloy and a human tooth tissue, using
GafChromic films [169]. Results demonstrate an increase in the absorbed dose of
up to a 100% in tissue on the backscatter side of the gold insert and up to 20%
adjacent to tooth tissue when irradiated by a collimated 60Co beam. Niroomand-
Rad et al. have reported an increase in dose of 22.5% and 20% for 6 and 18 MeV
photon beams at tissue-titanium dental interface in head and neck cancer patients
[170]. Ravikumar et al. have measured the change in the backscattered dose as a
function of the photon energy and the width and thickness of the inhomogeneity by
placing aluminium, steel, cadmium and lead implants of varying thickness within a
tissue equivalent phantom, irradiated by 60Co gamma rays and 6 MV and 18 MV
photon beams [171]. The measured backscattered dose was greater with lower energy
photons (1.17 MeV and 1.33 MeV photons emitted by 60Co) for all metallic implants.
Chin et al. have conducted Monte Carlo simulations studying backscatter effects of
various configurations of dental work, demonstrating an increase of up to 33% in the
absorbed dose in patients with metallic dentures undergoing radiotherapy [172]. Their
results indicate that the backscatter dose is completely absorbed within the first 3 to
5 mm of water-equivalent material.
In this Chapter, the results of experimental and simulation work to study the addi-
tional dose deposited by backscatter from the HDR BrachyView transrectal tungsten
probe in response to radiation from an 192Ir HDR source are presented. Backscatter
dose enhancement is quantified using the backscatter dose correction factor (BSDF),
first introduced by Das et al., which measures the dose enhancement effect of backscat-
ter resulting from radiation incident on the interface between a low-Z region (such as
human tissue) and high-Z region (such as a metallic surface) [173, 174].
An initial simulation of a planar tungsten collimator inside a water-equivalent
phantom was conducted, and the BSDF calculated for two source positions as a func-
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tion of distance x from the interface. The simulation was validated using an identical
experimental configuration for several different values of x. Finally, a second simula-
tion was performed using identical methodology with an accurate model of the actual
cylindrical probe used in the HDR BrachyView design; BSDF was again calculated at
a variety of locations around the collimator.
This chapter is divided into four main sections. Design of the simulation and ex-
perimental models are discussed in Section 5.2; specific simulation configurations for
two collimators (planar and cylindrical) are presented in Section 5.2.1 and 5.2.2 re-
spectively, while experimental validation of the planar simulation results are presented
in Section 5.2.1.1. Results of the simulations and experimental work are presented in
5.3; the implications of these are discussed in detail in Section 5.4. An evaluation of
the change in the dose distribution by the HDR BrachyView probe is given in Section
5.5.
5.2 Materials and Methods
All simulations and experiments described in this section use the backscatter dose
correction factor (BSDF) to quantify dose enhancement. BSDF is defined as the ratio
of the dose measured within a homogeneous tissue equivalent volume with and without
the presence of a high electron density region (Di and Dh respectively):
BSDF (E,A,w, d, t, x, Z,Θ) =
Di
Dh
(5.1)
where E is the energy of the photon beam, A is cross-sectional area of the field
at the point of measurement, t and w are the thickness and the width of the high-Z
region, d is the distance between the top surface of the high-Z region and the top
surface of the low-Z region, x is the distance between the point of measurement and
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Figure 5.1: The simulated 192Ir HDR brachytherapy source. The core consists of pure
iridium with a uniform distribution of 192Ir, surrounded by a steel shell [175].
the top surface of the high-Z region and Θ is the photon beam angle of incidence
[173, 174].
Two probe geometries (planar and cylindrical) and an 192Ir HDR brachytherapy
source were simulated using the Geant4 tool-kit. The source model used throughout
the simulations was based on a Nucletron microSelectron HDR 192Ir source, as shown
in Figure 5.1 [175, 156]. The core consists of a pure iridium metal cylinder (3.6 mm
long and 0.6 mm in diameter) with 192Ir uniformly distributed through its core volume,
surrounded by a steel shell (4.5 mm in length with an outer diameter of 0.9 mm), con-
nected to a short steel wire (2 mm long and and 0.7 mm in diameter). Primary particles
were generated using Geant4 Radioactive Decay Module (G4RadioactiveDecay). The
Geant4 Low Energy package (G4LowEnergy package), using the Livermore Evaluated
Data Libraries was employed to model low energy interactions.
5.2.1 Planar Tungsten Collimator
5.2.1.1 Experimental Configuration
The experiments were conducted at the HDR brachytherapy facilities at the St. George
Hospital Cancer Care Centre, Kogorah. The experimental configuration is illustrated
in Figure 5.2. A series of 90 mm×90 mm Computerized Imaging Reference Systems
(CIRS) Plastic Water sheets, each with a thickness of either 3 mm, 5 mm or 10 mm,
were stacked to construct a 90 mm×90 mm×100 mm tissue equivalent phantom. A
120 mm×50 mm×4 mm collimator, fabricated from a tungsten alloy (95% W, 3.5% Ni
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and 1.5% Cu) was placed immediately below the phantom; in turn, it was supported
by a further 90 mm×90 mm×20 mm slab of Plastic Water. For dose measurements
performed in the absence of the tungsten collimator, the tissue-equivalent phantom
block was simply placed directly on top of the final Plastic Water slab. One of the
10 mm sheets in the phantom assembly included a hole for the insertion of a catheter
into which the HDR brachytherapy source is inserted by an afterloader mechanism;
re-arrangement of the Plastic Water sheets allow the source to be placed either 20 mm
or 43 mm from the top surface of the collimator.
For each source position, a Nucletron microSelectron HDR afterloader remotely
inserted a microSelectron 192Ir source into the tip of the catheter. Source dwell times
were calculated to be equivalent to a 370 GBq (10 Ci) source being positioned for
10 s and 50 s at distances of 20 mm and 43 mm from the top surface of the tungsten
collimator respectively. Dose was measured at x = 0 mm, 5 mm and 10 mm from
the top surface of the tungsten collimator, using a pre-calibrated MOSkin detector.
This detector is a MOSFET based detector designed at CMRP with a sensitive volume
thickness of ≤ 1 µm, with high reproducibility between devices from the same batch
(coefficient of dispersion of 2.5%, measured using an 192Ir HDR brachytherapy source)
and a linear response up to a maximum threshold voltage of 24 V (corresponding to an
accumulated dose of approximately 70 Gy) [134, 176, 135]. For each dose measurement,
the detector was placed within a shallow groove, etched on the central axis of the
surface of a 90 mm×90 mm×5 mm Plastic Water sheet and spanning half its length.
This allowed the MOSkin detector to be positioned directly beneath the 192Ir source
at a precise distance from the top surface of the tungsten collimator. The source was
remotely moved into position for the desired dwell time by the afterloader, after which
it was retracted and safely stowed. The MOSkin threshold voltage was recorded thirty
seconds after each irradiation by the CMRP digital MOSFET readout system.
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It is anticipated that there will be a very high rate of change in the backscatter
dose near the surface of the collimator. Therefore, the actual point inside the MOSkin
detector at which the dose is measured needs to be considered. The geometry and
composition of the MOSkin detector employed in measuring the dose is such that its
effective water-equivalent depth (WED) is approximately 70 µm from its front face
[176]. Therefore, when placed in direct contact with the collimator’s surface, the dose
measurement will actually be performed at a distance of 70 µm rather than zero.
Similarly, 70 µm must be added to x for each additional measurement.
For each source position, the dose measurement procedure was repeated three times
at each collimator-sensor distance, with and without the tungsten collimator in place.
The change in the threshold voltage was calculated and converted to dose values for
each source position. The BSDF was then calculated as the ratio of the calculated
dose delivered with and without the tungsten collimator present.
5.2.1.2 Monte Carlo Simulations
Models of a 90 mm×90 mm×200 mm water phantom representing soft tissue with and
without a 90 mm×50 mm×4 mm rectangular tungsten plate (representing the HDR
BrachyView collimator) placed at the geometric centre were developed in Geant4. A
1 mm×1 mm×10 mm column of water directly above the centre of the top face of
the collimator was quantised into one hundred 1 mm×1 mm×0.1 mm rectangular
scoring voxels. One billion primary particles of 192Ir were generated with the source
model placed 20 mm above the centre of the top face of the collimator. A second
source position, 43 mm above the centre of the top face of the collimator, was also
simulated with four billion primary particles. The simulation was performed for each
source position, firstly with the tungsten collimator inside the water phantom and
secondly with the collimator replaced by the same volume of water. The ratio of dose
recorded in each scoring voxel with and without the collimator present was calculated
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Figure 5.2: The experimental configuration; measurements were made at three differ-
ent points (front face of MOSkin detector placed 0, 5 and 10 mm above the surface of
the tungsten collimator) for two different source positions (20 mm and 43 mm above
the surface of the collimator). The measurements were then repeated after the removal
of the collimator.
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to determine the BSDF for the two source positions as a function of distance x from
the centre of the front face of the collimator.
Considering the MoSkin detector used in experiment has a sensitive volume thick-
ness of ≤ 1 µm and a WED of approximately 70 µm, additional simulations with
sensitive volume thickness of 1 µm measuring the dose change within 1 mm above
the collimator is ideal to compare with the measurement from the MoSkin flush to
the collimator. However this is not feasible. The cut range of the simulation is 1 µm
and the thickness of sensitive volume should be at least 10 times of the cut range
for accurate measurement. Also a simulation with such a small sensitive volume is
unacceptably time consuming. To get a closer comparison with the MoSkin flush to
the collimator, additional simulations with sensitive volumes thickness of 10 µm (a
hundred voxels covering 1 mm above the collimator) were built to compare with the
measurement from the MoSkin flush to the collimator.
5.2.2 Cylindrical Tungsten Collimator
The dose enhancement effect of the cylindrical tungsten collimator on the surrounding
tissue was evaluated by performing Geant4 simulations with and without the probe
in a water phantom. The collimator was modelled as a 100 mm long half-cylindrical
tungsten shell with an inner radius of 8 mm and an outer radius of 12 mm. This was
placed at the centre of a 300 mm × 300 mm × 300 mm cubic water phantom. The
simulation model is illustrated in Figure 5.3. The sensitive volume used to evaluate
the dose was constructed by quantising the volume of water surrounding the probe
into scoring voxels with a cylindrical coordinate system. The sensitive volume extends
41 mm along the axis of the collimator (y ∈ {−20,−19, . . . , 19, 20} mm), divided into
41 1 mm slices; from 12 mm to 22 mm radially (along the r axis), divided into 101 con-
centric annular rings (r ∈ {12.05, 12.15, . . . , 21.95, 22.05} mm), and spans 170◦ in the
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Figure 5.3: The simulated cylindrical probe, surrounded by the tissue equivalent sen-
sitive volume, which is divided into scoring voxels in a cylindrical coordinate system.
azimuth divided into 17 10◦ sectors (ϕ ∈ {−80◦,−70◦, . . . ,+70◦,+80◦}). Therefore,
the dose is calculated for 41 × 17 × 101 = 70397 voxels, where each voxel is addressed
by its displacement along the collimator’s axis (y), the azimuth of its sector (ϕ) and
its radial distance from the probe axis (r). Again, BSDF is calculated as the ratio of
the dose measured in each scoring voxel with and without the collimator present.
5.3 Results
The following sections detail the simulation results for both types of collimator, to-
gether with experimental validation of the results for the planar collimator. All errors
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quoted or illustrated on graphs correspond to three standard deviations (99% confi-
dence intervals). dSC denotes the distance between the source and the centre of the
top surface of the planar collimator or the highest point of the cylindrical collimator;
x denotes the distance from the top surface of the collimator to the point at which
dose is measured.
5.3.1 Planar Tungsten Collimator
5.3.1.1 Monte Carlo Simulations
The BSDF values calculated for the two simulated source positions with and without
the planar tungsten collimator (described in Section 5.2.1.2) are plotted as a function
of distance x from the top surface of the collimator in Figure 5.4. For both source
positions, the BSDF approaches unity beyond a distance of 0.5 mm from the collimator.
The largest BSDF occurs near the surface of the tungsten collimator. As shown in
Figure 5.4(a) and Figure 5.4(b) the average BSDFs within 0.1 mm are 2.55±0.22 and
2.68±0.27 recorded for the source placed at 20 mm and 43 mm above the top surface
of the tungsten collimator respectively. Figure 5.4(c) and Figure 5.4(d) show a steep
BSDF gradient within 500 µm with a step of 10 µm. According to the plots, a larger
maximum BSDF and steeper BSDF gradient is obtained when the source placed at
43 mm above the top surface of the collimator. The BSDFs in sensitive volume 70 µm
above the collimator are 1.81±0.40 and 1.91±0.31 recorded for the source placed at
20 mm and 43 mm above the collimator respectively.
5.3.1.2 Experimental Validation
The BSDFs experimentally measured using the MOSkin detector are shown in Table
5.1.
The results are essentially identical for both source positions. The increase of dose
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Figure 5.4: The backscatter dose fraction (BSDF) calculated for two source positions
simulated above a 4 mm thick planar tungsten collimator. The calculated BSDFs
approach a value of 1 beyond a distance of 0.5 mm from the top surface of the tungsten
collimator.The MOSkin measurement is demonstrated as the red marker
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BSDF
Detector
face depth
(mm)
Sensitive
depth (mm)
dSC =
20 mm
dSC =
43 mm
0 0.07 1.87± 0.30 1.80± 0.69
x 5 5.07 0.98± 0.10 0.96± 0.42
10 10.07 1.04± 0.17 0.96± 0.11
Table 5.1: BSDF measured using MOSkin detector.
due to the presence of the tungsten plate is only observed in the measurement where
the MOSkin is flush to the top surface of tungsten collimator.
5.3.2 Cylindrical Tungsten Collimator
Figure 5.5 shows the BSDF as a function of distance from the top of the cylindrical
collimator (ϕ = 0◦, y = 0 mm). As distance from the cylindrical collimator increases,
the behaviour of the BSDF is similar to that exhibited in the simulation of the planar
tungsten collimator. Figure 5.6(c) and 5.6(d) show that BSDF around the tungsten
collimator is essentially independent of axial displacement for all values of r.
Figure 5.6(a) indicates that when the source is 20 mm from the collimator, the
BSDF is almost independent of |ϕ| when |ϕ| ≤ 60◦ with a peak value of 2.4, falling
sharply to unity when 60◦ < |ϕ| < 80◦ for radial distance of 12.05 mm. For larger
values of r, the falls in BSDF still occur at a similar angular threshold but are less
pronounced: while the maximum BSDF is 2.4 for r = 12.05 mm, the BSDF remains
essentially constant with respect to ϕ for all values of r and is close to unity for
r = 12.45 mm. There are two factors which are responsible for the BSDF being less
than one for |ϕ| = 80◦: firstly, at high angles of photon incidence, the backscattered
electrons will also be emitted at a very high angle (i.e. almost tangentially to the
collimator surface), leading to a very small backscatter dose immediately above the
surface; and secondly, incident photons are partially attenuated by passing through the
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Figure 5.5: BSDF directly above the centre of the simulated cylindrical tungsten
collimator as a function of r (y = 0 mm and ϕ = 0◦) for two source positions.
wall of the collimator, reducing the direct dose in comparison to the water phantom.
A similar trend is observed in the plotted BSDF values in Figure 5.6(b), where
the source is placed 43 mm above the cylindrical collimator, demonstrating a sharp
reduction in with increasing the radial distance. Larger BSDF values are observed in
comparison to the previous case for tangential incidence of radiation (|ϕ| = 80◦) which
is mostly due to the reduced angle of incidence for secondary electrons and hence their
effective back scattering in contrast to the 20 mm source-surface distance.
Heatmap surfaces illustrating BSDF as a function of y and ϕ for r = 12.05, 12.55
and 13.05 mm are shown in Figure 5.7. For each value of r, the BSDF remains nearly
constant with respect to the y axis, and its minimum value occurs when |ϕ| > 80◦.
5.4 Discussion
The simulations indicate that although there is significant dose enhancement in the
vicinity of the tungsten-phantom interface, BSDF rapidly declines to unity (that is,
no measurable backscatter dose enhancement) within a distance of less than 1 mm
from the collimator surface, both for planar and cylindrical tungsten collimator. For
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Figure 5.6: BSDF from the simulated cylindrical tungsten collimator as a function of ϕ
and y, calculated for four different values of r and two source positions (dSC = 43 mm
and dSC = 20 mm).
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Figure 5.7: BSDF values from the simulated cylindrical tungsten as a function of y
and ϕ were computed for three values of r and are shown as heatmap surface plots in
three dimensions, for the source placed at 20 mm above the collimator (dSC = 20 mm).
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the planar collimator, this result has been experimentally confirmed; at the closest
practical point of measurement (equivalent to approximately 70 µm from the collimator
surface) the BSDF was measured to be 1.87±0.10 and 1.80±0.23 for a source-collimator
distance of 20 mm and 43 mm respectively, while the dose measurements acquired at
distances of 5 mm and 10 mm from the surface of the collimator show no measurable
dose enhancement at all (BSDF is very close to unity). Therefore, based on the
MOSkin measurements it is safe to conclude that dose enhancement is insignificant
5 mm from the collimator surface in a tissue-equivalent medium, and according to
the Monte Carlo simulations, is expected to be negligible beyond 1 mm from the
collimator surface. In the complete HDR BrachyView probe design, collimator is
encased in a protective 1 mm thick medical-grade sterilisable tissue-equivalent plastic
shell - therefore the vast majority of the backscatter dose will be absorbed in this shell.
The result of experiment agreed well with the simulation with sensitive volume
thickness of 10 µm. Since MOSkin detector has WED of 70 µm, the measurements of
MOSkin flushed to the collimator are actually performed at 70 µm above the tungsten
plate within a voxel thickness less than 1 µm. The result of these measurements is
in good agreement with the value obtained in simulations when the sensitive volume
is 70 µm away the collimator. The results obtained demonstrate the ability of the
MOSkin dosimeter to characterise a very steep sub-millimetre dose gradient.
Although dose measured at tungsten interface is more than double the dose mea-
sured in the absence of the tungsten plate, this dose increase is limited to a very short
distance (approximately 1 mm) from the interface between the tungsten collimator
and the water-equivalent phantom. This is because the backscatter dose is mostly
contributed by low energy secondary electrons. This result agrees with the behaviour
described in studies published in 2004 and 2006 by Ravikumar et al. and Sathiyan et
al. respectively[171, 177], which showed that lower incident photon energy will lead
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to a shorter backscatter electron range. The lowest energy included in these studies
is 1.17 MeV (60Co) and a backscatter dose enhancement range of a few millimetres
was obtained. Since the average energy of 192Ir is around 340 keV and its spectrum
contains many low energy photons which contribute to the dose, it is reasonable to
expect a much shorter range of backscatter electrons, which is in agreement with the
results obtained both in Monte Carlo simulations and physical experiments. Although
different source-to-tungsten-interface distances will lead to variations in photon flux
density, it does not have a significant effect on BSDF, since BSDF is calculated as ratio
of dose in a volume with the same position relative to the source with and without
the presence of the tungsten inhomogeneity. Therefore, no significant difference in
BSDF was obtained when the source placed at different distances from the tungsten
interface.
The result of simulation with the cylindrical tungsten collimator shows that BSDF
is approximately constant with respect to displacement along the axis of the collimator
(for ϕ = 0◦ and constant r), which is similar to the results seen in Ravikumar’s previous
study [171]. The drop in BSDF at large values of ϕ (when y = 0 mm and r is very
small (12.05 mm and 12.15 mm)), for dSC = 20 mm is because at these angles, the
interface does not have direct line-of-sight with the source, so the photon flux reaching
the surface has already been attenuated additionally to reduction of electron back-
scattering explained earlier. The BSDF near the surface of tungsten is slightly greater
when the source is placed 43 mm above the collimator than when 20 mm; this is due
to changing angular condition of incident secondary electrons, i.e. partial reduction of
the electrons travelling tangentially to the cylindrical collimator surface.
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5.5 Conclusion
Experimental and simulation studies have been performed to investigate the backscat-
ter dose introduced by the tungsten collimator in the HDR BrachyView project. Both
Monte Carlo simulations and experiments were performed in the case of a planar
tungsten collimator, while a cylindrical collimator was investigated through simula-
tion only. Good agreement has been obtained between experiment and simulations,
confirming that the patient’s anterior rectal wall will not be exposed to a measurable
dose increase in the vicinity of the collimator when used in the final HDR BrachyView
design. This is because even though the dose is significantly enhanced at the surface
of the collimator, the short range of the backscattered recoil electrons is such that
all backscatter dose is deposited within 1 mm of the collimator surface. Since this
region is occupied by a tissue-equivalent plastic shell, the patient will not receive any
additional dose in the rectal wall or other tissues, confirming that the use of HDR
BrachyView will not cause additional radiation injury to the patient, while providing
real-time in vivo QA of treatment delivery.
Chapter 6
Monte Carlo Simulation Evaluation
of HDR BrachyView Design
6.1 Introduction
The design of the HDR BrachyView probe has been presented in detail in Chapter 3,
while Chapter 5 established that backscatter radiation from HDR BrachyView presents
no additional hazard to the patient. In this Chapter, the position-determination ca-
pabilities of the design are evaluated through Monte-Carlo simulations. Models of
tungsten collimator with single pinhole and double pinholes are established in ded-
icated Geant4 simulation applications. The single-pinhole model is used to perform
an evaluation of detector sensitivity, estimate the contrast between the projection and
the background of penetrated and scattered photons, and the evaluate accuracy of the
methods proposed for localising the CoM of source projection (as discussed in Chapter
4. The models of the double pinhole are used to examine the feasibility of distinguish-
ing between two adjacent projections and to estimate the accuracy of tracking the
source position within the treatment volume.
In the following parts of this Chapter, the geometry of single and double pinhole
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collimator simulations are detailed in Section 6.2.1 and 6.2.2. The results from the
simulations is presented in Section 6.3 followed by a detailed discussion in Section 6.4
and a conclusive summery of the result in Section 6.5.
6.2 Simulation Methodology
The overall environment of the simulations is same as the simulation described in
Section 3.4.3, including the setting of the cut value of secondary particle range, the
definition of material and physics interactions (Geant4 Low Energy package, using
the Livermore Evaluated Data Libraries was employed), etc. The model of HDR
source used in the simulations included in this chapter is the same model described in
Section 5.2. A model of 150 mm×150 mm×150 mm water phantom was established to
simulate patient body. The reason of using a relative small phantom compare to the
real human body is to accelerate the simulations, while the scatter of photons in the
full size of human body has little effect on the pinhole imaging of HDR BrachyView
. All simulations included in this chapter were developed in this water phantom.
1010 photon events were generated for each simulation (an added 10 × 109 photon
events was generated for the source placed at maximum distance from the collimator
to improve the statistic).
6.2.1 Single-Hole Collimator, Multiple Source Positions
The effect of source position on projection image contrast and count rate was studied
by simulating a single pinhole collimator and a 14 × 14 mm2 pixellated detector
(equivalent to a single Timepix device) with the source positioned in different locations.
The simulation configuration is illustrated in Figure 6.1, where the source is placed
above the collimator; h is the distance between the source and the pinhole centre and
θ is the incidence angle measured from the pinhole plane (θ = 90 is normal incidence).
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Eight simulations were conducted with three values of h (7 mm, 23 mm and 47 mm)
and three values of θ (90◦, 72◦, 57◦).
6.2.2 Simulation of two adjacent pinholes
A series of simulations were performed to evaluate the ability of the proposed collimator
geometry to resolve the source position at its minimum distance from the face of
the probe, where the ratio of penetrated to direct photons is at its maximum. A
collimator with two pinholes using the same geometry as described in Section 6.2.1
with a separation of 6.5 mm (centre to centre) was simulated. The configuration is
shown in Figure 6.2. The source was placed at a distance of 5 mm from the upper
surface of the collimator at the midpoint of the two pinholes and parallel to the Y axis
on which the pinholes lie. Ten billion photon events were simulated, and the location
of the CoMs of the resulting projections through adjacent pinholes were evaluated.
These were then used to estimate the source position.
To estimate the error in calculating the source position within the prostate volume
(i.e. simulating an error in source position in the X-Z and Y-Z planes), a second
pinhole was simulated, with the source occupying the same positions as shown in
Figure 6.1. The projection images through the second pinhole were used in conjunction
with those acquired in the single pinhole studies to estimate the source position within
the prostate volume. The error between the estimated and actual (simulated) source
position was then calculated.
6.3 Simulation Result
The projected images of the source placed in the positions described in Section 6.2.1
through the single pinhole are shown in Figure 6.3. The image intensity corresponds
to the number of counts recorded in each pixel. The range of counts is shown in the
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Figure 6.1: Source positions for the first group of simulations. Only one source position
is occupied at any given time. The source remains parallel to the plane of the collimator
throughout the procedure.
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Figure 6.2: Monte Carlo simulation set up for the double pinhole study.
colour-bar adjacent to each image.
The lowest count rates occur when the source is placed at the maximum distance
from the detector (Figure 6.3(h)), with a maximum of 17 counts per pixel recorded for
the 20 billion photons generated by the source. While the source can be resolved in
each of the simulated positions, a high background count occurs due to large number
of penetrated photons, which contributes to a degradation in signal to background ratio
(SBR). The SBR is at its minimum when the source is placed closest to the edge of
FoV (θ = 57◦). This is as expected, since the ratio of penetrated photons to direct
photons is at its maximum. The projection image corresponding to the source at this
position is shown in Figure 6.3(c); although the SBR is clearly at its lowest compared
to other simulated positions, the CoM of the projected image can still be accurately
determined. The theoretically calculated CoM i (corresponding to projection of the
source through an infinitely attenuating collimator) and the measured positions of the
CoM of source projections are marked with a x and a + respectively.
The error in estimating the location of the calculated CoM of the projected source
(+) compared to its theoretical position (x) is shown in Table 6.1. The X and Y axes
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Figure 6.3: Simulated projection images of a single pinhole collimator and source in
8 different positions within the FoV. h is the perpendicular distance between source
and the pinhole centre and θ is the incidence angle measured from the pinhole plane
(Figure 6.1). The positions of the CoM of source projections calculate from geometry
and simulation image are marked with a red x and a blue + respectively.
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Table 6.1: Error of estimated CoM on detector plane for the source in different posi-
tions.
Source position dx in detector plane (mm)
dy in detector plane
(mm)
h = 7.21 mm, θ = 90◦ 0.026 -0.012
h = 7.21 mm, θ = 72◦ -0.014 0.509
h = 7.21 mm, θ = 57◦ 0.028 0.945
h = 23.14 mm, θ = 90◦ 0.009 0.027
h = 23.14 mm, θ = 72◦ 0.191 -0.013
h = 23.14 mm, θ = 57◦ 0.055 0.155
h = 47.21 mm, θ = 90◦ -0.062 0.034
h = 47.21 mm, θ = 72◦ 0.075 0.107
are identical to those shown in Figure 3.1. The maximum error (in the detector plane)
in the X direction (dx) is less than 0.2 mm, while the most of these errors are around
0.05, which is within the intrinsic resolution of detector. The maximum error in the
Y direction (dy) occurs when the source is closest to the pinhole (h = 7 mm) and at
the edge of its FoV, and is approximately 0.945 mm.
Figure 6.4 shows the source projection image through two adjacent pinholes as
discussed in Section 6.2.2. As there is a clear separation of the two projections, it is
possible to correctly estimate the respective CoMs of each projection without contam-
ination from nearby projections.
The calculated error in resolving the centre of the reconstructed source placed at
different positions within the prostate volume is listed in Table 6.2.
6.4 Discussion
The projections observed in the single pinhole simulation (shown in Figure 6.3) demon-
strates that the SBR deteriorates at the edge of the FoV, with a minimum peak value
of 17 counts detected for the projected image of the source for 20 billion simulated
photons. However, given that the typical activity of the 192Ir sources used in HDR
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Figure 6.4: Simulation of double pinhole collimator; the distance between the pinholes
is 6.5 mm (centre to centre) and the source is placed 5 mm above the collimator and
aligned with the axis joining the two pinholes.
Table 6.2: Estimated difference in reconstructed and pre-defined source locations
within the prostate phantom.
Source position dx (mm) dy (mm) dz (mm)
√
dx2 + dy2 + dz2
(mm)
h = 7.21 mm, θ = 72◦ 0.014 -0.053 1.475 1.476
h = 7.21 mm, θ = 57◦ 0.020 -0.114 1.367 1.372
h = 23.14 mm, θ = 90◦ 0.001 -0.075 -0.358 0.366
h = 23.14 mm, θ = 72◦ 0.262 -0.248 -0.933 1.001
h = 23.14 mm, θ = 57◦ 0.168 -0.057 0.593 0.619
h = 47.21 mm, θ = 90◦ -0.280 -0.189 -0.127 0.361
h = 47.21 mm, θ = 72◦ 0.468 -0.290 1.030 1.168
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prostate brachytherapy is around 370 GBq (corresponding to a photon flux of 870 bil-
lion photons per second), it is reasonable to predict that HDR BrachyView system is
capable of resolving the source within a sub-second dwell time. Therefore, the system
is suitable for real-time source tracking.
The uncertainty values listed in Table 6.1 demonstrate that the source positioning
error on detector plane in the X direction is within the intrinsic spatial resolution
of the detector. The maximum error in resolving the CoM of the source projection
in the Y direction is 0.945 mm. This shift could be due to the asymmetry of pinhole
sensitivity with respect to the point of origin of emitted photons along the longitudinal
axis of the source. The sensitivity of a pinhole collimator St is defined as the fraction
of photons emitted from a point source that reach the camera detector, and is the sum
of the “direct” (Sd) and “penetrative” (Sp) sensitivities:
St(θ) = Sd(θ) + Sp(θ) (6.1)
where θ is the incidence angle of photons on the pinhole plane. For an aperture
with a pinhole diameter of d, the direct sensitivity calculated for a point source placed
at a distance h from the pinhole plane is given by [178]:
Sd(θ) =
d2 sin3(θ)
16h2
(6.2)
The penetrative term can be analytically determined by calculating the path length
of incident photons through the collimator from an ideal point source and then inte-
grating the attenuated flux over all points constituting a line source such as an 192Ir
seed [179]. Furthermore, the penetrative sensitivity can be further approximated, as-
suming that photons with an incident angle of θ < (π − α)/2 are mostly stopped due
to the large volume of material they traverse [179]. Therefore, for a pinhole collimator
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Figure 6.5: Analytical estimate of HDR BrachyView pinhole sensitivity (with pene-
tration) versus theta using an 192Ir point source with tungsten collimator, normalised
to 1 at θ = 90◦ and h = 7 mm.
with an opening angle of α and a diameter of d:
Sp(θ) ≈
sin5 θ tan2 α
2
8h2µ2
×
(
1− cot
2 θ
tan2 α
2
)1/2
×
[
1− cot
2 θ
tan2 α
2
+ µd csc θcot
α
2
]
(6.3)
The theoretical relative sensitivity of the HDR BrachyView pinhole is plotted for
a point source placed at different heights above the collimator (normalised for h =
7 mm and θ = 90◦) and is shown in Figure 6.5. When the source is placed 7 mm above
the pinhole, θ varies from 58◦ to 74◦ for photons emitted along the Y-axis, resulting in
an 84% variation in sensitivity across the length of the source. The predicted relative
reduction in the total sensitivity for different source positions based on the analytic
model is in good agreement with the results of the Monte Carlo simulations presented
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Figure 6.6: Geometry for asymmetric projection: Ideal centre projection is a reference
position defined as the projection of source centre on detector through the centre of
pinhole. The projection image centre is the centre position calculated from the image.
in Section 6.3.
The non-uniform distortion of the pinhole response function in the Y direction
for a linear brachytherapy source is illustrated in Figure 6.6. As the source is moved
along the Y axis (from position S to S ′), its inverted projection moves in the opposite
direction. While the Y-axis projection profile is symmetric at normal incidence angle
(θ = 90◦), the reconstructed source profile is significantly distorted when the source is
moved along the Y axis, with its CoM moving towards the pinhole. Since the variation
of the relative sensitivity along the longitudinal source axis is inversely proportional
to the square of the distance between the source and the pinhole (h2), the error in
the CoM (on the detector plane) also decreases with the increased source to pinhole
distance.
To further investigate the effect of asymmetry of pinhole sensitivity on locating the
CoM, a one dimensional sensitivity correction map was obtained from simulation and
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Figure 6.7: Figure illustrates the configuration of the simulation to obtain the sensi-
tivity correction map.
applied to the source projections presented above. Then, the errors of CoMs located
using the images before and after the sensitivity uniformity correction are compared.
The configuration of the simulation is illustrated in Figure 6.7, the model of collimator
is same as the single pinhole collimator described above. A line 192Ir source is placed at
the top surface of the collimator to cover half of the pinhole’s FoV. The line source is
parallel to the axis of the probe in the plane of X=0. The primary particles generated
in the simulation is restricted in the plane of X=0 to accelerate the computing speed.
Since the real 192Ir source for HDR brachytherapy can be regarded as a part of the
line source across half of the FoV, the distortion of the projection of real 192Ir source
can be corrected by the corresponding region of the profile of the image obtained in
this line source simulation.
A line profile of X=0 is retrieved from the image obtained from the simulation.
This profile is then normalized to its maximum (denoted as P(y),where y is the y
coordinate of the pixel) and used to correct the asymmetry of pinhole sensitivity. The
profile is plotted in Figure 6.8. The detector responds of the line source could reduce
to 30% of its responds close to the centre of the detector. The drop of responds at
the centre of the detector (in this scenario, the centre of the detector is refer to the
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Figure 6.8: Plot demonstrates the change of detector respond of a line source cover
half of the FoV along the line of X=0. The centre of the detector is represented as y
= 128.
position of detector right below the center of pinhole) shown in the profile is due to
the absence of source at the other side of pinhole’s FoV (Figure 6.9). However, since
the non-uniform distortion is not significant at the centre of the detector, the P(y) at
the region close to centre is set as one.
The source projection images from single pinhole collimator simulation are modified
by dividing the pixel values with the corresponding P(y). Figure 6.10 demonstrates
the image after the sensitivity correction. As expected the overall counts distribution
shifted toward the edge of the image. However a significant over boost of counts is ob-
served at the edge of the image, although the source projection is still distinguishable.
This over correction of sensitivity is caused by the under-estimation of sensitivity in
the correction map. It could be due to the same reason of the under estimation at
the centre of the detector, which has been discussed above. To avoid the effect of
sensitivity over-correction on the CoM locating, the sensitivity correction only applied
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Figure 6.9: Figure demonstrate the reduce of detector respond at the centre of the
detector
to the region of source projection and its perimeter. Then the CoMs of these modified
images are calculated and compared to the original results.
The improvement of the accuracy of estimating the location of the calculated CoM
caused by the sensitivity correction is presented in Table 6.3. No variation was ob-
served for the source positions of θ = 90◦, since the P(y) was set as one at the cen-
tre of the detector. The errors are significantly reduced for other source positions at
h=7.21 mm, where the effect of asymmetry of pinhole sensitivity dominants. Although
the sensitivity correction was only applied at the region of source projection, shift of
calculated CoMs toward the edge of the detector caused by over boost of sensitivity at
the edge of the detector was found when sources were placed at θ = 67◦ (close to the
edge of FoV). The significant improvement of accuracy after the sensitivity correction
validated that the asymmetry of pinhole sensitivity is a majority source of error when
estimating the position of CoM. However, it is hard to apply this correction in practise
due to its dependency of pre-knowledge of the pinhole position corresponding to the
target source projection. Thus, the evaluation of the localization of CoM in the fol-
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Figure 6.10: Images of source projection before and after the sensitivity correction
when source placed at h = 7mm, θ = 72◦ .
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Table 6.3: Error of estimated CoM in y direction on detector planewith and without
sensitivity correction.
Source position
dy in detector plane (mm)
with sensitivity correction
dy in detector plane (mm)
without sensitivity correction
h = 7.21 mm, θ = 90◦ -0.012 -0.012
h = 7.21 mm, θ = 72◦ 0.193 0.509
h = 7.21 mm, θ = 57◦ -0.215 0.945
h = 23.14 mm, θ = 90◦ 0.027 0.027
h = 23.14 mm, θ = 72◦ 0.016 -0.013
h = 23.14 mm, θ = 57◦ -0.077 0.155
h = 47.21 mm, θ = 90◦ 0.034 0.034
h = 47.21 mm, θ = 72◦ 0.050 0.107
lowing part of this chapter is still based on the source images without the sensitivity
correction.
The error in resolving the location of the source within the prostate volume varies
between 0.361 mm (where the source is directly above the collimator) and 1.476 mm
(when the source is at the edge of the field of view). While the error is significant, it is
worth noting that it was only calculated based on two projections, where as in reality,
there will be seven projections for source placed at that distance. This will ultimately
result in a more accurate estimation of the CoM of the source. Furthermore, the error
clearly includes a component which is clearly a function of source position; this is due
to the fact that the CoM of the projected image is not quite perfectly aligned with the
ideal point of intersection of the line projected from the centre of the source. Therefore
it will be possible to develop a model for the error as a function of position, either via
simulation or experimentally using a calibration procedure, which can correct for this
systematic component of the error. This issue will be addressed in the future phase of
research.
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6.5 Conclusion
The simulation results presented in this Chapter indicate that HDR BrachyView
should be able to accurately determine the position of the 192Ir source centre from
multiple images projected on an array of Timepix detectors through a series of pin-
holes in a tungsten collimator within the minimum the dwell time of the source. Several
sets of Geant4 simulations have been performed to validate the design. These sim-
ulations show that there is a small shift toward the perpendicular projection of the
pinhole centre on the detector plane in each image, which is a result of the asymmetry
of the projected image when the source is not placed directly above the pinhole. The
simulation results show that the errors in estimating the CoM of the projection in
the detector plane will not exceed 1 mm in the worst case, and that the positioning
error decreases when the source is placed further away from the collimator. The simu-
lated double pinhole studies indicate that the maximum error in calculating the source
position within the prostate volume will be less than 1.5 mm.
A partial prototype of the HDR BrachyView system has been developed with
two tiled Timepix chips (14 mm × 28 mm, half of the proposed detection area in
the complete design, and sufficient for the purpose of this research. Experimental
studies with this prototype collimator and an actual HDR source have been performed
in a phantom to validate the simulation results; the result of these experiments are
presented in next Chapter.
Chapter 7
Experimental Evaluation of HDR
BrachyView Design
7.1 Introduction
The previous Chapter characterised the expected performance of HDR BrachyView
in detail via Monte Carlo simulations. The results from simulations indicate that a
maximum error of 1.5 mm within the maximum extent of the prostate volume can
be obtained within a sub-second acquisition time (with the source up to 45 mm away
from the collimator’s top surface). Furthermore, additional Monte Carlo simulations
and preliminary experimental work presented in Chapter 5 have demonstrated that
the dose enhancement at the rectal wall resulting from backscatter from the tungsten
wall of HDR BrachyView probe is negligible provided that the probe is encapsulated
in a tissue-equivalent plastic shell with a thickness of at least 0.5 mm.
This Chapter presents an experimental validation of the range and accuracy of
source position tracking using the HDR BrachyView probe. It starts with a feasibility
validation of the design using a planar tungsten collimator with a single Timpix detec-
tor. Next, a prototype of the HDR BrachyView probe is introduced. A comprehensive
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experimental evaluation of HDR BrachyView is performed using this prototype, and
the results are presented.
The rest of this chapter is structured into two main sections. The preliminary
experimental validation of the feasibility of the HDR BrachyView design is presented
in Section 7.2; the complete evaluation of a system using a limited prototype of HDR
BrachyView is presented in Section 7.3.
7.2 Experimental Feasibility Study with Planar Col-
limator and Single Timepix
7.2.1 Material and Methods
The experimental study was performed at St. George Hospital Cancer Care Cen-
tre, Kogorah, NSW. The objective of this study is to validate the feasibility of HDR
BrachyView design in terms of its sensitivity and experimental uncertainty, in partic-
ular to assess the reliability of determining the CoM of the source projection (no 3D
image reconstruction being performed at this stage; this will be explored in Section
7.3. Figure 7.1 shows the experimental apparatus, which consists of a 4 mm thick
planar tungsten collimator with seven double-cone pinholes positioned 9 mm above a
single Timepix detector (as measured from the top surface of detector to the centre
plane of collimator). The planar collimator is used in this experiment rather than the
cylindrical collimator as it permits more convenient repositioning of the detector for
preliminary experimental characterisation of the design, and is considerably easier and
cheaper to manufacture.
A catheter was placed inside a solid water prostate phantom, in a channel which
is parallel to the collimator pinholes and positioned 45 mm above the central axis of
the collimator. This height was selected as the worst case in terms of source tracking
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Figure 7.1: Experimental apparatus.
accuracy and uncertainty which are proportional to the source to detector distance.
The source positions in a close proximity of the detector plane may also be interesting
to study. However, due to single Timepix was used in this experiment, it is difficult
to obtain multiple full size source projections for most source depths in the catheter
placed most close to the detector (5 mm above the collimator surface). Measurement
of source placed to a close proximity will be interesting to investigate the FoV of HDR
BrachyView system in the future study with a prototype of full length Timepix detec-
tor array. A Flexitron afterloader was used to deliver a 192Ir source into the phantom
via the catheter. At the time of the experiment, the source activity is approximately
217.6 GBq; this source was stepped through the catheter in 1 mm increments, with a
dwell time of 1.7 s for each source position. This dwell time is equivalent to 1 s for a
standard 370 GBq source, which is calculated by afterloader system.
The Timepix detector was coupled to the Fitpix USB data acquisition module and
connected to a dedicated data acquisition laptop. The detector was operated with
a frame duration of 0.5 seconds per frame, with each frame displayed in real time
via the Pixelman user interface. The index of the frame which registered the first
source projection was recorded as the start frame. Since the source dwell time is 1.7 s,
the 3 frames following the start frame correspond approximately to one particular
source position. The position of the CoM for each projection in these images was
then calculated as per the methods discussed in Chapter 4. As shown in Figure 7.2,
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Figure 7.2: Schematic showing distance between CoMs
the distance between the CoMs of any two adjacent source projections (Dc) can be
expressed as:
Dc =
hpd + hsp
hsp
× Dp (7.1)
where hsp is the distance between the source and collimator, hpd is the distance
between the detector and the collimator, and Dp is the distance between adjacent
pinholes.
Because the value of hsp, hpd and Dp were kept constant as 45 mm, 9 mm and
6 mm, respectively, throughout the experiment, Dc on the detector plane also remains
constant and is expected to be 7.2 mm. This quantity was measured and used to
estimate the uncertainty of the HDR BrachyView probe in locating the projection’s
CoM.
7.2.2 Results
Two projection frames in which the source has been projected through adjacent pin-
holes on the detector are shown in Figure 7.3. The position of the centres of mass
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Figure 7.3: Projection images of the source through two pinholes on the detector plane
for two different source positions; exposure time is 0.5 s.
180 190 200 210 220 230 240 250 260
0
5
10
15
Frame number
C
e
n
tr
e
 p
o
s
it
io
n
s
 o
n
 d
e
te
c
to
r 
p
la
n
e
 (
m
m
)
in
 d
ir
e
c
ti
o
n
 a
lo
n
g
 s
o
u
rc
e
 m
o
v
e
m
e
n
t
Figure 7.4: Positions of the source CoM on the detector plane
of the source projections through two adjacent pinholes for all source locations were
plotted and are shown in Figure 7.4. The movement of the projection on the detector
plane along the direction of the source movement in constant increments is clearly vis-
ible. The measured distance between the centres of mass of two adjacent projections
on the detector plane is also shown in Figure 7.5. The average distance between the
two projections in same frame was measured to be 7.1±0.1 mm and are shown for all
source positions. This value is with a good agreement to the expected value (7.2 mm).
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Figure 7.5: Distance between CoMs of projections on detector plane
7.2.3 Discussion
The experiment serves to validate several basic concepts used in the HDR BrachyView
design. Although the experiment does not yet provide an estimate of the error of
the estimated source position in three dimensions, it is a necessary preliminary step
in quantifying the error in the detector plane (which is directly related to the final
positioning error via the geometry of the detector and collimator arrangement).
The plot of the CoMs (Figure 7.3) demonstrates the capability of HDR BrachyView
to resolve the projection CoMs when the source was placed 43 mm above the collimator.
The Timepix has not been masked or equalised, and the raw response of the detector
can be seen in the images, which show an interesting concentric artifact resulting from
non-uniformities in the doping of the detector’s semiconductor substrate (bias voltage
of 100 V was applied to the sensor). The appearance of a minority of samples in an
adjacent position are due to the difference between source dwell time and interval of
samples. Since the frame duration is 0.5 s per frame and every third frame was plotted,
the interval between samples is 1.5 s which is 0.2 s shorter than the source dwell time
(1.7 s). This makes it possible that two adjacent plotted frames are obtained when
source is in same position. The value of hsp of 43 mm corresponds to the most distant
extent of the maximum prostate size that HDR BrachyView probe is expected to need
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to be able to to track with the specified sub-1 mm accuracy, which represents the worst
case of ‘minification’ seen within the treatment volume.
As shown in Figure 7.5, the consistency of the distance between the CoMs of two
projections in each frame is a confirmation of the ability of the system to precisely track
the CoM of the source image independently of the angular view of the source. The
distance is estimated with a maximum error of 0.2 mm on the detector plane, which
includes the uncertainty of both CoMs. Therefore, for the source locations evaluated
(43 mm above the plane of the centre of the collimator), the maximum error in CoM
location determined by the HDR BrachyView probe is approximately 0.1 mm
7.3 Evaluation with HDR BrachyView prototype
A HDR BrachyView prototype has been fabricated and its accuracy in tracking the
HDR source for sub-second dwell times was evaluated experimentally. The design of
the HDR BrachyView prototype and the experimental configuration are detailed in
Section 7.3.1. The resulting source positions are presented and compared with planned
positions in Section 7.3.3. A thorough analysis of the results including a discussion on
the possible sources of error is presented in Section 7.3.4. The conclusion and possible
approaches to improve the accuracy of source tracking are provided in Section 7.4.
7.3.1 Material and Methods
The design of the prototype implementation of HDR BrachyView is described in sub-
section 7.3.1.1. The experimental configuration is detailed in subection 7.3.1.2. Finally,
a description of the data processing methods is given in subsection 7.3.2.
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7.3.1.1 Design of HDR BrachyView prototype
The prototype is developed based on the design of HDR BrachyView described in
Chapter 3, while a small modification has been applied due to the different geometry
of the Timepix array provided by the manufacturer. As shown in Figure 7.6, the
prototype probe consists of a semi-cylindrical tungsten collimator, coupled to a semi-
cylindrical aluminium base of the same diameter which houses two tiled Timepix
detector arrays. The Timepix detectors array is located at one side of the probe axis
while the PCB is connected at the side of the detector array. The detector array
includes two 14 mm × 14 mm Timepix detectors, providing a total 14 mm × 28 mm
sensitive detection area. Although this is smaller than the full HDR BrachyView
design, it was the only working multi-detector module available at the time of the
experiment, so a full four-detector array could not be tested. However, a two-detector
array is sufficient to demonstrate the source tracking accuracy of the resulting system.
The array of two Timpix detectors in the prototype is capable of covering half of the
target volume. This is sufficient for the evaluation of the probe performance by moving
the source within the first half of the FoV.
Seven equi-distant double-cone pinholes (centre-to-centre spacing of 6.5 mm) were
machined into the collimator, parallel to the central axis of the probe. The axis of
the pinholes is right above the central axis of the detector array. The geometry of
the truncated double cone pinholes and their preferred placement have been discussed
in previous Chapters. However, the geometry of the prototype board on which the
Timepix chips were mounted were such that it was not possible to align the centre
of the detectors with the centre of the collimator tube. Therefore the pinholes were
fabricated with the same offset as the detectors to maintain the alignment of pinholes
centre and the centre of detector array. As shown in Figure 7.6, such an arrangement
of detector array and pinhole array results in a pinhole centre to detector distance of
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Figure 7.6: Schematic diagram showing the cross section of the prototype.
9 mm and an acceptance angle of the double cone pinhole of 90◦. A cylindrical channel
with a diameter of 0.5 mm and a length of 0.5 mm connects the top and bottom cones.
7.3.1.2 Configuration of Experimental Apparatus
The experiment was again conducted at the HDR Brachytherapy facilities at the St.
George Hospital Cancer Care Centre, Kogorah, NSW. The experimental apparatus
consists of four main components: the HDR BrachyView prototype probe, a linear
translational stage, a simplified prostate phantom, and a HDR brachytherapy source
delivered by an Flexitron HDR afterloader. The experimental configuration is shown in
Figure 7.7(a). A schematic of the probe and the Plastic Water phantom is illustrated in
Figure 7.7(b). A global Cartesian coordinate system was introduced and is also shown
in Figure 7.7(b), with its origin placed at the top left corner of the first detector (first
row and first column of the imaging plane).
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(a) Experimental Configuration (b) Schematic
Figure 7.7: The experimental configuration showing the probe, translational linear
stage and the phantom; the relative positioning of the components and the coordinate
system is shown in Figure 7.7(b)
The phantom comprises a series of 90 mm × 90 mm Computerized Imaging Ref-
erence Systems (CIRS) Plastic Waterrsheets, each with a thickness of either 5 mm
or 10 mm and optimised for photon energies from 15 keV to 8 MeV (agree with water
within 1%). A 2 mm diameter channel was etched halfway along the central axis (y
axis) of a 90 mm × 90 mm × 10 mm Plastic Water sheet. This allowed for the insertion
of a catheter into which a 192Ir HDR brachytherapy source was remotely moved by a
Flexitron HDR afterloader. In each catheter, the source was moved into six preplanned
positions along the y axis, starting at the entrance of the catheter within the phantom
and moving in positive y direction in steps of 4 mm. The Plastic Water sheets were
rearranged to place the catheter either 40 mm or 60 mm above the detector plane
of the HDR BrachyView probe along the y axis, as illustrated in Figure 7.7(b) and
Figure 7.8.
A Newport M-460A-XYZ linear translational stage with a 1 um accuracy was used
to move the probe laterally (along the x axis) in four 2.5 mm steps, relative to the
phantom and the catheter. A total of eight catheter positions were thus simulated.
The position of the phantom relative to the probe is shown in Figure 7.8(a), where
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Table 7.1: Planned Source Positions for each test.
Test
Source Positions
x (mm) y(mm) z (mm)
1 7
6 positions from
8.5 to 28.5 with
a step of 4
37
2 7 57
3 9.5 57
4 9.5 37
5 12 37
6 12 57
7 17 57
8 17 37
the front face of the phantom is offset from the centre of the first pinhole by 0.3 mm,
due to the mechanical constraints of the experimental apparatus.
Source dwell times were calculated for an equivalent full strength 192Ir source, with
an air kerma strength of 40.7 mGyh−1m2. A 43 s dwell time at each preplanned source
position was calculated by the Nucletron treatment planning system, equivalent to a
20 s dwell time for a full strength source. A list of all planned source positions is
provided in Table 7.1.
7.3.2 Image Acquisition and Source Position Computation
The two Timepix2 chips were calibrated and equalised to ensure a uniform response
across the full array and were configured to continuously acquire and record frames
at a rate of ten frames per second. Groups of ten frames were accumulated to pro-
duce images with an effective acquisition time of one second; an average of 18 such
images were collected for each source position, with any frames captured during source
movement being discarded. The images collected for each source position were then
individually processed to extract the centres of mass (CoMs) of all visible projections,
which is used as an approximation for the projected source centre. The CoMs were
backprojected through their corresponding pinholes and the three dimensional source
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(a) Longitudinal Cross-section
(b) Transversal Crosss-ection
Figure 7.8: The cross-sections of the HDR BrachyView prototype probe, the phantom
and the planned source positions. The experimentally evaluated catheter positions are
marked within the phantom. Sheet boundaries are omitted.
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location, the point with the least square distance to these rays is found for each one-
second acquisition. The mean source position estimate and corresponding standard
deviation for each source position were then calculated across the set of images for
that position.
The detail of the image processing and the calculation of source position in the
volume has been explained in detail in Chapter 4. For the prototype probe, an ad-
ditional complication was that the pixels at the boundary between the two adjacent
detectors were observed to suffer from very high levels of background noise. Therefore,
the counts recorded by these pixels are replaced by a linear interpolation between the
neighbouring pixel values. An example of the detector response recorded before and
after the correction is shown in (Figure 7.9).
7.3.2.1 Film Verification of the Displacement in y Direction
The source displacement along the y axis was independently verified using a set of film
projection images, taken concurrently with the measurements acquired by the HDR
BrachyView probe.
Gafchromic®EBT3 films were cut into 90 mm × 90 mm pieces and inserted be-
tween the plastic water sheets comprising the phantom, 5 mm below the centre of the
catheter. The source was moved into five pre-planned positions along the y axis in
steps of 10 mm, starting at the entrance of the catheter within the phantom. The
measurements were repeated for two source to detector plane distances of 40 mm and
60 mm.
The source projection images on each films were analysed and their CoMs were
calculated. The y coordinates of the CoMs were compared with the source positions
tracked by the HDR BrachyView probe.
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Figure 7.9: Source projection shown at the boundary of the two Timepix detectors;
the non-uniform response of the detector array has been corrected using linear inter-
polation.
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(c) Source positions plotted in x-z plane
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Figure 7.10: Figures demonstrate the coordinates of calculated and planned source
positions.
7.3.3 Results
The mean calculated source positions are plotted in Figure 7.10, both in three dimen-
sions and projected on to the three main planes of the coordinate system (defined in
Section 7.3.1.2); nominal (planned) source positions are shown in red for comparison.
The difference between the calculated and planned source positions is greatest in the
z (vertical) direction, with the error in x slightly greater than for y at z = 40 mm and
the error in y greater than that in x at z = 60 mm.
The mean and standard deviation of the experimentally-estimated source positions
are listed together with the nominal (planned) source position, mean error in each
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Table 7.2: The coordinates of calculated and planned source positions for a vertical
source displacement of 40 mm from the top surface of the detector plane. Standard
deviation is denoted SD. The total error between planned and measured/estimated
source position dtotal =
√
d2x + d
2
y + d
2
z.
Planned
(mm)
Mean Estimated Source Positions
(mm)
Difference
(mm)
x y x SDx y SDy z SDz dx dy dz dtotal
7.1 9.8 7.2 0.03 9.5 0.04 39.8 0.15 0.1 -0.3 -0.1 0.3
7.1 13.8 7.2 0.02 13.5 0.09 40.6 0.14 0.1 -0.3 0.7 0.8
7.1 17.8 7.2 0.03 17.5 0.09 40.8 0.20 0.1 -0.3 0.9 1.0
7.1 21.8 7.3 0.03 21.2 0.14 40.5 0.20 0.2 -0.6 0.6 0.9
7.1 25.8 7.2 0.03 25.6 0.07 40.4 0.16 0.1 -0.2 0.5 0.5
7.1 29.8 7.2 0.02 29.1 0.12 39.9 0.19 0.1 -0.7 0.0 0.7
9.6 9.8 9.9 0.03 10.1 0.05 39.8 0.16 0.3 0.3 -0.1 0.4
9.6 13.8 9.9 0.04 14.0 0.23 40.8 0.30 0.3 0.2 0.9 1.0
9.6 17.8 9.9 0.05 18.1 0.04 40.8 0.22 0.3 0.3 0.9 1.0
9.6 21.8 9.8 0.03 21.7 0.05 40.2 0.16 0.2 -0.1 0.3 0.4
9.6 25.8 9.8 0.03 26.0 0.11 40.1 0.15 0.2 0.2 0.2 0.3
9.6 29.8 9.9 0.03 29.8 0.09 40.1 0.16 0.3 0.0 0.2 0.4
12.1 9.8 12.3 0.04 10.0 0.05 39.5 0.14 0.2 0.2 -0.4 0.5
12.1 13.8 12.3 0.04 13.9 0.03 40.0 0.14 0.2 0.1 0.1 0.2
12.1 17.8 12.4 0.04 18.0 0.06 40.2 0.13 0.3 0.2 0.3 0.5
12.1 21.8 12.2 0.04 21.5 0.08 39.7 0.17 0.1 -0.3 -0.2 0.4
12.1 25.8 12.2 0.04 25.9 0.07 39.6 0.14 0.1 0.1 -0.3 0.3
12.1 29.8 12.3 0.02 29.8 0.06 39.7 0.11 0.2 0.0 -0.2 0.3
14.6 9.8 14.8 0.05 9.9 0.06 40.0 0.18 0.2 0.1 0.1 0.2
14.6 13.8 14.9 0.05 13.8 0.04 40.6 0.17 0.3 0.0 0.7 0.8
14.6 17.8 14.9 0.07 17.8 0.03 40.8 0.20 0.3 0.0 0.9 0.9
14.6 21.8 14.8 0.06 21.4 0.11 40.6 0.23 0.2 -0.4 0.7 0.8
14.6 25.8 14.8 0.05 25.9 0.07 40.2 0.15 0.2 0.1 0.3 0.4
14.6 29.8 14.8 0.05 29.7 0.09 40.1 0.14 0.2 -0.1 0.2 0.3
dimension (the difference between planned and estimated positions) and overall mean
error in Table 7.2 and 7.3 for nominal vertical (z) source-detector distances of 40
mm and 60 mm respectively. Larger errors (nominal to measured) and uncertainties
(standard deviation between measurements) were found for the larger vertical source-
detector distance, especially in the z direction. For 60 mm nominal vertical source-
detector distance, the four largest positioning errors of 2.0 mm, 1.8 mm, 2.1 mm and
1.7 mm were observed when the source was at the front of the phantom (i.e. when
y = 9.8 mm) for each of the four respective values of x. The errors observed in
these positions are significantly greater than for other source positions, for which the
maximum overall error is 1.4 mm. The main contributing component to the overall
error is an error in the z direction, which is negative for the extreme values of y (at
the front surface of the phantom and at the end of the catheter). There is also a
smaller positive error in z for the central y positions. It is noted that this pattern in
the positioning error is not observed at z = 40 mm; a complete explanation of this
error is presented in Section 7.3.4.
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Table 7.3: The coordinates of calculated and planned source positions for a vertical
source displacement of 60 mm from the top surface of the detector plane. Standard
deviation is denoted SD. The total error between planned and measured/estimated
source position dtotal =
√
d2x + d
2
y + d
2
z.
Planned
(mm)
Mean Estimated Source Positions
(mm)
Difference
(mm)
x y x SDx y SDy z SDz dx dy dz dtotal
7.1 9.8 7.0 0.07 9.6 0.08 57.9 0.50 -0.1 -0.2 -2.0 2.0
7.1 13.8 7.0 0.09 13.1 0.07 59.4 0.63 -0.1 -0.7 -0.5 0.9
7.1 17.8 6.9 0.09 17.1 0.12 60.9 0.69 -0.2 -0.7 1.0 1.2
7.1 21.8 6.9 0.07 20.7 0.08 60.8 0.63 -0.2 -1.1 0.9 1.4
7.1 25.8 6.9 0.06 25.1 0.20 60.4 0.66 -0.2 -0.7 0.5 0.9
7.1 29.8 6.9 0.06 28.9 0.17 60.1 0.59 -0.2 -0.9 0.2 0.9
9.6 9.8 9.7 0.08 10.7 0.10 58.3 0.50 0.1 0.9 -1.6 1.8
9.6 13.8 9.7 0.08 14.0 0.16 60.0 0.77 0.1 0.2 0.1 0.2
9.6 17.8 9.6 0.10 17.9 0.25 60.8 0.75 0.0 0.1 0.9 0.9
9.6 21.8 9.5 0.07 21.4 0.09 60.8 0.60 -0.1 -0.4 0.9 1.0
9.6 25.8 9.5 0.10 25.3 0.23 60.3 0.74 -0.1 -0.5 0.4 0.6
9.6 29.8 9.4 0.07 28.8 0.16 59.7 0.60 -0.2 -1.0 -0.2 1.0
12.1 9.8 11.9 0.12 10.9 0.09 58.1 0.64 -0.2 1.1 -1.8 2.1
12.1 13.8 12.1 0.11 14.4 0.09 60.3 0.60 0.0 0.6 0.4 0.7
12.1 17.8 12.1 0.11 18.3 0.13 60.8 0.71 0.0 0.5 0.9 1.0
12.1 21.8 12.0 0.09 22.0 0.18 60.4 0.68 -0.1 0.2 0.5 0.5
12.1 25.8 11.9 0.09 26.1 0.20 60.4 0.85 -0.2 0.3 0.5 0.6
12.1 29.8 11.9 0.10 29.7 0.21 60.5 0.64 -0.2 -0.1 0.6 0.6
14.6 9.8 14.2 0.12 10.4 0.08 58.4 0.66 -0.4 0.6 -1.5 1.7
14.6 13.8 14.3 0.13 13.8 0.10 60.4 0.74 -0.3 0.0 0.5 0.6
14.6 17.8 14.4 0.17 17.7 0.09 61.3 0.79 -0.2 -0.1 1.4 1.4
14.6 21.8 14.3 0.12 21.2 0.12 60.7 0.79 -0.3 -0.6 0.8 1.0
14.6 25.8 14.1 0.14 25.0 0.21 59.7 0.68 -0.5 -0.8 -0.2 1.0
14.6 29.8 14.2 0.13 28.9 0.21 60.6 0.64 -0.4 -0.9 0.7 1.2
Figure 7.11: Film image obtained for 5 source positions at z = 60 mm, with y-axis
steps of 10 mm. The image obtained for z = 40 mm is essentially identical.
7.3. Evaluation with HDR BrachyView prototype 164
Figure 7.11 shows the image recorded on EBT3 Gafchromic film (placed 5 mm
below the source) when the source is located 60 mm above the top of the detector
(the image obtained when the source is located at z = 40 mm is essentially identical,
since the source-film distance is also 5 mm). Five horizontal source displacements
were evaluated using this method for each value of z; however, only three full source
images were obtained at each position. From left to right, only part of the image of the
first source position is visible on the image, and the optical density of the last source
image is significant lower than the others. Thus, only the three full source images
were used for comparison with the source positions tracked by the HDR BrachyView
probe. Table 7.4 shows the three source positions in the y direction as measured by
film and the HDR BrachyView probe, for both values of z. The differences between
the two methods are up to 0.31 mm for all measured source positions.
Table 7.4: Measured position of source in y direction, as measured by EBT3 film
placed 5 mm from the source and the HDR BrachyView probe. The height listed in
the table is measured from the bottom of the phantom.
Measured distance of source centre from the edge of the phantom (mm)
Height (mm) Film HDR BrachyView Difference
25
9.96 10.05 -0.09
19.60 19.87 -0.27
29.68 29.86 -0.18
45
9.71 9.9 -0.19
19.73 19.84 -0.11
29.38 29.69 -0.31
7.3.4 Discussion
The measurement of the source position when the source was placed at a nominal
height of 60 mm above the detector plane demonstrates the performance of the HDR
BrachyView probe in terms of source tracking accuracy and consistency in the worst
case for both sensitivity and minification. Standard deviations of less than 1 mm
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Figure 7.12: Illustration of the calculation of z, demonstrating the overestimation in
z that results from using centres of mass of non-uniform-intensity source projections
on the imaging plane.
were obtained for all evaluated source positions within a 1 s acquisition time using a
19.5 mGyh−1m2 source (equivalent to an acquisition time of 0.5 s for a full strength
source). The increase in standard deviation of measurements with increased source-
detector distance is expected, since increasing this distance results in a smaller number
of photons being collected within the fixed acquisition period, reducing the signal to
noise ratio in the calculation of the projection’s CoM. In addition, the magnification
of random error during the pinhole imaging reconstruction is also proportional to
the distance between the source and the pinhole centres. However, in therapeutic
practice, the dwell time of the source is usually much longer than 0.5 s; therefore,
this uncertainty will be reduced when the probe is put into clinical use. The accuracy
obtained in these experiments closely matched the performance obtained from the
simulation studies presented in Chapter 6, although the errors are somewhat larger
due to source positioning uncertainties which are not present in the simulation.
Several factors contribute to the error in the estimated position in the z direction.
Firstly, although the phantom itself is solid, and therefore the channel in which the
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catheter is inserted is rigid, there could be a small difference between the diameter of
the channel and the diameter of the catheter. Due to the position of the afterloader
relative to the phantom, a small downward force is exerted on the external part of the
catheter, which is greater at (nominal) z = 60 mm than for z = 40 mm. This force
results in the catheter being deflected into an approximately parabolic shape inside the
channel through the phantom. The central region of the catheter is deflected upward,
while the catheter is deflected downward at both the tip of the catheter and at the
point of entrance to the phantom. This partially explains the discrepancy between
the planned and measured values of z at the nominal height of z = 60 mm, rather
than being a measurement error, it is an error in the accuracy of the experimental
configuration, which is being correctly measured by HDR BrachyView system. In
particular, the first position of the source appears to have been partially outside the
volume of the phantom (confirmed by the images obtained on Gafchromic film, which
will be discussed at the end of this Section), and therefore subjected to a greater bend
in the catheter, resulting in the offset in z of approximately -2 mm for nominal z =
60 mm. The problem of the bend in the catheter is much less significant for other
source positions deep inside the catheter hole when nominal z = 60 mm and all the
source positions when nominal z = 40 mm.
The remainder of the error (at both z = 60 mm and z = 40 mm) is a consequence of
the fact that the centre of mass (CoM) of the projection is not precisely collinear with
the source and pinhole, but rather is shifted slightly both in x and y in the direction of
the corresponding pinhole, a phenomenon which was also observed in the simulation
study and has been explained in Chapter 6. The shift is due to the source being
cylindrical rather than a point source, with photons from the more distant end of the
source travelling a greater distance (and arriving at a shallower angle) at the detector
plane compared to photons emitted from the near end. Because of the difference
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in path distances, the intensity (but not the geometry) of projections of a cylindrical
source with uniform activity distribution oriented parallel to the detector plane will be
non-uniform. The CoM will therefore be biased in the direction of maximum projection
intensity (in the direction of the pinhole) and will not perfectly coincide with the true
‘ideal’ geometric centre of the projection (CoMi). For projections closest to the source,
this effect is further exaggerated by the background of photons which penetrate the
body of the collimator directly under the source.
As can be seen from Figure7.12, the error resulting from the use of the projection
CoM to estimate the geometric centre of the projection causes an overestimation of
the height of the source (i.e., a positive error in z). This error is smallest for the
projections nearest to the source in x and y, progressively increasing in the more dis-
tant projections. Currently, all projections are equally weighted during the position
reconstruction process (with the estimated position being calculated as the point with
minimum mean squared distance from all backprojected lines). Therefore, position
estimates for those source positions from which a larger number of distant projections
are visible will be more severely degraded by this error than those from which only a
few nearby projections can be seen. This explains the apparently paradoxical result
that source positions above the middle of the detector array, from which multiple pro-
jections are visible, accumulate a greater positive bias in height estimation compared
to source positions near either end of the detector array, which effectively give more
weight to the projection with a smaller error between projection CoM and the true
geometric centre of the projection. The same error was observed in the Monte Carlo
simulation study discussed in Chapter 6, confirming that it is a consequence of the
simplified methods used to estimate the geometric centre of the projection from the
projection’s CoM.
This latter source of error will be reduced in future versions of the reconstruction
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software, by using a non-equal weighting of projections (preferentially weighting the
brighter projections, which also gives greater weight to projections with higher SNR).
It will also be possible to improve the localisation of the geometric centre of the pro-
jection by deconvolving the projection by the point spread function of the pinhole
(which will reduce blurring, although it cannot eliminate the effect of photon pene-
tration through the collimator) and iterative post-segmentation intensity correction
(i.e., following initial segmentation and approximate determination of the CoMs and
hence source position, the intensity of the projection can be corrected for the 1/d2
reduction in intensity, after which the CoM should be equal to the geometric centre of
the projection).
It is also noted that there is some variation in y between individual runs of the
experiment; this is due to the afterloader’s own intrinsic positioning error of ±1 mm
(95% confidence interval). Incremental movements in y during each individual run
remain highly consistent, but due to mechanical backlash in the afterloader’s actuator
following the complete retraction and reinsertion of the source, combined with slight
differences in catheter insertion between runs, small, random inter-run translations in
y are observed.
The intrinsic accuracy of HDR BrachyView (i.e., independent of afterloader posi-
tioning error) in the y direction was further evaluated using Gafchromic films. Ex-
cellent agreement is observed from the results of film and HDR BrachyView probe.
The difference in y displacement between the measurements by film and the HDR
BrachyView probe is significantly smaller than the error between the estimated and
planned source positions. This is further confirmation that the catheter shift or after-
loader positioning uncertainty are the main reason for the differences between planned
and estimated source position in the y direction shown in Tables 7.2 and 7.3. Further-
more, the incomplete projection of the first source position in the film image confirms
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that the first source position is partly outside the phantom, which was observed in the
results plotted in Figure 7.10.
7.4 Conclusion
In this Chapter, a feasibility study was performed for HDR BrachyView with a planar
collimator combined with single Timepix detector, and the results of the experimental
evaluation of HDR BrachyView probe in term of source tracking accuracy have been
presented.
The result of the initial experimental work demonstrated that the design is capa-
ble of tracking the HDR source within a sub-second acquisition time. The source was
moved parallel to the detector plane with a source-collimator distance of 43 mm, the
maximum (worst-case) distance during HDR prostate brachytherapy treatment. Pro-
jection frames demonstrate the accurate resolution of source position in the detector
plane within a sub-second dwell time.
The experimental evaluation of the prototype confirmed that most planned source
positions (more than 90%) could be measured with an sub-millimetre accuracy in an
equivalent acquisition time of 0.5 s for a full strength HDR source, with the largest dif-
ference found between planned and measured source position being 2.1 mm (although
part of that error is a result of uncertainties in the mechanical positioning of the
source). The overall performance, including a systemic overestimation of the source
height, was in good agreement with the results of the previous GEANT4 simulation
study, and can potentially be improved through more sophisticated image processing
techniques. A fully-populated four-detector prototype with integrated trans-rectal ul-
trasound is currently under development, which will be able to register the calculated
source position with the prostate volume.
Chapter 8
Conclusion and Future Work
An in-body source tracking system (HDR BrachyView ) which can be used to perform
intra-fraction quality assurance for HDR prostate brachytherapy has been successfully
developed. Its functionality and source tracking accuracy have been evaluated through
simulations and experiments performed using a prototype device with a Plastic Water
phantom.
8.1 Conclusion
Chapter 2 presented a thorough literature review, including a general introduction to
the prostate and prostate cancer, a review of all major treatment options currently
available, the specific treatment modality known as brachytherapy (in particular, high
dose rate prostate brachytherapy), and a detailed review of current quality assurance
methods used in HDR prostate brachytherapy. In particular, several approaches re-
lated to the methods proposed in this Thesis were discussed in detail.
After analysing the limitations of image-based source tracking using out-of-body
imaging systems, a novel in-body multi pinhole collimated gamma camera imaging
system featuring an ultra high resolution solid state detector array was introduced in
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Chapter 3. In the same chapter, the key design parameters of HDR BrachyView ,
including the characteristics of the detector, the material and thickness of the colli-
mator, the shape of pinhole and the coverage of the field of view were investigated,
derived analytically and validated using Monte Carlo simulations.
The complete process of source position reconstruction is achieved by a series of
software modules developed in Matlab, which are discussed in Chapter 4). Potential
problems during the identification and segmentation of source projections, projection
grouping, CoM calculation and projection-to-pinhole matching were introduced and
the corresponding solutions implemented in the software were presented.
To ensure the safety of placing the high-Z material comprising HDR BrachyView
’s collimator in the patient’s rectum during HDR brachytherapy source delivery, Chap-
ter 5 evaluated the dose enhancement observed at the tissue-tungsten interface result-
ing from back-scatter radiation caused by irradiation of the tungsten collimator by
the 192Ir source. Although the dose enhancement is significant in the region extremely
close to the surface of the collimator, it only affects the first 0.5 mm of the tissue
side of the interface. Therefore, if the tissue is protected by a 1 mm thick tissue-
equivalent plastic shell, as will be the case with the HDR BrachyView probe, no dose
enhancement will occur in rectal tissue due to the backscattered radiation from HDR
BrachyView probe. Therefore, BrachyView probe is safe for clinical application during
the delivery of HDR brachytherapy source.
The design of HDR BrachyView was validated by simulations and experiments
conducted using a combination of a planar pinhole collimator and single Timepix de-
tector. The system was evaluated in terms of efficiency, positioning uncertainty (i.e.
the variance between individual measurements) and accuracy (i.e. the deviation of
the positions estimated by HDR BrachyView from the known physical position of the
source). A more complete prototype of HDR BrachyView probe was then constructed
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using a cylindrical collimator with a two-detector Timepix array, which was used to
perform experimental evaluation of the system under more realistic conditions. For
both the prototype systems, results of the simulations and experiments were observed
to be in close agreement, and are presented in Chapters 6 and 7. These results demon-
strated the ability of HDR BrachyView to track the source position with an average
sub-millimetre accuracy, within a sub-second acquisition time, as per the original de-
sign specifications for the probe.
8.2 Recommendations for Future Work
A number of potential opportunities to improve the performance of theHDR BrachyView
probe have been identified. The first is to optimise the reconstruction algorithm; a
systematic shift in the calculated CoM from its ideal position was observed in both
the simulation and experimental studies, which is correlated to the distance between
the projection and its corresponding pinhole. Therefore this error could be reduced
by using a non-equal weighting of projections (preferentially weighting the brighter
projections, which also gives greater weight to projections with higher SNR). It may
also be possible to improve the localisation of the geometric centre of an individual
projection by deconvolving the projection by the point spread function of its corre-
sponding pinhole (which will reduce blurring, although it cannot eliminate the effect of
photon penetration through the collimator). Finally, iterative post-segmentation in-
tensity correction should be able to reduce the systemic shift by compensating for the
1
d2
variation in intensity resulting from the range of path lengths of photons emitted
by the cylindrical source as they travel to the detector plane. This last point should
result in the CoM of the segmented projection to be be equal to the ideal centre of
mass of the projection (that is, collinear with the pinhole and the geometric centre of
the source).
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Another direction for future potential improvement to the HDR BrachyView probe
is its potential for monitoring the source dwell time. Timepix is capable of capturing
up to 400 images per second. Although a short acquisition time will lead to insufficient
statistics to accurately track the source position, the difference in response map may
still be enough to measure source movement. Thus, a comprehensive evaluation of
methods to evaluate source transit with HDR BrachyView would be interesting.
Finally, the ultimate objective of the project is real-time correction of treatment
plans during treatment; once the trans-rectal ultrasound probe is fully integrated, it
will be necessary to develop plug-ins to treatment planning systems to enable them to
utilise the information provided by HDR BrachyView .
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vas, I. Herruzo, M. Ortiz, H. Villavicencio, et al. Health-related quality of life
2 years after treatment with radical prostatectomy, prostate brachytherapy, or
external beam radiotherapy in patients with clinically localized prostate cancer.
Int. J. Radiat. Oncol. Biol. Phys., 72(2):421–432, 2008.
References 183
[72] M. Fatyga, J.F. Williamson, N. Dogan, D. Todor, J.V. Siebers, R. George,
I. Barani, and M. Hagan. A comparison of hdr brachytherapy and imrt tech-
niques for dose escalation in prostate cancer: A radiobiological modeling study.
Med. Phys., 36(9):3995–4006, September 2009.
[73] J. Hermesse, S. Biver, N. Jansen, E. Lenaerts, N. De Patoul, S. Vynckier,
P. Coucke, P. Scalliet, and P. Nickers. A dosimetric selectivity intercomparison
of hdr brachytherapy, imrt and helical tomotherapy in prostate cancer radiother-
apy. Strahlenther. Onkol., 185(11):736–742, 2009.
[74] G.C. Morton and P.J. Hoskin. Brachytherapy: Current status and future strate-
gies—can high dose rate replace low dose rate and external beam radiotherapy?
Clin. Oncol., 25(8):474–482, August 2013.
[75] A. Challapalli, E. Jones, C. Harvey, G.O. Hellawell, and S.A. Mangar. High
dose rate prostate brachytherapy: an overview of the rationale, experience and
emerging applications in the treatment of prostate cancer. Br. J. Radiol., 85:s18–
s27, 2014.
[76] C. Shah, T.B. Lanni Jr, M.I. Ghilezan, G.S. Gustafson, K.S. Marvin, H. Ye,
F.A. Vicini, and A.A. Martinez. Brachytherapy provides comparable outcomes
and improved cost-effectiveness in the treatment of low/intermediate prostate
cancer. Brachytherapy, 11(6):441–445, November/December 2012.
[77] C. Kirisits, M.J. Rivard, D. Baltas, F. Ballester, M. De Brabandere, R. van der
Laarse, Y. Niatsetski, P. Papagiannis, T.P. Hellebust, J. Perez-Calatayud,
K. Tanderup, and F.A. Siebert J.L.M. Venselaarm. Review of clinical brachyther-
apy uncertainties: Analysis guidelines of gec-estro and the aapm. Radiother.
Oncol., 110(1):199–212, January 2014.
References 184
[78] Varian Medical Systems. Varisource afterloader feature sheet, 06 2014.
[79] Elekta AB. microSelectron digital brachytherapy afterloading platform, 2014.
[80] R.J.M. Elfrink, I.K.K. Kolkman-Deurloo, H.J. Kleffens, A. Rijnders,
B. Schaeken, T.H.L. Aalbers, W.J.F. Dries, and J.L.M. Venselaar. Determina-
tion of the accuracy of implant reconstruction and dose delivery in brachytherapy
in the netherlands and belgium. Radiother. Oncol., 59(3):297–306, 2001.
[81] A. Manikandan, S. Biplab, P.A. David, R. Holla, T.R. Vivek, and N. Sujatha.
Relative dosimetrical verification in high dose rate brachytherapy using two-
dimensional detector array imatrixx. J. Med. Phys., 36(3):171, July/September
2011.
[82] P. Kohr and F.A. Siebert. Quality assurance of brachytherapy afterloaders using
a multi-slit phantom. Phys. Med. Biol., 52(17):N387, 2007.
[83] T.P. Hellebust, K. Tanderup, E.S. Bergstrand, B.H. Knutsen, J. Røislien, and
D.R. Olsen. Reconstruction of a ring applicator using ct imaging: impact of the
reconstruction method and applicator orientation. Phys. Med. Biol., 52(16):4893,
2007.
[84] D. Waid, J. Morrison, and G. Glennie. Su-ff-t-30: Commissioning the ring &
tandem combination applicator set-ct & mr compatible, for clinical use with the
varisource hdr unit. Med. Phys., 36(6):2525–2525, 2009.
[85] R. Stern and T. Liu. Dwell position inaccuracy in the varian gammamed hdr
ring applicator. J. Appl. Clin. Med. Phys., 11(4):291–296, Fall 2010.
[86] A. Q. Jangda, S. Hussein, and Z. Rehman. A new approach to measure dwell
position inaccuracy in hdr ring applicators-quantification and corrective qa. J.
Appl. Clin. Med. Phys., 12(1):3–13, September 2011.
References 185
[87] R. McMahon, T. Zhuang, B.A. Steffey, H. Song, and O.I. Craciunescu. Com-
missioning of varian ring & tandem hdr applicators: reproducibility and interob-
server variability of dwell position offsets. J. Appl. Clin. Med. Phys., 12(4):50–62,
Fall 2011.
[88] D. Berger, J. Dimopoulos, R. Pötter, and C. Kirisits. Direct reconstruction of the
vienna applicator on mr images. Radiother. Oncol., 93(2):347–351, July 2009.
[89] P.J. Hoskin, P.J. Bownes, P. Ostler, K. Walker, and L. Bryant. High dose rate
afterloading brachytherapy for prostate cancer: catheter and gland movement
between fractions. Radiother. Oncol., 68(3):285–288, 2003.
[90] T. Simnor, S. Li, G. Lowe, P. Ostler, L. Bryant, C. Chapman, D. Inchley, and
P.J. Hoskin. Justification for inter-fraction correction of catheter movement in
fractionated high dose-rate brachytherapy treatment of prostate cancer. Radio-
ther. Oncol., 93(2):253–258, November 2009.
[91] A.A. Martinez, I. Pataki, G. Edmundson, E. Sebastian, D. Brabbins, and
G. Gustafson. Phase ii prospective study of the use of conformal high-dose-rate
brachytherapy as monotherapy for the treatment of favorable stage prostate can-
cer: a feasibility report. Int. J. Radiat. Oncol. Biol. Phys., 49(1):61–69, January
2001.
[92] J.D. Kiffer, W.A. Schumer, C.A. Mantle, B.J. McKenzie, M. Feigen, G.G.
Quong, and F.M. Waterman. Impact of oedema on implant geometry and
dosimetry for temporary high dose rate brachytherapy of the prostate. Aus-
tralas. Radiol., 47(2):172–176, June 2003.
References 186
[93] Y. Kim, I.C. Hsu, E. Lessard, J. Vujic, and J. Pouliot. Dosimetric impact of
prostate volume change between ct-based hdr brachytherapy fractions. Int. J.
Radiat. Oncol. Biol. Phys., 59(4):1208–1216, July 2004.
[94] F.L. Cury, M. Duclos, A. Aprikian, H. Patrocinio, and L. Souhami. Prostate
gland edema after single-fraction high-dose rate brachytherapy before external
beam radiation therapy. Brachytherapy, 9(3):208–212, July/September 2010.
[95] N. Kovalchuk, K.M. Furutani, O.K. MacDonald, and T.M. Pisansky. Dosi-
metric effect of interfractional needle displacement in prostate high-dose-rate
brachytherapy. Brachytherapy, 11(2):111–118, March/April 2012.
[96] A.M. Dinkla, B.R. Pieters, K. Koedooder, N. van Wieringen, R. van der Laarse,
and A. Bel. Prostate volume and implant configuration during 48 hours of
temporary prostate brachytherapy: limited effect of oedema. Radiat. Oncol.,
9(1):272, 2014.
[97] S.J. Damore, A.M.N. Syed, A.A. Puthawala, and A. Sharma. Needle displace-
ment during hdr brachytherapy in the treatment of prostate cancer. Int. J.
Radiat. Oncol. Biol. Phys., 46(5):1205–1211, 2000.
[98] E. Mullokandov and G. Gejerman. Analysis of serial ct scans to assess template
and catheter movement in prostate hdr brachytherapy. Int. J. Radiat. Oncol.
Biol. Phys., 58(4):1063–1071, March 2004.
[99] Y. Kim, I. Hsu, and J. Pouliot. Measurement of cranio-caudal catheter displace-
ment between fractions in ct-based hdr brachytherapy of prostate cancer. J.
Appl. Clin. Med. Phys., 8(4):1–13, 2007.
References 187
[100] M. Whitaker, G. Hruby, A. Lovett, and N. Patanjali. Prostate hdr brachyther-
apy catheter displacement between planning and treatment delivery. Radiother.
Oncol., 101(3):490–494, December 2011.
[101] P. Ortiz. Lessons learned form accidental exposures in radiotherapy. IAEA
Safety Reports Series, 17:59–61, 2000.
[102] I.J. Das, C. Cheng, R.J. Watts, A. Ahnesjö, J.Gibbons, X. Li, J. Lowenstein,
R.K. Mitra, W.E. Simon, and T.C. Zhu. Accelerator beam data commissioning
equipment and procedures: report of the tg-106 of the therapy physics committee
of the aapm. Med. Phys., 35(9):4186–4215, September 2008.
[103] Z. Li, T.P. Mitchell, J.R. Palta, and C. Liu. A quality assurance test tool for high
dose-rate remote afterloading brachytherapy units. Med. Phys., 25(2):232–235,
February 1998.
[104] A. Espinoza, B. Beeksma, M. Petasecca, I. Fuduli, C. Porumb, D. Cutajar,
S. Corde, M. Jackson, M.L.F. Lerch, and A.B. Rosenfeld. The feasibility study
and characterization of a two-dimensional diode array in ”magic phantom” for
high dose rate brachytherapy quality assurance. Med. Phys., 40(11):111702,
November 2013.
[105] D.A. Wilkinson. High dose rate (hdr) brachytherapy quality assurance: a prac-
tical guide. Biomed. Imaging. Interv. J., 2(2):1–7, 2006.
[106] R.J.M. Elfrink, H.J. van kleffens, I.K.K. Kolkman-Deurloo, A.H.L. Aalbers,
W.J.F. Dries, A. Rijnders, B. Schaeken, and J.L.M. Venselaar. Quality control
in brachytherapy. Technical Report 13, Netherlands Commission on Radiation
Dosimetry, Task Group Quality Control in Brachytherapy, 2000.
References 188
[107] F. Bochud, B. Leemann, R. Linder, R. Moeckli, K. Munch, H. Nemec, M. Sas-
sowsky, and G. Stucki. Dosimetry and quality assurance in high dose rate
brachytherapy with iridium-192. Technical Report 13, Swiss Society for Ra-
diobiology and Medical Physics, january 2005.
[108] J.F. Williamson. Current brachytherapy quality assurance guidance: Does it
meet the challenges of emerging image-guided technologies? Int. J. Radiat.
Oncol. Biol. Phys., 71(1):S18–S22, May 2008.
[109] C. Dempsey, R. Smith, T. Nyathi, A. Ceylan, L. Howard, V. Patel, R. Das,
and A. Haworth. Acpsem brachytherapy working group recommendations for
quality assurance in brachytherapy. Australas. Phys. Eng. Sci. Med., 36(4):387–
396, December 2013.
[110] G.J. Kutcher, L. Coia, M. Gillin, W.F. Hanson, S. Leibel, R.J. Morton, J.R.
Palta, J.A. Purdy, L.E. Reinstein, G.K. Svensson, M. Weller, and L. Wingfield.
Comprehensive qa for radiation oncology: report of aapm radiation therapy
committee task group 40. Med. Phys., 21:581–581, April 1994.
[111] M.A. Gadhi, S.A. Buzdar, M. Afzal, Sh. Fatmi, M.S. Akhtar, and A.H. Niza-
mani. Calibration of iridium-192 source by ionization chamber for high dose rate
brachytherapy. Int. J. Radiat. Res., 11(3):189–193, July 2013.
[112] T.P. Loftus. Standardization of iridium-192 gamma-ray sources in terms of ex-
posure. J. Res. Nat. Bur. Stand, 85(1):19–25, January/February 1980.
[113] S. J. Goetsch, F. H. Attix, D. W. Pearson, and B. R B. R. Thomadsen. Cali-
bration of 192Ir high-dose-rate afterloading systems. Med. Phys., 18(3):462–467,
1991.
References 189
[114] S. J. Goetsch, F. H. Attix, L. A. DeWerd, and B. R. Thomadsen. A new
re-entrant ionization chamber for the calibration of iridium-192 high dose rate
sources. Int. J. Radiat. Oncol. Biol. Phys., 24(1):167–170, 1992.
[115] N . Reynaert, F. Verhaegen, and H. Thierens. In-water calibration of pdr 192ir
brachytherapy sources with an ne2571 ionization chamber. Phys. Med. Biol.,
43(8):2095–2107, 1998.
[116] L.A. DeWerd, P. Jursinic, R. Kitchen, and B.R. Thomadsen. Quality assurance
tool for high dose rate brachytherapy. Med. Phys., 22(4):435–440, April 1995.
[117] A.S. Kirov, J.F. Williamson, A.S. Meigooni, and Y. Zhu. Tld, diode and monte
carlo dosimetry of an 192ir source for high dose-rate brachytherapy. Phys. Med.
Biol., 40(12):2015–2036, 1995.
[118] P. Karaiskos, A. Angelopoulos, L. Sakelliou, P. Sandilos, C. Antypas, L. Vlachos,
and E. Koutsouveli. Monte carlo and tld dosimetry of an 192ir high dose-rate
brachytherapy source. Med. Phys., 25(10):1975–1984, October 1998.
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Appendix A
Software Documentations
The appendix documents the codes of Matlab functions developed forHDR BrachyView
project. These functions cover the whole source tracking process, which starts from
the image outputted from the readout system of Timepix, ends with the coordinates of
the source. The codes with annotation are included below following the consequence
of their applications:
 BV MultiFindCentre.m, master function, accomplishes the whole process of
source tracking by controlling the implantation of other developed functions.
1 function [SP Info] = BV MultiFindCentre(varargin)
2 %%
3 %BV MultiFindCentre find the centre coordinate of source ...
images from input image.
4 %BV MultiFindCentre first filters out pixel with value less ...
than p*maximum in input image.
5 %Then group remain pixels into clusters with a radius of R
6 %Then calculate the centre of each cluster
7 %Then Reconstruct all possible source positions
8 %Then calculate the CoM of the whole image
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9 %ind is the index of frames
10 %ff is the flag to control visualization
11 %varargin{1}:imi
12 %varargin{2}: testnumber
13 %varargin{3}: ind of source position
14 %varargin{4}: figure flag
15 %varargin{5}: R
16 %Varargin{6}: P
17 %[SP Info] = BV MultiFindCentre(input image,p,R,ind) returns
18 %SP Info{1}:CoC: the coordinate of Euclidean centres of source...
images pixel)
19 %SP Info{2}:CoM: the coordinate of mass centres of source ...
images (pixel)
20 %SP Info{3}:NoC: number of pixel clusters (source images ...
without selection)
21 %SP Info{4}:NoPic: number of pixels in each cluster
22 %SP Info{5}:matrix of initial source positions in volume (mm)
23 %SP Info{6}:matrix of possible source positions in volume (mm)
24 %Sp Info{7}:CoM of the whole medfiltered image (mm)
25 %Sp Info{8}:final source postion in volume
26 %Sp Info{9}: Distance between first and last CoC
27 %Sp Info{10}: Distance between first and last CoM
28 %Sp Info{11}: Distance between each projections
29 %Sp Info{12}: Sum of distance from source centre to each back ...
projection
30 %Sp Info{13}: shift from ideal position of projection 3
31 %%
32 %%%%%%%%%%%%%%%%%%%%%%%%% initial %%%%%%%%%%%%%%%%%%%
33 close all
34 warning off
35 %%%%%%%%%%%%%%%%%%%%%%initial parameters
36 ff=0; %triger of visualization
200
37 R=50; %radius of projection for grouping
38 p=0; %percentage for threshold
39 th pre=0.7; %Global threshold
40 th reg=1000; %regional threshold
41 para gap=0; %gap between two detectors
42 para interpW=5; %width of interpilation
43 diskSize=3; %Module size for erode anddilate
44 CoC Pre=[]; %initial the rough projection centres of mass
45 distEPAll=[]; %initial distance beween projection centres
46 Ridle=0; %initial the idle space at right
47 %%
48 %%%%%%%%%%%%%%Define a cell of out put SP Info
49 SP Info=cell(1,13);
50 Pre SP Info=SP Info;
51 %%
52 %%%%%%%%%%%%%%%%%%%%%%get input
53 imi=varargin{1};
54 test number=varargin{2};
55 ind=varargin{3};
56 if nargin>4 | | nargin==4
57 ff=varargin{4};
58 if nargin>5 | | nargin==5
59 R=varargin{5};
60 if nargin==6
61 p=varargin{6};
62 end
63 end
64 end
65 %%
66 %%%%%%%%%%%%%% h flag for exp3
67 if test number==6 | | test number == 9 | | test number == 15 | | ...
test number == 25
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68 h flag=29;
69 elseif test number==7 | | test number == 8 | | test number == 16...
| | test number == 23
70 h flag=49;
71 else
72 error('no such test ')
73 end
74 %%
75 %%%%%%%%%%%%%%%%%%%%%%%%%%%preprocessing of image
76 if p>1
77 th reg=p;
78 end
79 %%
80 %%%%%%%%%%%%%%%%%%%%%%%%%% save the ori to im ori and ...
temp image
81 %im ori=input image;
82 temp im=imi;
83 %%%%%%%%%%%%%%%%%normalise for each detectors
84 temp im=BV NorDoubleD(temp im);
85 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%correct the gap
86 gap length=para gap; %define the length of gap between the 2 ...
detectors
87 temp im=BV GapFix(temp im,gap length);
88 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%Bilinear interpulation
89 interp halfWidth=para interpW;
90 interp range=[256+1-interp halfWidth,256+gap length+...
interp halfWidth];
91 % mask high count region between 2 detectors
92 temp im=BV Mask range(temp im,interp range);
93 %medfilter on masked image
94 temp im=medfilt2(medfilt2(medfilt2(temp im)));
95 % bilinear interpulate the gap
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96 temp im=BV Interp bilinear1D(temp im,interp range);
97 %%
98 %%%%%%%%%%%%%%%%%%%%%%%%store filered img
99 im prefilt=temp im;
100 SZ im pre=size(im prefilt);%find the size of prefiltedIm
101 %%
102 %%%%%%%%%%%%%%%%%%%%%visualization of interpulated image%%%
103 if flag figure == 1
104 figure;
105 imagesc(temp im);
106 colormap gray;
107 axis equal;
108 end
109 %%
110 %toc;
111 %%%%%%%%%%%%%%%%thresholding the back-ground counts
112 %%%%%%%%%%%%%%%%%%global TH
113 %%
114 %tic;
115 while Ridle<SZ im pre(2)
116 temp im=BV Thresholding(temp im,th pre);
117 %%%%%%%%%%%%%%%%%%visualization of thresholded image
118 if flag figure == 1
119 figure;
120 imagesc(temp im);
121 colormap gray;
122 axis equal;
123 end
124 %%
125 %%%%%%%%%%%%%%%%%%%%%%%%regular the shape of projections
126 %tic;
127 if flag sim==0
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128 mdl=strel('disk',diskSize); %create a disk model
129 temp im=imerode(temp im,mdl); %erode the image with a ...
disk model
130 temp im=imdilate(temp im,mdl);%dilate the image with a...
disk model
131 if flag figure == 1 %visualiation of regulared ...
projections
132 figure;
133 imshow(temp im,[]);
134 colormap gray;
135 axis equal;
136 end
137 end
138 %toc;
139 %%
140 %%%%%%%%%%%%%%%%%%%%%%%%%%find projection centres (inpixel...
)
141 %tic;
142 [Pre SP Info{1},Pre SP Info{2},Pre SP Info{3},Pre SP Info...
{4},Pre SP Info{9},Pre SP Info{10},Pre SP Info{11}]=...
BV MultiCentroid(temp im,R,h flag,ind);%find source ...
image mass centre
143 %%
144 %%%%%%%%%%%%%%%%%%%%%%%%%%determine the width of idle area
145 clear CoC Temp
146 CoC Temp(:,:)=Pre SP Info{1}(:,:);
147 if CoC Temp(:,:)==0;
148 CoC Temp=[];
149 break;
150 end
151 if size(CoC Pre)>0
152 if max(CoC Temp(:,1))-mean(CoC Pre(:,1))>10
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153 break;
154 end
155
156 if mean(CoC Pre(:,1))-min(CoC Temp(:,1))>10
157 break;
158 end
159 end
160 CoC Pre=[CoC Pre;CoC Temp];
161 CoC Pre=sortrows(CoC Pre,2);
162 SZ SPTemp=size(CoC Temp);
163 SZ SPInfo1=size(CoC Pre);
164
165 if SZ SPTemp>1
166 distEPAll temp=Pre SP Info{11};
167 distEPAll=[distEPAll;distEPAll temp];
168 distEP=mean(distEPAll);
169 else
170 %distEPAll=200;
171 distEP=200;
172 end
173 Ridle=CoC Pre(end,2)+distEP;
174 temp im=im prefilt;
175 temp im(:,1:CoC Pre(end,2)+0.5*distEP)=0;
176 if flag figure==1
177 imshow(temp im,[]);
178 end
179 end
180 %%
181 %%%%%%%%%%%%Regional threshold
182 %%%%%%%%%%%%%%%%initial
183 temp im=im prefilt;
184 clear distEP;
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185 SZ CoC Pre=size(CoC Pre);
186 distEP=(CoC Pre(end,2)-CoC Pre(1,2))./SZ CoC Pre(1);
187 if (CoC Pre(1,2)-distEP/2)>0
188 temp im(:,1:floor((CoC Pre(1,2)-distEP/2))+1)=0;
189 end
190 if floor(CoC Pre(end,2)+distEP/2)<SZ im pre(2)
191 temp im(:,floor(CoC Pre(end,2)+distEP/2):SZ im pre(2))=0;
192 end
193 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
194 if SZ CoC Pre(1)>1
195 clear i;
196 last end=1;
197 for i=1:SZ CoC Pre(1)
198 th reg start=floor(CoC Pre(i,2)-distEP/2)-1;
199 th reg end=floor(CoC Pre(i,2)+distEP/2)+1;
200 if th reg start>last end
201 temp im(:,last end:th reg start)=0;
202 end
203 last end=th reg end;
204 if i==1
205 temp im(:,1:th reg end)=BV TH hist(temp im(:,1:...
th reg end),th reg,1 );
206 elseif i==SZ SPInfo1(1)
207 temp im(:,th reg start:end)=BV TH hist(temp im(:,...
th reg start:end),th reg,1 );
208 else
209 temp im(:,th reg start:th reg end)=BV TH hist(temp im...
(:,th reg start:th reg end),th reg,1 );
210 end
211 end
212 end
213 %%%%%%%%%%%%%%%%%%visualization of thresholded image
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214 if flag figure == 1
215 figure;
216 imagesc(temp im);
217 colormap gray;
218 axis equal;
219 end
220 %%
221 %%%%%%%%%%%%%%%%%%%%%%%%regular the shape of projections
222 %tic;
223 if flag sim==0
224 mdl=strel('disk',diskSize); %create a disk model
225 temp im=imerode(temp im,mdl); %erode the image with a disk...
model
226 temp im=imdilate(temp im,mdl);%dilate the image with a ...
disk model
227 if flag figure == 1 %visualiation of requlared ...
projections
228 figure;
229 imagesc(temp im);
230 colormap gray;
231 axis equal;
232 end
233 end
234 %toc;
235 %%
236 %%%%%%%%%%%%%%%%%%%%%%%%%%find projection centres (inpixel)
237 %tic;
238 [SP Info{1},SP Info{2},SP Info{3},SP Info{4},SP Info{9},...
SP Info{10},SP Info{11}]=BV MultiCentroid(temp im,R,h flag...
,ind);%find source image mass centre
239 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
240 [SP Info{5},SP Info{6},SP Info{12}]=BV 3DRecon(SP Info{1})...
207
;
241 %toc;
242 %%%%%%%%%%%%find the COM of the whole image%%%%%%%%%%%%
243 %tic;
244 if special flag==15
245 temp im=whole im;
246 end
247 [SP Info{7}]=BV FindCOMwhole(temp im);
248 %toc;
249 %%%%%%%%%%%find the final source position in volume...
%%%%%%%%
250 %tic;
251 SP Info{8}=BV ChooseSP(SP Info{6},SP Info{7});
252 %toc;
253 end
 BV GapFix.m, corrects the gap betwen different detectors if necessary.
1 function [ imo ] = BV GapFix( imi,Gap length)
2 % This fucntion fix if a gap is existing between the detectors
3 % imi: input image
4 % Gap length: gap length IN PIXEL
5 % imo: output image
6 GL=Gap length;
7 SZ imi=size(imi); %get the size of input image
8 SZ imo=SZ imi;
9 SZ imo(2)=SZ imo(2)+GL; %calculate the size of output image
10 %fill the gap between the detectors with 0
11 imo=zeros(SZ imo);
12 imo(:,1:256,:,:)=imi(:,1:256,:,:);
13 imo(:,257+GL:512+GL,:,:)=imi(:,257:512,:,:);
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14
15 end
 BV Interp bilinear1D.m, interpolates the masked region.
1 function [ imo ] = BV Interp bilinear1D( imi,range)
2 %This function interpolate the masked columns
3 %imi: input image
4 %range: start and end of the columns will be interpolated
5 r=[252,260];
6 if range
7 r=range;
8 end
9 %linear interpolation
10 imo=imi;
11 R=r;
12 R(1)=r(1)-1;
13 R(2)=r(2)+1;
14 for i=r(1):r(2)
15 F1=(R(2)-i)/(R(2)-R(1));
16 F2=(i-R(1))/(R(2)-R(1));
17 imo(:,i,:,:)=imo(:,R(1),:,:).*F1+imo(:,R(2),:,:).*F2;
18 end
19 end
 BV Thresholding.m, isolates source projections by thresholding the image ac-
cording to a pre-set percentage of maximum count in the image.
1 function imo=BV Thresholding(imi,t)
209
2 %This function filter out pixel value smaller than t* the ...
maxium counts
3 %imi: input image
4 %t: threshold in percentage
5 %imo: output image
6 %Value in imo =0 if the value with same position in imi is ...
less than t* maximum value of imi
7 %Value in imo = the value with same position in imi, if this ...
value is larger or equal to t* maximum value of imi
8 imo=imi; %copy imi to imo
9 Max imi=max(max(imi)); %calculate the maximum of imi
10 th index= imi< t*Max imi; %find index of pixel with value ...
smaller than threshold
11 imo(th index)=0;
12 end
 BV TH hist.m, isolates source projections by thresholding the image according
to its histogram.
1 function [ imo ] = BV TH hist(imi,ts,flag dir)
2 % threshold the image based on its accumulated histram
3 % imi: input image
4 % ts: the amount of pixels that will be kept/removed by the ...
thresholding
5 % flag dir: falg determine the operation of keep or remove;
6 % 1 means keep; -1 means removed
7 imo=imi; %copy input image to output image
8 if max(imi(:))>100
9 n bins=max(imi(:));
10 else
11 n bins=1000;
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12 end
13 hist imi=hist(imi(:),n bins); %histgram of imi
14 Cum hist imi=cumsum(hist imi); % cumulative integral of ...
histgram of imi
15 mx cumh imi=sum(hist imi); %calculate the total number of ...
pixels
16 %find the counts value that there are ts of pixels have the ...
counts above it
17 th=find(Cum hist imi>mx cumh imi-ts, 1 );
18 switch flag dir
19 case 1
20 %find index of pixel with value smaller than threshold
21 th index= imi < th;
22 case -1
23 %find index of pixel with value bigger than threshold
24 th index= imi > th;
25 end
26 imo(th index)=0;
27 end
 BV Mask range.m, masks the abnormal high counts region at the connection of
the detectors.
1 function [ imo ] = BV Mask range( imi,range)
2 %This function masks the abnormal columns with 0
3 %imi: input image
4 %range: start and end of abnormal columns
5 r=[252,260];% default start and end of abnormal columns
6 if range
7 r=range;
8 end
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9 %masks the abnormal columns with 0
10 imo=imi;
11 imo(:,r(1):r(2),:,:)=0;
12 end
 BV MultiCentroid.m, locates the centre of mass of all the projections. It is
able to recognise and group the pixels clusters (source projections) in any two
dimensional distribution of clusters. Either continue or discrete clusters could
be resolved. This function is only applicable in case that the diameter of the
cluster is smaller than the minimum distance between the cluster centres.
1 function [CCoC,CCoM,NoC,NoPiC,DistC,DistM,DistEP]=...
BV MultiCentroid(input image,R)
2 %BV MultiCentroid find the centre of source projections from ...
input image.
3 %input image is thresholded image with all pixel value equal ...
to 0 except
4 %source projections(clusters). R is the radius to determine a ...
cluster.
5 %[CoC CoM NoC] = BV MultiFindCentre(input image,p,R) returns
6 %CoC: the coordinate of Euclidean centres of source ...
projections
7 %CoM: the coordinate of mass centres of source projections
8 %NoC: number of pixel clusters (source projections)
9 if nargin==1
10 R=50; %set default R
11 end
12 %%
13 %%%%%%%%%%%%%%%%%%%% Initialization
14 clear CoC CoM NoC CoPiC DistC DistM DistEP;
212
15 if max(max(input image))==0
16 NoC=0; CCoM=0; NoPiC=0; CCoC=0;
17 DistC=0;
18 DistM=0;
19 DistEP=0;
20 else
21 temp=input image;
22 sizeIm=size(input image);
23 iniflag=0;
24 for i=1:sizeIm(1)
25 if iniflag==1
26 break;
27 end
28 for j=1:sizeIm(2)
29 if temp(i,j)~=0
30 iniflag=1;
31 CoC(1,1)=i; %set first non-zero pixel as centre...
of cluster1
32 CoC(1,2)=j;
33 CoM(1,1)=i;
34 CoM(1,2)=j;
35 NoC=1; %Set Number of clusters as 1
36 NoPiC(1)=0; %Set Number of pixels in cluster1 ...
as 0
37 MoPiC(1)=0; %Set Mass of pixels in cluster1 as ...
0
38 %break;
39 end
40 end
41 end
42 clear i j;
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43 %% Group the cluster of pixels corresponding to each ...
projection and
44 %% calcualte the centre
45 for i=1:sizeIm(1) %scan image matrix in vertical ...
dir
46 for j=1:sizeIm(2) %scan image matrix in horizontal dir
47 if temp(i,j)~=0 %find non-zero pixel
48 flagiC=0;
49 %check distance of cerrent pixel to existing cluster euclidean...
centres
50 for k=1:NoC
51 if (i-CoC(k,1))ˆ2+(j-CoC(k,2))ˆ2<Rˆ2
52 flagiC=1;
53 %calculate euclidean centres
54 CoC(k,1)=(CoC(k,1)*NoPiC(k)+i)/(NoPiC(k)+1);
55 CoC(k,2)=(CoC(k,2)*NoPiC(k)+j)/(NoPiC(k)+1);
56 NoPiC(k)=NoPiC(k)+1;
57 %Calculate Mass centre
58 CoM(k,1)=(CoM(k,1)*MoPiC(k)+i*temp(i,j))/(MoPiC(k)+...
temp(i,j));
59 CoM(k,2)=(CoM(k,2)*MoPiC(k)+j*temp(i,j))/(MoPiC(k)+...
temp(i,j));
60 MoPiC(k)=MoPiC(k)+temp(i,j);
61 %break;
62 end
63 end
64
65 %when current pixel don't belong to all existing clusters, ...
create a new
66 %cluster, then initialize.
67 if flagiC==0
68 NoC=NoC+1;
214
69 CoC(NoC,1)=i;
70 CoC(NoC,2)=j;
71 CoM(NoC,1)=i;
72 CoM(NoC,2)=j;
73 NoPiC(NoC)=1;
74 MoPiC(NoC)=temp(i,j);
75 end
76 end
77 end
78 end
79 %%
80 %remove cluster whos size were smaller than 10 pixels
81 clear i j;
82 threshSize=50;
83 j=0;
84 for i=1:NoC
85 if NoPiC(i)>threshSize
86 j=j+1;
87 CCoC(j,:)=CoC(i,:);
88 CCoM(j,:)=CoM(i,:);
89 NNoC=j;
90 %NoPiC(i)=[];
91 %i=i-1;
92 end
93 end
94 if ~exist('CCoC','var')
95 CCoC=[0,0;0,0];
96 CCoM=[0,0;0,0];
97 end
98 if size(CCoC,2)~=2;
99 CCoC=[0,0;0,0];
100 CCoM=[0,0;0,0];
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101 end
102 %%
103 %%%%%%%%%%%%%%%%%%%%%%sort the matrix
104 CCoC=sortrows(CCoC,2);
105 CCoM=sortrows(CCoM,2);
106 %%
107 %%%%%%%%%%%%%remove projection close to the edge of left ...
detector
108 if ind<51
109 if CCoC(1,2)<1
110 CCoC(1,:)=[];
111 CCoM(1,:)=[];
112 end
113 else
114 if CCoC(1,2)<40
115 CCoC(1,:)=[];
116 CCoM(1,:)=[];
117 end
118 end
119
120 if h<19
121 if CCoC(1,2)<50
122 CCoC(1,:)=[];
123 CCoM(1,:)=[];
124 end
125 end
126 %%
127 SzC=size(CCoC);
128
129 DistC=max(CCoC(:,2))-min(CCoC(:,2));
130 DistM=max(CCoM(:,2))-min(CCoM(:,2));
131 DistEP=zeros(1,SzC(1)-1);
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132 clear i
133 for i=1:SzC(1)-1
134 DistEP(i)=CCoC(i+1,2)-CCoC(i,2);
135 end
136
137 end
138 end
 BV 3DRecon.m, calculates all the possible source positions in volume.
1 function [ pp, mindis ] = BV 3DRecon( CentPs)
2 % This function solves the source position in volume
3 % CentPs: the array of projection centres IN PIXEL
4 % CentPs should be sorted by its 2nd column
5 % pp: store all the possible source positions in volume
6 % mindis: the sum distance from the calculated source centre ...
to all the
7 % line of interest
8 clear i Sx Sy Pinhole P;
9 %%
10 % %%%%%%%%%%%%%%%%%%%%%%%use only 2 projections
11 % if Sc(1)>2
12 % Sc(1)=2;
13 % %Sc(1)=3;
14 % end
15
16 %%%%%%%%%%%%%%check number of centres
17 if Sc(1) > 7 | | Sc(1)<2
18 %set an impossible value in case of the number centre is not a...
a resolvable
19 %range to prevent expected interruption
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20 pp=[-50 -50 -50];
21 mindis=0;
22 %end
23 else
24 %%
25 %%%%%%%%%%%%%%% get array of projections centre
26 PC3D=zeros(Sc(1),3);
27 %%%%%%%%%%%%%%%%%%%%%transfer the coordinate of CoM on ...
detector (in pixel) to the coordinate in volume (in mm) ...
%%%%%%%%%%%%%%%%%%%%%%
28 PC3D(:,1)=(MCentPsX+Xpd-0.5).*0.055-7;
29 PC3D(:,2)=19.5-(CentPs(1:Sc(1),2)+Ypd-0.5).*0.055;
30 PC3D(:,3)=0-Hdp;
31 %%
32 %%%%%%%%%%%%%%%define pinhole positions
33 Pinhole=zeros(7,3);
34 for i=1:7
35 Pinhole(i,:)=[0 39-(i-1).*dpin 0];
36 end
37 %%
38 %%%%%%%%%%%%%%%% reconstruct all possible source contre
39 %create symbolic variable of temp source centre in volume
40 Symp=sym(zeros(Sc(1),3));
41 Symp(:,1)=sym('Sympp(1)');
42 Symp(:,2)=sym('Sympp(2)');
43 Symp(:,3)=sym('Sympp(3)');
44 SymPinhole=sym(Pinhole);
45 %%%%%%%sort series of pinhole&projection groups
46 pp=zeros(8-Sc(1),3);
47 ppinit=zeros(8-Sc(1),3);
48 mindis=zeros(8-Sc(1),1);
49 for j=1:8-Sc(1) %%%7-Sc(1)+1
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50 %protential source centres in volume in each pinhole&...
projection group
51 clear Dir Pinit;
52 Dir=Pinhole(j:j+Sc(1)-1,:)-PC3D; %get direction of each ...
projection
53 %get a init source position for searching poition with minimum...
with fixed X
54 A=[Dir(1,2) -1.*Dir(2,2);Dir(1,3) -1.*Dir(2,3)];
55 B=[Pinhole(j+1,2)-Pinhole(j,2);Pinhole(j+1,3)-Pinhole(j,3)];
56
57 r=A\B;
58 Pinit=Pinhole(j,:)+r(1).*Dir(1,:);
59 ppinit(j,:)=Pinit;
60 %distance to all projection
61 %create symbolic variable of dirctions and temp source centre ...
in volume
62 SymDir=sym(Dir);
63 SymPV=Symp-SymPinhole(j:j+Sc(1)-1,:);
64 %distances from the temp source centre to each back ...
projections
65 % tic; %% 0.05 s
66 for i=1:Sc(1)
67 TempDSP(i)=norm(cross(SymDir(i,:),SymPV(i,:)))./norm(...
SymDir(i,:));
68 end
69 % toc;
70 %Sum of the distance and find the minimum
71 % tic;
72 Sum TempDSP=sum(TempDSP);
73 Char Sum TempDSP=char(Sum TempDSP);
74 f Sum TempDSP=eval(['@(Sympp)' Char Sum TempDSP]);
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75 [pp(j,:),mindis(j),exi flag]=fminsearch(f Sum TempDSP,...
Pinit());
76 %pp is the matrix of possible source centre in volume
77 if exi flag==0
78 pp(j,:)=[-50 -50 -50];
79 end
80 %%directly calculate z use distance between first and last CoC
81 %MeanDistc=(max(PC3D(:,2))-min(PC3D(:,2)))./(Sc(1)-1);
82 %pp(j,3)=dpin.*Hdp./(MeanDistc-dpin);
83 % toc;
84 end
85 end
86 end
 BV ChooseSP.m, chooses the correct source position in volume.
1 function [ SP Inf7 ] = BV ChooseSP( pp,CoM whl )
2 %This function choose the right source position in volume ...
based on the mass
3 %centre of the whole image
4 %pp: possible source centres in volume
5 %CoM whl: centre of mass of the whole image
6 %SP Inf7: choose source centre in volume
7 clear size pp M d M dd SP Inf7
8 size pp=size(pp);
9 M d=zeros(size pp(1),2);
10 %colulate the distance between the source centre and the CoM ...
of the whole
11 %image in plane of XY
12 M d(:,1)=CoM whl(1)-pp(:,1);
13 M d(:,2)=CoM whl(2)-pp(:,2);
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14 M dd=sum(M d.ˆ2,2).ˆ0.5;
15 %choose the source centre position with minimun distance to ...
the CoM of the
16 %whole image
17 SP Inf7=pp(M dd==min(M dd),:);
18 end
